Dictyostelium Mutants

Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0350059	mcln-	mcln	aberrant cellular response to fluid shear stress \| increased growth rate \| aberrant post-lysosomal vacuole exocytosis
DBS0351382	myoB-/ [act15]: GFP: myoB(1-921,1057-1111)	myoB	abolished protein localization to actin wave
DBS0350826	pinA-	pinA	decreased growth rate \| decreased mound size \| decreased sporulation
DBS0235412	1C7	gp130	decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0238601	5NT-	5nt	delayed development of tipped mound \| increased number of mound tips \| increased number of early culminant tips
DBS0235584	CF45-1-	cf45-1	increased mound size \| increased glucose level \| decreased mound size \| decreased cell motility \| increased cell-cell adhesion
DBS0235585	CF50-	cf50-1 \| cf50-2	decreased response to Gram-negative bacterium \| decreased response to Gram-positive bacterium \| increased mound size \| increased cell-cell adhesion \| increased prespore gene expression \| increased protein level \| decreased protein secretion
DBS0235596	ChLim-	ChLim	increased growth rate \| increased phagocytosis
DBS0351197	D2B-	D2B	aberrant chemotaxis to cAMP
DBS0235659	DD3-3-	DD3-3	decreased gene expression \| precocious aggregation
DBS0236049	DDB_G0268012-	DDB_G0268012	wild type
DBS0236046	DDB_G0268158-	DDB_G0268158	wild type
DBS0236039	DDB_G0268678-	DDB_G0268678	wild type
DG1007	DDB_G0269232-	DDB_G0269232	abolished culmination
DBS0236025	DDB_G0270366-	DDB_G0270366	wild type
DBS0236026	DDB_G0270368-	DDB_G0270368	wild type
DBS0236036	DDB_G0270744-	DDB_G0270744	wild type
DBS0351081	DDB_G0272538-	DDB_G0272538	delayed aggregation \| increased cell-substrate adhesion
LAS29	DDB_G0273201-	DDB_G0273201	decreased socially cooperative development
LAS8	DDB_G0273809-	zplC-1 \| zplC-2	decreased socially cooperative development
LAS43	DDB_G0274429-	DDB_G0274429	decreased socially cooperative development
DBS0351079	DDB_G0274679-	DDB_G0274679	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236043	DDB_G0276221-	fam21	wild type
DBS0236042	DDB_G0276689-	DDB_G0276689	wild type
DBS0236041	DDB_G0277179-	DDB_G0277179	wild type
LAS26	DDB_G0277239-	DDB_G0277239	decreased socially cooperative development
DBS0236045	DDB_G0277575-	DDB_G0277575	wild type
DBS0236044	DDB_G0278315-	DDB_G0278315	wild type
LAS34	DDB_G0278585-	DDB_G0278585	decreased socially cooperative development
DBS0236038	DDB_G0279005-	cnot11	wild type
DBS0236032	DDB_G0279163-	DDB_G0279163	wild type
DBS0236033	DDB_G0279163-	DDB_G0279163	wild type
LAS70	DDB_G0279405-	DDB_G0279405	decreased socially cooperative development
DBS0236028	DDB_G0279609-	DDB_G0279609	wild type
DBS0236029	DDB_G0279609-	DDB_G0279609	wild type
LAS103	DDB_G0280089-	DDB_G0280089	decreased socially cooperative development
LAS54	DDB_G0280299-	DDB_G0280299	decreased socially cooperative development
DBS0236035	DDB_G0280481-	DDB_G0280481	wild type
DBS0351082	DDB_G0281485-	DDB_G0281485	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0351080	DDB_G0281497-	DDB_G0281497	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236019	DDB_G0281735-	DDB_G0281735	wild type
DBS0236020	DDB_G0281735-	DDB_G0281735	wild type
LAS92	DDB_G0283373-	DDB_G0283373	decreased socially cooperative development
LAS106	DDB_G0283595-	DDB_G0283595	decreased socially cooperative development
DBS0351085	DDB_G0284955-	DDB_G0284955	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
LAS3	DDB_G0287153-	DDB_G0287153	decreased socially cooperative development
LAS10	DDB_G0288547-	DDB_G0288547	decreased socially cooperative development
LAS9	DDB_G0289789-	DDB_G0289789	decreased socially cooperative development
DBS0236027	DDB_G0290225-	DDB_G0290225	wild type
DBS0351086	DDB_G0290519-	DDB_G0290519	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
LAS7	DDB_G0290685-	DDB_G0290685	decreased socially cooperative development
DG1003	DDB_G0291992-	DDB_G0291992	aberrant late culminant morphology
LAS39	DDB_G0292148-	DDB_G0292148	decreased socially cooperative development
DBS0236037	DDB_G0292186-	DDB_G0292186	wild type
DBS0350073	DDB_G0293074-	DDB_G0293074	decreased spore germination \| delayed aggregation
DBS0351083	DDB_G0293098-	DDB_G0293098	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236023	DDB_G0293116-	DDB_G0293116	wild type
DBS0236024	DDB_G0293116-	DDB_G0293116	wild type
DBS0350516	DDB_G0293356-	DDB_G0293356	decreased defense response to Gram-negative bacterium
DBS0236030	DDB_G0293762-	DDB_G0293762	wild type
DG1039	DG1039-	DDB_G0284037	aberrant fruiting body morphogenesis
DG1040	DG1040-	DDB_G0276029	aberrant fruiting body morphogenesis
DG1041	DG1041-	DDB_G0269126	aberrant fruiting body morphogenesis
DG1054	DG1054-	DDB_G0277719	aberrant fruiting body morphogenesis
DG1060	DG1060-	DDB_G0281953	aberrant fruiting body morphogenesis
DG1062	DG1062-	cdl1A	aberrant fruiting body morphogenesis
DG1074	DG1074-	DDB_G0272108	aberrant fruiting body morphogenesis
DG1080	DG1080-	DDB_G0281559	aberrant fruiting body morphogenesis
DG1091	DG1091-	DG1091	decreased fruiting body size
DG1098	DG1098-	DG1098	decreased fruiting body size
DG1104	DG1104-	DDB_G0283535	abolished aggregation
DG1106	DG1106-	keaA	abolished aggregation
DG1110	DG1110-	DDB_G0269128	aberrant fruiting body morphogenesis
DG1112	DG1112-	DG1112	decreased stalk width
DG1113	DG1113-	DG1113	increased stalk length
DG1122	DG1122-	DG1122	aberrant fruiting body morphogenesis
DG1124	DG1124-	DG1124	development arrests at loose mound stage
DG2033	DG2033-	DG2033	development arrests at mound stage
DG2044	DG2044-	DG2044	development arrests at loose mound stage
DBS0266700	Dd5P1-	Dd5P1	increased chemotaxis to cAMP \| decreased phagocytosis
DBS0235660	Dd5P2-	Dd5P2	increased chemotaxis to cAMP \| increased actin filament polymerization
DBS0266702	Dd5P3-	Dd5P3	wild type
DBS0266692	Dd5P4-	Dd5P4	increased protein localization \| increased protein phosphorylation \| increased contractile vacuole size \| decreased defense response to Gram-negative bacterium \| increased number of mound tips \| aberrant contractile vacuole discharge \| decreased growth rate \| decreased phagocytosis \| decreased engulfment during phagocytosis \| aberrant endosome morphology \| aberrant vacuole organization \| decreased protein localization \| increased cell motility \| increased activation of GTPase activity
DBS0266693	Dd5P4-/ [act15]: Dd5P4	Dd5P4	wild type
DBS0266719	Dd5P4-/ [act15]: Dd5P4: GFP	Dd5P4	wild type
DBS0266695	Dd5P4-/ [act15]: GAP5P4	Dd5P4	increased number of mound tips \| decreased growth rate
DBS0351414	Dd5P4-/ [act15]: GFP: Dd5P4(D319G)	Dd5P4	increased contractile vacuole size \| aberrant contractile vacuole discharge \| aberrant protein localization to contractile vacuole
DBS0266720	Dd5P4-/ [act15]: Hs-OCRL	Dd5P4	decreased phagocytosis
DBS0266721	Dd5P4-/ [act15]: Hs-OCRL(D422A)	Dd5P4	decreased phagocytosis
DBS0266694	Dd5P4-/ [act15]: cat5P4	Dd5P4	increased number of mound tips \| decreased growth rate
DBS0351050	DidioMp27-	DidioMp27	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
DBS0351049	DidioMp36-	DidioMp36	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
DBS0236015	GEG04K11 (tmcB- in KAX3)	tmcB	decreased macrocyst size \| aberrant macrocyst formation
DBS0236017	GEG10K23 (tmcC- in KAX3)	tmcC	aberrant macrocyst formation
DBS0302615	GFP: phgA(1-274: 283-438)/ phgA-	phgA	aberrant hypotonic response
DBS0302614	GFP: phgA/ phgA-	phgA	wild type
DBS0236085	GP138C-	cfrC	wild type
AP1	HSPC300-	hspc300	aberrant cytokinesis
AP2	HSPC300-	hspc300	decreased actin filament polymerization \| decreased cell motility \| decreased vegetative cell size \| decreased phototaxis \| decreased pseudopodium size
DBS0351312	HSPC300-/ [act15]: abpB(129-295)	abpB \| hspc300	aberrant cellular process
HTY506	HTY506	pkaR	aberrant spore morphology \| precocious sporulation \| aberrant fruiting body morphogenesis \| decreased actin phosphorylation \| precocious development \| decreased cAMP level \| decreased sporulation
DBS0236426	I6KA-	I6KA	aberrant cellular homeostasis \| aberrant inositol phosphate metabolic process \| increased growth rate
DBS0236840	R7	nosA	development arrests at mound stage
DBS0304456	[AS]alrA/ gcsA-	alrA \| gcsA	aberrant cellular metabolic process \| increased gene expression \| decreased growth rate \| mitotic G1 phase arrest
DBS0236827	[AS]proA/ proB-	proA \| proB	decreased exocytosis \| decreased pinocytosis \| aberrant exocytosis \| increased actin filament polymerization \| development arrests at slug stage \| aberrant cytokinesis \| decreased cell motility \| abolished vegetative growth \| decreased secretion of lysosomal enzymes \| increased phagocytosis
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA \| proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA \| proB	wild type
DBS0302658	[act15]: cnrN: myc/ smlA-	cnrN \| smlA	decreased fruiting body size
DBS0304457	[act15]: sodA/ gcsA-	gcsA \| sodA	wild type
DBS0304460	[act]: alrA/ gcsA-	alrA \| gcsA	wild type
DBS0235407	[carA]: carA(1-317)	carA-1 \| carA-2	delayed development
DBS0350696	[pkaC]: pkaC/ srfA-	pkaC \| srfA	aberrant spore coat morphology \| aberrant gene expression
DBS0351463	[tet]rasD(G12T)/ rigA-	rasD \| rigA	wild type
HAD186	aarA-	aarA	aberrant stalk morphogenesis \| aberrant Golgi localization \| aberrant epithelium-like organization \| decreased prespore gene expression \| aberrant centrosome localization \| aberrant stalk development \| aberrant establishment or maintenance of cell polarity \| decreased sporulation
DBS0349920	aarA-/ [act15]: GFP-mhcA	aarA	aberrant stalk morphogenesis \| aberrant protein localization
DBS0351078	abcG6-	abcG6	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0266687	abiA-	abiA	abolished protein localization to pseudopodium \| decreased protein level \| aberrant cytokinesis \| decreased growth rate \| decreased chemotaxis to folate
DBS0266688	abiA-	abiA	abolished protein localization to pseudopodium
DBS0351531	abiA-/ AX2	abiA	abolished protein localization to pseudopodium \| decreased migratory slug size \| aberrant filopodium formation \| aberrant macropinocytosis \| decreased cell motility \| aberrant pseudopodium formation \| decreased fruiting body size
DBS0350386	abiA-/ abiA(45-136)	abiA	decreased protein level \| aberrant cytokinesis
DBS0350384	abiA-/ abiA(45-332)	abiA	aberrant cytokinesis
DBS0351065	abnC-	abnC	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0235459	abpA-	abpA	aberrant hyperosmotic response
DBS0305672	abpB-	abpB	increased filopodium formation
HG1264	abpC-	abpC	aberrant actin cytoskeleton organization
DBS0350936	abpC-	abpC	aberrant cortical actin cytoskeleton organization \| decreased phagocytosis \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant pseudopodium formation \| decreased establishment of cell polarity
DBS0236077	abpC-	abpC	decreased response to Gram-negative bacterium \| aberrant thermotaxis \| aberrant cortical actin cytoskeleton organization \| decreased cell motility \| aberrant phototaxis \| decreased establishment of cell polarity \| aberrant actin filament polymerization
DBS0237938	abpC-/ [act15]: GFP: abpC(9-148)	abpC	aberrant phototaxis
DBS0235426	abpC-/ [act15]: abpC	abpC	wild type
DBS0350938	abpC-/ [act15]: abpC	abpC	wild type
DBS0237945	abpC-/ [act15]: abpC(1-348: 449-857): GFP	abpC	aberrant phototaxis \| aberrant actin filament organization
DBS0237946	abpC-/ [act15]: abpC(1-556: 644-857): GFP	abpC	aberrant phototaxis \| aberrant actin filament organization
DBS0237941	abpC-/ [act15]: abpC(1-739): GFP	abpC	aberrant phototaxis
DBS0351553	abpC-/ [act15]: qkgA(425-1553)	abpC \| qkgA-1 \| qkgA-2	aberrant actin filament polymerization
DBS0237949	abpC-/ [cotB]: abpC: GFP	abpC	aberrant phototaxis
DBS0237948	abpC-/ [ecmA]: abpC: GFP	abpC	wild type
DBS0235427	abpD-	abpD	decreased cell-cell adhesion \| decreased spore germination \| aberrant sorocarp development \| delayed development
DBS0235428	abpE-	abpE-1 \| abpE-2	increased lateral pseudopodium formation
DBS0349851	abpE-	abpE-1 \| abpE-2	aberrant phagosome maturation \| precocious phagosome acidification \| increased phagocytosis
DBS0349852	abpE-/ [act15]: abpE	abpE-1 \| abpE-2	decreased phagocytosis
DBS0350529	abpG-	abpG	increased actin filament polymerization \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0235562	acaA-	acaA	abolished stream development \| abolished gene expression \| abolished establishment of cell polarity \| decreased gene expression \| increased cellular thermotolerance \| abolished aggregation \| decreased adenylate cyclase activity \| decreased cAMP level
GP6	acaA-	acaA	increased lateral pseudopodium formation \| decreased chemotaxis rate \| aberrant actin filament organization \| aberrant cell morphology \| increased protein kinase activation
DBS0235429	acaA-	acaA	decreased gene expression \| abolished oscillatory cAMP signaling
DBS0350720	acaA-/ [acaA-agg]: acaA: myc	acaA	decreased gene expression \| decreased fruiting body size
DBS0350721	acaA-/ [acaA-psp]: acaA: myc	acaA	decreased gene expression \| decreased mound size \| decreased fruiting body size
DBS0350722	acaA-/ [acaA-pst]: acaA: myc	acaA	wild type
DBS0350702	acaA-/ [act15]: HA: pkaC	acaA \| pkaC	wild type \| delayed development \| decreased cAMP level
DBS0350737	acaA-/ [act15]: acaA	acaA	aberrant slug development
DBS0350738	acaA-/ [act15]: acaA(1-390;398-1407)	acaA	abolished aggregation
DBS0350739	acaA-/ [act15]: acaA(L394T/ K482N)	acaA	wild type
DBS0350603	acaA-/ [act15]: cap: GFP	acaA \| cap	development arrests at loose mound stage \| increased calcium-dependent cell-cell adhesion \| wild type
DBS0350735	acaA-/ [act15]: pkaR(G135E/ G261A)	acaA \| pkaR	increased cAMP level
DBS0350736	acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T)	acaA	decreased gene expression \| abolished oscillatory cAMP signaling \| decreased cAMP level
DBS0350734	acaA-/ [unk]: acaA(N333D,G633S)	acaA	abolished adenylate cyclase activity
DBS0350733	acaA-/ [unk]: acaA(V427I,S642F)	acaA	abolished activation of adenylate cyclase activity
DBS0350711	acaA-/ [unk]: acgA	acaA \| acgA	aberrant sorocarp development
DBS0306125	acapA-	acapA	wild type
DBS0350051	acapA-	acapA	aberrant exocytosis \| aberrant filopodium formation \| increased defense response to Gram-negative bacterium \| aberrant endocytosis \| aberrant cytokinesis \| aberrant stream morphology \| decreased cell motility \| delayed development \| aberrant lysosome organization
DBS0350055	acapA-/ [act15]: acapA(R633Q): GFP	acapA	aberrant filopodium formation \| aberrant lysosome organization
DBS0350054	acapA-/ [act15]: acapA: GFP	acapA	increased filopodium formation
DBS0306127	acapB-	acapB	wild type
TL177	acbA-	acbA	decreased response to Gram-negative bacterium \| abolished cell migration to prestalk region \| abolished spore cell differentiation \| decreased sporulation \| decreased resistance to cisplatin
DBS0350194	acbA-/ [act15]: acbA(Y72A)	acbA	abolished spore cell differentiation
DBS0235440	acgA-	acgA	abolished polyketide metabolic process \| decreased spore germination \| decreased spore cell differentiation \| precocious spore germination \| abolished response to biotic stimulus
DBS0237788	acgA-	acgA	decreased prespore cell differentiation \| decreased prespore gene expression
DBS0237790	acgA-/ [acrA]: lacZ	acgA \| acrA	aberrant prestalk gene expression
DG1100	acrA-	acrA	decreased gene expression \| increased stalk length \| decreased prespore gene expression \| decreased sporulation
DBS0349939	acrA-	acrA	aberrant spore coat morphology \| decreased stalk width
DBS0350723	acrA-/ [act15]: acaA(L394S)	acaA \| acrA	precocious spore germination
DBS0237786	acrA-/ [act15]: acgA(1-401)	acgA \| acrA	decreased prespore gene expression \| decreased prespore cell differentiation \| decreased sporulation
DBS0349970	acrA-/ [act15]: acrA(D1010A)	acrA	decreased adenylate cyclase activity
DBS0349971	acrA-/ [act15]: acrA(D1174A)	acrA	increased adenylate cyclase activity
DBS0349969	acrA-/ [act15]: acrA(N796D/ D854A/ G856A)	acrA	wild type
DBS0350724	acrA-/ [pkaC]: pkaC	acrA \| pkaC	decreased spore germination \| decreased fruiting body size \| precocious development \| decreased sporulation
DBS0350443	adcB-	adcB	wild type
DBS0350444	adcC-	adcC	wild type
DBS0351190	adcC-/ [act15]: adcC(1-485)	adcC	decreased protein localization to plasma membrane
DBS0351189	adcC-/ [act15]: adcC(101-654): GFP	adcC	abolished protein localization to plasma membrane
DBS0350538	adprt1A-	adprt1A	decreased resistance to phleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0351248	adprt1A-	adprt1A	decreased gene expression \| increased gene expression \| decreased ATP level \| delayed mitotic cell cycle \| decreased growth rate \| delayed aggregation \| increased prestalk gene expression \| decreased mound size \| aberrant response to oxidative stress \| decreased fruiting body size \| increased mitochondrial fission \| decreased cAMP level \| abolished chemotaxis to cAMP
DBS0264268	adprt1B-	adprt1B	wild type \| decreased single-strand break repair \| aberrant oscillatory cAMP signaling
DBS0350539	adprt2-	adprt2	decreased single-strand break repair \| decreased double-strand break repair \| decreased resistance to cisplatin
DBS0238203	adrm1-	adrm1-1	decreased catalytic activity \| precocious gene expression \| aberrant response to nutrient \| precocious development
DBS0351596	agnA-	agnA	increased pre-miRNA processing \| aberrant production of siRNA involved in RNA interference \| increased gene expression \| abolished transitive RNA interference
DBS0351602	agnB-	agnB	decreased gene expression
HW420	agtA-	agtA	development arrests at slug stage
DBS0235457	ahhA-	ahhA	aberrant late culminant morphology
DBS0252637	aip1-	aip1	decreased pinocytosis \| delayed cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased actin filament polymerization \| aberrant nucleus morphology \| decreased cell motility
DBS0266759	alp-	alp	wild type
DBS0235513	alrA-	alrA	increased mound size \| decreased cell motility \| decreased glucose level \| decreased protein secretion
DBS0235473	alrA-/ [act15]: alrA	alrA	wild type
DBS0235474	alxA-	alxA	development arrests at loose mound stage \| aberrant standing slug morphology \| decreased growth rate
DBS0235475	alxA-	alxA	abolished sporulation \| aberrant standing slug morphology \| aberrant cellular process \| decreased gene expression \| development arrests at mound stage
DBS0235488	alxA-/ [act15]: FLAG: alxA	alxA	delayed development
DBS0235476	alxA-/ [act15]: alxA(1-596): myc2	alxA	aberrant standing slug morphology
DBS0235477	alxA-/ [act15]: alxA(1-697): myc2	alxA	wild type
DBS0235478	alxA-/ [act15]: alxA(155-697): myc2	alxA	aberrant standing slug morphology
DBS0235479	alxA-/ [act15]: alxA(293-697): myc2	alxA	aberrant standing slug morphology
DBS0235480	alxA-/ [act15]: alxA(460-794): myc2	alxA	aberrant standing slug morphology
DBS0235481	alxA-/ [act15]: alxA(D310A/ N311A)	alxA	wild type
DBS0235482	alxA-/ [act15]: alxA(Q181E/ Q183)	alxA	wild type
DBS0235483	alxA-/ [act15]: alxA(S700A/ S704A/ S708A)	alxA	wild type
DBS0235484	alxA-/ [act15]: alxA(S700D/ S704D/ S708D)	alxA	wild type
DBS0235485	alxA-/ [act15]: alxA(Y315D)	alxA	wild type
DBS0235486	alxA-/ [act15]: alxA(Y315F)	alxA	wild type
DBS0235487	alxA-/ [act15]: alxA: myc2	alxA	wild type
DBS0235489	alyA-	alyA	increased phagocytosis
AK1350	alyL-	alyL	decreased response to Gram-negative bacterium
DG1114	amdA-	amdA	decreased spore germination \| aberrant sorus color \| increased prestalk A cell differentiation
HM1158	amdA-	amdA	decreased fruiting body size \| decreased sporulation \| increased cell differentiation
DBS0235490	amiB-	amiB	abolished aggregation
DBS0235491	amiB-	amiB	aberrant cell motility \| increased gene expression \| decreased gene expression \| decreased oscillatory cAMP signaling \| decreased cGMP-mediated signaling \| abolished aggregation \| decreased chemotaxis to cAMP
DBS0235493	ampA-	ampA	delayed development of tipped mound \| delayed prestalk gene expression \| precocious prespore gene expression \| increased cell-cell adhesion \| increased cell-substrate adhesion \| aberrant gene expression \| delayed development \| decreased prestalk cell differentiation
DBS0349962	ampA-	ampA	wild type \| decreased actin filament polymerization \| aberrant chemotaxis to folate \| increased cell-substrate adhesion \| decreased pseudopodium formation
DBS0235496	ampA-/ pspD: lacZ	ampA	aberrant prespore gene expression
DBS0349952	ampA/ [ampA]: ampA/ lmbd2B-	ampA \| lmbd2B	aberrant chemotaxis
BS155	amtA-	amtA	decreased slug migration \| decreased mound size \| decreased fruiting body size \| increased growth rate \| decreased ammonia level
DBS0267100	amtA-	amtA	increased number of mounds \| increased glucose level \| decreased mound size \| decreased ammonia level \| decreased stalk length \| aberrant sporulation \| increased intracellular ammonia level
DBS0267101	amtA-/ [OE]: amtA	amtA	wild type
	amtB-	amtB
BS154	amtC-	amtC	abolished protein localization to nucleus \| development arrests at slug stage \| aberrant gene expression \| decreased prestalk gene expression \| aberrant fruiting body morphogenesis \| decreased ammonia level \| delayed culmination
DBS0235501	amtC-/ [act15]: cudA	amtC \| cudA	delayed culmination
DBS0235502	amtC-/ [ecmA]: cudA	amtC \| cudA	delayed culmination
DBS0235503	amtC-/ [pspA]: cudA	amtC \| cudA	development arrests at slug stage
DBS0350432	aoxA-	aoxA	decreased resistance to hydrogen peroxide \| aberrant cellular process \| aberrant sorocarp development
DBS0349869	ap1b1-	ap1b1	aberrant aggregation \| aberrant cell separation during cytokinesis \| aberrant contractile vacuole organization \| decreased growth rate \| aberrant hypotonic response \| decreased protein stabilization
DBS0305197	ap2a1-	ap2a1-1 \| ap2a1-2	aberrant cell separation during cytokinesis
DBS0350296	aph1-	aph1	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0351357	aph1-	aph1	increased protein modification \| decreased phagocytosis \| decreased macropinocytosis \| aberrant sorocarp development \| decreased protein processing in phagocytic vesicle \| delayed phagosome acidification
DBS0350805	apl-	apl	aberrant response to cisplatin
DBS0351160	aplD-	aplD	decreased defense response to Gram-negative bacterium \| decreased growth rate
DBS0351161	aplP-	aplD	decreased growth rate
DBS0235505	apm1-	apm1	decreased spore germination \| aberrant contractile vacuole organization \| decreased growth rate \| aberrant endosome morphology \| aberrant hypotonic response \| delayed development \| decreased stalk width
DBS0235506	apm2-	apm2	aberrant cell separation during cytokinesis
DBS0305085	apm2-/ [dscB]: GFP: vamp7A	apm2 \| vamp7A	increased protein localization to plasma membrane
DBS0235507	apm3-	apm3	decreased pinocytosis \| increased exocytosis \| aberrant endosome morphology \| decreased cellular localization \| aberrant secretion \| aberrant lysosome organization
DBS0305083	apm3-/ [dscB]: GFP: vamp7A	apm3 \| vamp7A	increased protein localization to plasma membrane
DBS0235508	apm4-	apm4	wild type
DBS0235509	aprA-	aprA	aberrant cellular homeostasis \| increased mound size \| decreased spore germination \| increased cell death \| aberrant cytokinesis \| aberrant vegetative growth \| aberrant fruiting body morphogenesis \| increased growth rate \| abolished chemorepellant activity \| decreased sporulation
DBS0235510	aprA-/ [act15]: aprA	aprA	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0350009	aprA-/ [act15]: bzpN: GFP	aprA \| bzpN	abolished negative regulation of vegetative growth
DBS0238124	aqpA-	aqpA	decreased spore germination \| decreased sporulation
DBS0351484	aqpB-	aqpB	decreased cell motility
DBS0351067	araA-	araA	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0350886	areA-	areA	increased autophagy
DBS0350887	areB-	areB	increased autophagy
DBS0235511	arkA-	arkA	increased gene expression \| aberrant fruiting body morphogenesis
DBS0350191	arpin-	arpin	increased cell motility
DBS0350206	arpin-/ [act15]: GFP: arpin	arpin	wild type
DBS0350654	ase1A-	ase1A	aberrant mitotic spindle organization \| aberrant cytokinesis \| aberrant microtubule cytoskeleton organization
DBS0350655	ase1B-	ase1B	aberrant cell morphology
DBS0235514	aslA-	aslA-1 \| aslA-2	wild type
DBS0351219	ate1-	ate1	aberrant cell motility \| decreased cell-substrate adhesion \| decreased vegetative cell size \| aberrant actin filament organization
DBS0236305	atg1-	atg1	aberrant macroautophagy \| abolished autophagosome organization
DBS0236304	atg1-	atg1	aberrant macroautophagy \| aberrant mitochondrion morphology \| abolished autophagosome organization
DBS0350450	atg1-	atg1	aberrant autophagy \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| aberrant vacuole organization
DBS0350839	atg1-	atg1	decreased catalytic activity \| abolished protein localization to autophagosome
HR131	atg1-	atg1	abolished macroautophagy \| increased number of autophagosomes \| aberrant autophagy \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased growth rate \| abolished spore cell differentiation \| aberrant vacuole organization \| abolished stalk cell differentiation \| abolished aggregation \| increased defense response to fungus \| decreased defense response to Gram-positive bacterium \| aberrant protein localization
DBS0238085	atg1-/ [act15]: atg1	atg1	wild type
DBS0238092	atg1-/ [act15]: atg1(1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238087	atg1-/ [act15]: atg1(K36A)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238093	atg1-/ [act15]: atg1(P138S)	atg1	abolished aggregation
DBS0350884	atg101-	atg101	increased number of tip-organizers \| decreased autophagy
DBS0351232	atg12-	atg12	decreased pinocytosis \| increased cell death \| decreased spore germination \| decreased catalytic activity \| increased gene expression \| increased number of mound tips \| increased protein modification \| decreased phagocytosis \| aberrant phagosome maturation \| aberrant fruiting body morphogenesis
DBS0351233	atg12-/ tipD-	atg12 \| tipD	decreased pinocytosis \| increased cell death \| decreased spore germination \| increased gene expression \| increased number of mound tips \| increased protein modification \| decreased phagocytosis \| aberrant phagosome maturation \| aberrant fruiting body morphogenesis
DBS0350883	atg13-	atg13	aberrant autophagy \| abolished aggregation
DBS0350885	atg17-	atg17	wild type
HR75	atg5-	atg5	increased number of tip-organizers \| aberrant macroautophagy \| abolished sporulation \| aberrant cellular response to nitrogen starvation \| abolished aggregation \| aberrant protein localization
DBS0351478	atg5-	atg5	abolished sporulation \| decreased gene expression \| delayed development
DBS0351582	atg5-	atg5	increased cell death \| decreased catalytic activity \| decreased growth rate \| aberrant phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis \| increased growth rate
HR174	atg6-	atg6A	increased number of tip-organizers \| aberrant macroautophagy \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased spore cell differentiation \| decreased defense response to fungus \| decreased fruiting body size \| decreased stalk length \| decreased sporulation
HR79	atg7-	atg7	increased number of tip-organizers \| aberrant macroautophagy \| abolished sporulation \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| abolished spore cell differentiation \| aberrant protein localization
DBS0351476	atg7-	atg7	aberrant sorus morphology \| decreased spore germination \| decreased gene expression \| decreased prespore cell differentiation \| delayed development
DBS0351477	atg7-/ [act15]: YFP: atg7(C563A)	atg7	aberrant sorus morphology \| decreased spore germination \| delayed development
DBS0351479	atg7-/ [act15]: pkaC: YFP	atg7 \| pkaC	decreased gene expression \| decreased sporulation
HR141	atg8-	atg8a	increased number of tip-organizers \| aberrant macroautophagy \| aberrant spore morphology \| aberrant cellular response to nitrogen starvation \| decreased spore cell differentiation \| aberrant vacuole organization \| decreased fruiting body size \| decreased defense response to Gram-positive bacterium \| decreased sporulation
DBS0351222	atg8a-	atg8a	increased cell death \| decreased catalytic activity \| increased number of mound tips \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| delayed development \| decreased fruiting body size \| aberrant lysosome organization
DBS0351223	atg8b-	atg8b	precocious development \| aberrant lysosome organization
DBS0305977	atg9-	atg9	increased stalk width \| decreased pinocytosis \| abolished sporulation \| aberrant sorus morphology \| aberrant autophagy \| decreased protein localization to autophagosome \| increased number of mound tips \| decreased gene expression \| decreased phagocytosis \| decreased growth rate \| abolished catalytic activity \| aberrant slug development \| aberrant slug migration \| aberrant protein modification \| aberrant phagosome maturation \| decreased prespore cell differentiation \| aberrant fruiting body morphogenesis \| delayed development \| abolished phototaxis
DBS0350535	atg9-/ [act15]: cdcD(R154C): RFP	atg9 \| cdcD	decreased growth rate \| decreased phototaxis
DBS0351589	atg9-/ [act15]: cdcD(R154C/ E219K): RFP	atg9 \| cdcD	wild type
DBS0350534	atg9-/ [act15]: cdcD: RFP	atg9 \| cdcD	decreased growth rate \| aberrant fruiting body morphogenesis \| abolished phototaxis
DBS0351480	atg9-/ [act15]: pkaC: YFP	atg9 \| pkaC	abolished sporulation
DBS0351043	atp1-	atp1	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
DBS0351044	atp6-	atp6	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
HM1591	axeB-	axeB	aberrant macropinocytosis \| increased macropinocytosis \| increased phagocytosis
DBS0351503	bcas3-	bcas3	decreased number of autophagosomes \| aberrant fruiting body morphogenesis \| aberrant phototaxis \| decreased sporulation
DBS0351039	bzpF-	bzpF	decreased spore germination \| decreased gene expression \| aberrant fruiting body morphogenesis \| aberrant sporulation \| decreased sporulation
DBS0349965	bzpN-	bzpN	aberrant cytokinesis \| abolished negative regulation of vegetative growth \| increased growth rate
DBS0350419	bzpR-	bzpR	increased stalk width \| aberrant sorus morphology \| decreased sporulation
DBS0351486	c2gapB-	c2gapB	increased cell motility \| increased activation of GTPase activity
DBS0351619	cadA-	cadA	aberrant vegetative growth
TL97	cadA-	cadA	increased number of tip-organizers \| decreased calcium-dependent cell-cell adhesion \| decreased protein level \| increased gene expression \| abolished cell migration to prestalk region \| increased chemotaxis to cAMP \| aberrant cytokinesis \| decreased sporulation \| delayed culmination \| increased prestalk cell differentiation
DBS0351372	cadA-	cadA	aberrant defense response to bacterium \| decreased growth rate \| aberrant response to oxidative stress
JB4	carA-	carA-1 \| carA-2	abolished aggregation
JS14	carA-	carA-1 \| carA-2	abolished protein tyrosine phosphorylation \| abolished protein localization to nucleus \| aberrant phagocytosis \| increased cell-substrate adhesion \| decreased oscillatory cAMP signaling \| decreased cGMP-mediated signaling \| aberrant regulation of GTPase activity \| abolished aggregation \| aberrant regulation of protein kinase activity \| abolished chemotaxis to cAMP
DBS0351266	carA-/ [act15]: gpbA: YFP	carA-1 \| carA-2 \| gpbA	abolished aggregation
DBS0350431	carA-/ [unk]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A): eYFP	carA-1 \| carA-2	aberrant adaptation of signaling pathway \| aberrant protein localization to plasma membrane
DBS0235570	carB-	carB	development arrests at mound stage
DBS0350661	carB-	carB	development arrests at mound stage \| abolished development of tipped mound \| increased prespore gene expression \| decreased prestalk gene expression
JB6	carC-	carC	wild type
DBS0235568	carD-	carD	decreased migratory slug size \| decreased slug migration \| increased prespore gene expression \| decreased prestalk gene expression \| aberrant slug migration \| aberrant fruiting body morphogenesis \| decreased stalk length \| decreased prestalk cell differentiation
DBS0235573	carmil-	carmil	decreased pinocytosis \| decreased actin filament polymerization \| decreased growth rate \| decreased mound size
IR40	catA-	catA	abolished catalase activity
IR41	catA-	catA	abolished catalase activity
IR29	catA-	catA	decreased resistance to hydrogen peroxide
DBS0235574	catB-	catB	decreased spore resistance to hydrogen peroxide \| aberrant gene expression \| delayed development \| delayed gene expression
DBS0350249	cbhA-	cbhA	delayed development
DBS0350250	cbhA-/ [cbhA]: cbhA	cbhA	wild type
DBS0304455	cblA-	cblA-1 \| cblA-2	aberrant slug development \| abolished basal disc formation \| aberrant signal transduction
DBS0351096	cbpG-	cbpG	decreased cell-substrate adhesion \| decreased vegetative cell size
DBS0235575	cbpJ-	cbpJ	wild type
DBS0350238	ccdc53-	ccdc53	abolished exocytosis \| decreased growth rate \| abolished phagosome reneutralization \| abolished actin filament polymerization
DBS0235661	cdk8-	cdk8	decreased gene expression \| aberrant gene expression \| abolished aggregation
DBS0350435	cdk8-	cdk8	decreased spore germination \| decreased gene expression \| aberrant gene expression \| abolished aggregation
DBS0350436	cdk8-/ [act15]: myc: cdk8	cdk8	wild type
DBS0350437	cdk8-/ [act15]: myc: cdk8(D194A)	cdk8	decreased spore germination \| abolished aggregation
DBS0235578	cdk8-/ [cdk8]: cdk8	cdk8	wild type
DBS0306226	cenB-	cenB	increased number of centrosomes \| aberrant cell separation during cytokinesis \| aberrant nuclear envelope morphology \| abolished protein localization to microtubule organizing center \| aberrant nucleus morphology \| aberrant cytokinesis \| decreased microtubule nucleation \| aberrant centrosome organization
DBS0306227	cenB-/ [act15]: RFP: cenB	cenB	wild type
DBS0349926	cepC-	cepC	aberrant mitotic spindle organization \| decreased growth rate \| aberrant Golgi localization \| abolished vegetative growth \| aberrant centrosome organization
DBS0350265	cepK-	cepK	decreased protein level \| decreased protein localization to nuclear envelope \| aberrant chemotaxis to cAMP \| decreased growth rate \| decreased mound size \| decreased vegetative cell size \| decreased fruiting body size
DBS0302444	cfaD-	cfaD	aberrant cellular homeostasis \| increased cell death \| decreased spore germination \| aberrant vegetative growth \| aberrant cytokinesis \| aberrant fruiting body morphogenesis \| increased growth rate \| decreased sporulation
DBS0350010	cfaD-/ [act15]: bzpN: GFP	bzpN \| cfaD	abolished negative regulation of vegetative growth
DBS0302446	cfaD-/ [act15]: cfaD	cfaD	wild type
HO101	chcA-	chcA	decreased pinocytosis \| delayed cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate
HO103	chcA-	chcA	abolished sporulation \| abolished cytokinesis \| abolished gene expression \| delayed aggregation \| abolished vegetative growth \| aberrant fruiting body morphogenesis
DBS0350090	chcA-/ [act15]: GFP: ap2a1	ap2a1-1 \| ap2a1-2 \| chcA	increased protein localization
DBS0235588	chcA-/ [act15]: GFP: mhcA	chcA \| mhcA	decreased positive regulation of GTPase activity
DBS0302455	chcA-/ [act15]: epnA: GFP	chcA \| epnA	aberrant protein localization to clathrin-coated pit
DBS0350091	chcA-/ [act15]: gppA: GFP	chcA \| gppA	aberrant protein localization to plasma membrane
DBS0235589	chcA-/ [cotB]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235590	chcA-/ [ecmA]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235591	chcA-/ [ecmB]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235592	chcA-/ [pspA]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0350524	chdA-	chdA	aberrant culmination \| aberrant gene expression \| decreased chemotaxis to cAMP
DBS0350525	chdB-	chdB	aberrant gene expression \| delayed development
DBS0350526	chdC-	chdC	decreased growth rate \| development arrests at mound stage \| aberrant gene expression \| aberrant chromatin assembly \| decreased chemotaxis to cAMP
DBS0350528	chdC-/ [ecmA]: lacZ	chdC	decreased prestalk cell differentiation
DBS0350527	chdC-/ [pspA]: lacZ	chdC	decreased prespore cell differentiation
HM1522	chlA-	chlA	abolished DIF-1 biosynthesis \| aberrant slug development \| aberrant fruiting body morphogenesis
LAS1	chtB-	chtB	decreased socially cooperative development \| increased growth rate
CCR2	chtC-	chtC	decreased socially cooperative development \| decreased prestalk A cell differentiation
LAS5	chtC-REMI	chtC	decreased socially cooperative development
DBS0235601	clc-	clc	abolished cytokinesis \| decreased protein localization to plasma membrane \| aberrant hypotonic response \| abolished vegetative growth \| aberrant fruiting body morphogenesis
DBS0235604	clc-/ [act15]: GFP-clc(146-194)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0235605	clc-/ [act15]: GFP-clc(85-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0235607	clc-/ [act15]GFP: clc(1-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0350408	cldA-	cldA	decreased gene expression
AK1338	clkB-	clkB	decreased response to Gram-negative bacterium
DBS0235608	clmA-	clmA	aberrant contractile vacuole morphology \| aberrant hypotonic response
DBS0350473	cln3-	cln3	aberrant aggregation \| increased protein secretion \| aberrant cell separation during cytokinesis \| decreased hypotonic response \| aberrant cellular process \| increased pinocytosis \| delayed aggregation \| aberrant cell adhesion \| aberrant slug migration \| aberrant hyperosmotic response \| precocious development \| increased growth rate \| decreased chemotaxis to cAMP \| decreased protein secretion
DBS0350474	cln3-/ [act15]: GFP: cln3	cln3	wild type
DBS0351175	cln5-	cln5	decreased cell-cell adhesion \| aberrant lipid storage \| decreased cell-substrate adhesion \| decreased chemotaxis to cAMP
DBS0235609	cluA-	cluA	decreased mitochondrial fusion \| decreased mitochondrial fission \| aberrant cytokinesis \| aberrant intracellular distribution of mitochondria \| aberrant mitochondrion organization
DBS0349875	cluA-/ [act15]: cluA	cluA	wild type
DBS0235612	cmfB-	cmfB	decreased gene expression \| abolished aggregation
DBS0235613	cnrB-	cnrB	wild type
DBS0350308	cnrF-	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350311	cnrF-/ cnrF(E623Q/ D659Q)	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350310	cnrF-/ cnrF(R270A)	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0302655	cnrN-	cnrN	increased oscillatory cAMP signaling \| increased number of mounds \| decreased spore germination \| increased actin filament polymerization \| aberrant cytokinesis \| aberrant stream morphology \| increased growth rate \| abolished positive regulation of chemorepellant activity \| decreased sporulation
DBS0302656	cnrN-/ [act15]: cnrN	cnrN	wild type
HG1770	cnxA-	cnxA	decreased calcium ion import \| aberrant calcium-mediated signaling
DBS0235615	cofB-	cofB	wild type
DBS0235616	cofC-	cofC-1	wild type
DBS0350522	comA-	comA	aberrant defense response to bacterium \| aberrant phagocytosis \| aberrant hyperosmotic response
DG1016	comB-	comB	abolished culmination
DBS0235618	comC-	comC	aberrant aggregation \| aberrant stream morphology
DBS0235619	comD-	comD	abolished culmination
DBS0235620	comE-	comE	aberrant fruiting body morphogenesis \| aberrant sorus color
DBS0235621	comF-	comF-1 \| comF-2	abolished aggregation
DBS0235622	comG-	comG	increased number of tip-organizers \| development arrests at mound stage
DBS0235623	comH-	comH	development arrests at mound stage
HG1570	corA-	corA	increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
HG1571	corA-	corA	increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
DBS0351402	corA-	corA	aberrant actin cytoskeleton organization \| aberrant cytokinesis
HG1569	corA-	corA	decreased defense response to Gram-negative bacterium \| increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased actin filament polymerization \| decreased cell motility \| aberrant cell morphology \| decreased defense response to Gram-positive bacterium
DBS0350370	corA-	corA	decreased defense response to Gram-negative bacterium \| decreased gene expression \| aberrant chemotaxis to cAMP \| aberrant response to cAMP \| decreased phagocytosis \| aberrant cellular response to extracellular stimulus \| decreased establishment of cell polarity \| abolished aggregation
DBS0351521	corA-/ [act15]: FLAG: corA(1-432)	corA	abolished aggregation
DBS0350345	corA-/ [act15]: GFP: mhkA	corA \| mhkA	wild type
DBS0350346	corA-/ [act15]: GFP: mhkB	corA \| mhkB	wild type
DBS0350344	corA-/ [act15]: GFP: mhkC	corA \| mhkC	decreased catalytic activity \| wild type
DBS0350343	corA-/ [act15]: GFP: pakA(797-1197)	corA \| pakA	wild type
DBS0350371	corA-/ [act15]: corA	corA	wild type
DBS0350341	corA-/ [act15]: corA(I118A/ S119A/ P121A): GFP	corA	wild type \| aberrant binding \| increased myosin II assembly
DBS0305825	corB-	corB	increased lateral pseudopodium formation \| aberrant phagocytosis \| decreased growth rate \| increased cell-substrate adhesion
DBS0349942	cosA-	cosA	decreased cell motility \| decreased fruiting body size \| decreased chemotaxis to cAMP \| aberrant actin filament organization \| increased pseudopodium formation
TL55	cotA-	cotA	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL26	cotB-	cotB	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL52	cotC-	cotC	aberrant spore coat morphology
DBS0351045	cox3-	cox3	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant fruiting body morphogenesis \| aberrant phototaxis
DBS0351538	cpnA-/ AX4	cpnA	increased contractile vacuole size
DBS0238297	cpnA-/ NC4A2	cpnA	delayed hypotonic response \| increased migratory slug size \| decreased post-lysosomal vacuole size \| increased mound size \| aberrant thermotaxis \| increased contractile vacuole size \| increased exocytosis \| decreased growth rate \| aberrant cytokinesis \| aberrant stalk cell differentiation \| development arrests at slug stage \| decreased number of post-lysosomal vacuoles \| aberrant fruiting body morphogenesis \| delayed development \| abolished phototaxis
DBS0238320	cpnA-/ [act15]: GFP: cpnA	cpnA	delayed hypotonic response \| decreased culmination \| delayed development
DBS0350869	crlA-/ AX2	crlA	wild type
DBS0235627	crlA-/ KAX3	crlA	delayed development of tipped mound \| abolished polyketide metabolic process \| increased mound size \| decreased spore germination \| decreased spore cell differentiation \| decreased cell migration to prestalk region \| increased growth rate
DBS0235628	crlA-/ [crlA]: crlA	crlA	increased mound size
DBS0235629	crlB-	crlB	wild type
DBS0235630	crlC-	crlC	wild type
HG1768	crtA-	crtA	decreased calcium ion import \| aberrant calcium-mediated signaling
DBS0235633	crtf-	crtf	abolished sporulation \| decreased gene expression \| abolished aggregation
DBS0351557	cryS-	cryS	decreased pinocytosis \| decreased culmination \| decreased phagocytosis \| aberrant cytokinesis \| decreased growth rate
AX2-T10	csaA-	csaA	decreased cell-cell adhesion \| decreased culmination \| abolished protein localization to cell-cell contact zone \| delayed aggregation \| increased cell-substrate adhesion \| decreased sporulation
WTC127	cshA-	cshA	development arrests at loose mound stage \| decreased phagocytosis \| decreased growth rate \| delayed aggregation
DBS0235624	ctnA-	ctnA	increased cGMP-mediated signaling \| aberrant cellular metabolic process \| increased glucose level \| decreased protein level \| increased mound size \| decreased catalytic activity \| increased guanylyl cyclase activity \| decreased actin filament polymerization \| decreased oscillatory cAMP signaling \| increased cell-cell adhesion \| increased protein level \| increased cell motility \| decreased myosin II assembly
DBS0235636	ctnB-	ctnB	increased number of mounds \| decreased gene expression \| decreased fruiting body size
DBS0304927	ctnnA-	ctnnA	wild type
DG1071	ctr9-	ctr9	aberrant fruiting body morphogenesis
DG1058	ctrA-	ctrA	decreased fruiting body size
DBS0350915	ctsD-	ctsD	aberrant protein modification
DBS0235598	ctxA-	ctxA	aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology
HS1151	ctxA-	ctxA	aberrant cytokinesis \| decreased growth rate \| aberrant stream morphology \| aberrant cellular response to stress
DBS0237568	ctxA-/ [RNAi]enlA	ctxA \| enlA	wild type
DBS0349922	ctxA-/ [act15]: GFP-mhcA	ctxA	aberrant protein localization to basolateral plasma membrane \| aberrant stalk morphogenesis \| aberrant development of tipped mound
DBS0237536	ctxA-/ [act15]: enlA(92-497)	ctxA \| enlA	wild type
DBS0235600	ctxB-	ctxB	aberrant cytokinesis \| aberrant stream morphology \| aberrant cell morphology
DBS0350404	ctxC-	ctxC	increased pinocytosis \| decreased oscillatory cAMP signaling \| aberrant stream morphology \| decreased chemotaxis to cAMP \| increased growth rate \| increased phagocytosis
DBS0235639	cudA-	cudA	abolished sporulation \| decreased gene expression \| development arrests at slug stage \| decreased prespore gene expression \| abolished stalk cell differentiation
DBS0238017	cudA-	cudA	abolished gene expression
DBS0235640	culA-	culA	increased number of tip-organizers \| development arrests at tipped mound stage
DBS0235641	culA-/ [cotC]: culA	culA	increased sorus size \| decreased stalk length \| decreased sporulation
DBS0235642	culA-/ [ecmA]: culA	culA	increased sorus size \| decreased stalk length
DBS0235643	culA-/ [pkaC]pkaC	culA \| pkaC	wild type
DBS0266745	culB-	culB	increased number of mound tips \| precocious prestalk gene expression \| aberrant slug development \| decreased fruiting body size \| decreased sporulation
DBS0266761	culB-/ [act15]: pkaC	culB \| pkaC	abolished sporulation \| precocious prestalk gene expression \| abolished aggregation \| abolished prespore gene expression
DBS0235651	cybA-	cybA	abolished sporulation \| aberrant sorocarp development
DBS0350641	cynA-	cynA	aberrant cell motility \| decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| delayed aggregation \| aberrant cell morphology
DBS0351047	cytB-	cytB	decreased defense response to Gram-negative bacterium \| decreased gene expression \| development arrests at mound stage \| decreased growth rate \| aberrant phototaxis
AK108	dagA-	dagA	abolished gene expression \| decreased gene expression \| abolished activation of adenylate cyclase activity \| abolished aggregation \| decreased chemotaxis to cAMP
BW4	dagA-	dagA	abolished positive regulation of chemorepellant activity
DBS0235652	dagA-/ [act15]: dagA	dagA	wild type
DBS0235560	dagA-/ acaA(L394S)	acaA \| dagA	wild type
DBS0235653	darA-	darA	decreased mound size \| abolished aggregation
DBS0350531	dclre1-	dclre1	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining \| aberrant double-strand break repair via homologous recombination
DBS0236307	dcsA-	dcsA	abolished cellulose biosynthesis
DG1099	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk cell differentiation
DG1128	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis
TL127	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk cell differentiation \| aberrant stalk development
TL128	dcsA-/ [act15]: dcsA	dcsA	wild type
DBS0351195	dct-	dct	aberrant chemotaxis to cAMP \| increased activation of GTPase activity
DBS0349967	dcx-/ lis1(D327H)	dcx \| lis1	abolished aggregation
DBS0349804	detA-	detA	increased mound size \| decreased growth rate \| delayed development
DBS0349813	detA-/ [cotB]: GFP	detA	decreased prespore cell differentiation
DBS0349811	detA-/ [ecm0]: lacZ	detA	aberrant prestalk O cell differentiation
DBS0349812	detA-/ [ecmA0]: GFP	detA	increased prestalk cell differentiation
DBS0349808	detA-/ [ecmA0]: lacZ	detA	increased prestalk cell differentiation
DBS0349809	detA-/ [ecmA]: lacZ	detA	increased prestalk A cell differentiation
DBS0349810	detA-/ [ecmB]: lacZ	detA	delayed development
DBS0350392	dgat1-	dgat1	aberrant cellular metabolic process \| abolished lipid droplet formation \| increased sporulation
DBS0349911	dgcA-	dgcA	decreased gene expression \| development arrests at slug stage \| abolished stalk cell differentiation
DBS0349917	dgcA-/ [act15]: dgcA(1-124): YFP	dgcA	development arrests at slug stage
DBS0349918	dgcA-/ [act15]: dgcA(1-273): YFP	dgcA	development arrests at slug stage
DBS0349914	dgcA-/ [act15]: dgcA(125-521): YFP	dgcA	wild type
DBS0349915	dgcA-/ [act15]: dgcA(274-521): YFP	dgcA	wild type
DBS0349916	dgcA-/ [act15]: dgcA(350-521): YFP	dgcA	development arrests at slug stage
DBS0349913	dgcA-/ [act15]: dgcA-Ppal: YFP	dgcA	wild type
DBS0349912	dgcA-/ [act15]: dgcA: YFP	dgcA	wild type
DBS0235695	dgkA-	dgkA	decreased spore germination \| increased myosin II assembly \| aberrant sorocarp development \| decreased chemotaxis rate
DBS0351179	dgkA-	dgkA	aberrant cellular metabolic process \| increased resistance to valproic acid \| aberrant response to lithium
AK299	dhkA-	dhkA	aberrant stalk morphogenesis \| increased prestalk gene expression \| aberrant gene expression \| aberrant fruiting body morphogenesis \| increased sporulation \| abolished response to biotic stimulus \| decreased sporulation
DBS0350665	dhkA-/ [act15]: dhkA(D2076N)	dhkA	decreased sporulation
DBS0350664	dhkA-/ [act15]: dhkA(H1396Q)	dhkA	decreased sporulation
DBS0350666	dhkA-/ [act15]: dhkA(H2396Q)/ [act15]: dhkA(D2076N)	dhkA	wild type
DBS0235703	dhkA-/ [pkaC]: pkaC	dhkA \| pkaC	aberrant stalk morphogenesis
DBS0235704	dhkB-	dhkB	precocious spore germination \| decreased cAMP level \| aberrant sorus color
TL135	dhkC-	dhkC	precocious culmination \| decreased spore germination \| precocious aggregation \| precocious development \| precocious gene expression
DBS0350855	dhkC-	dhkC	aberrant chemotaxis to cAMP
DBS0350379	dhkD-	dhkD	abolished stream development \| aberrant slug development \| aberrant sorocarp development \| precocious gene expression \| aberrant late culminant morphology
DBS0350381	dhkD-/ [ecmAO]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350382	dhkD-/ [ecmB]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350383	dhkD-/ [pspA]: lacZ	dhkD	aberrant prespore cell differentiation
LAS99	dhkE-	dhkE	decreased socially cooperative development
DBS0351297	dhkI-	dhkI-1 \| dhkI-2	aberrant chemotaxis to cAMP \| delayed aggregation
DBS0235710	dhkK-	dhkK	aberrant slug migration \| delayed culmination \| delayed gene expression
DBS0235712	dhkK-/ [act15]: dhkK(D1125N)	dhkK	aberrant fruiting body morphogenesis
DBS0348046	dhkM-	dhkM	abolished autophagosome organization \| aberrant autophagic cell death
DBS0348047	dhkM-	dhkM	abolished autophagosome organization \| abolished actin filament depolymerization \| abolished cellulose biosynthesis \| abolished autophagic cell death
DBS0350173	dhkM-	dhkM	decreased autophagic vacuole organization \| delayed development
DBS0235895	dimA-	dimA	increased standing slug length \| increased migratory slug size \| abolished prestalk cell differentiation \| decreased standing slug width \| aberrant fruiting body morphogenesis \| increased prespore cell differentiation \| decreased prestalk O cell differentiation
DBS0235901	dimB-	dimB	decreased prestalk B cell differentiation \| abolished response to DIF-1 \| increased gene expression \| aberrant prespore gene expression \| aberrant chemotaxis to cAMP
DBS0235903	dimB-/ [act15]: dimA: GFP	dimA \| dimB	abolished protein localization to nucleus
DBS0235904	dimB-/ [act15]: dimB: GFP	dimB	wild type
DBS0235902	dimB-/ [cotB]: lacZ	dimB	increased prespore cell differentiation
DBS0350573	dimB-/ [dimB]: dimB(S590A)	dimB	wild type
DBS0235906	dimB-/ [ecmAO]: lacZ	dimB	decreased prestalk O cell differentiation
DBS0349974	dimB-/ [ecmB]: lacZ	dimB	abolished prestalk gene expression
DBS0235907	dimB-/ [ecmO]: lacZ	dimB	aberrant prestalk cell differentiation
DBS0350495	dio3-	dio3	decreased cell-cell adhesion \| aberrant aggregation \| decreased gene expression \| decreased growth rate \| decreased prespore cell differentiation \| decreased chemotaxis to folate \| increased prestalk cell differentiation \| decreased cAMP level \| decreased phototaxis
DBS0350496	dio3-/ [act15]: GFP: dio3	dio3	wild type
DBS0304919	dlpA-	dlpA	aberrant cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate \| increased actin filament depolymerization \| increased vegetative cell size \| decreased protein localization \| abolished protein localization to cleavage furrow \| aberrant actin filament organization
DBS0304920	dlpB-	dlpB	aberrant cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate \| increased vegetative cell size \| abolished protein localization to cleavage furrow
DBS0304921	dlpC-	dlpC	aberrant cytokinesis
DBS0235913	dmpA-	dmpA	aberrant stream morphology \| aberrant fruiting body morphogenesis \| delayed development \| decreased stalk cell differentiation \| decreased sporulation \| aberrant sorus color
HM1030	dmtA-	dmtA	delayed development of tipped mound \| abolished DIF-1 biosynthesis \| decreased outer basal disc size \| wild type \| abolished prestalk O cell differentiation \| decreased standing slug width \| decreased lower cup size \| decreased prestalk gene expression \| aberrant vacuole organization \| aberrant fruiting body morphogenesis \| delayed development \| decreased prestalk O cell differentiation \| decreased prestalk cell differentiation
DBS0350410	dmtA-/ [act15]: dmtA	dmtA	wild type
DBS0349975	dmtA-/ [dimB]: dimB	dimB \| dmtA	decreased prestalk B cell differentiation
DBS0235914	dnapkcs-	dnapkcs	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0266875	dnapkcs-/ GFP: pcna	dnapkcs \| pcna	aberrant response to bleomycin
DBS0235915	dng1-	dng1	decreased growth rate \| delayed aggregation
DBS0235917	dnmA-	dnmA	decreased DNA methylation on cytosine
DBS0235916	dnmA-	dnmA	decreased DNA methylation on cytosine \| aberrant late culminant morphology \| aberrant sorus color \| decreased sporulation
DBS0350457	docA-	docA	decreased chemotaxis to cAMP
DG2015	docA-	docA	development arrests at mound stage
LAS32	docA-	docA	decreased socially cooperative development
DBS0350458	docD-	docD	decreased cell motility \| decreased chemotaxis to cAMP
DBS0235920	dokA-	dokA	aberrant hyperosmotic response \| aberrant sorus color \| decreased sporulation
DBS0349789	dotA-	dotA	aberrant response to UV \| decreased growth rate \| decreased spore size \| delayed development \| abolished histone H3-K79 methylation
HAD172	dpoA-	dpoA	increased gene expression \| aberrant sorocarp development
HAD200	dpoA-	dpoA	aberrant sorocarp development
HAD201	dpoA-	dpoA	aberrant sorocarp development
HAD202	dpoA-	dpoA	aberrant sorocarp development
HAD203	dpoA-	dpoA	aberrant sorocarp development
HM1467	drcA-	drcA	abolished catalytic activity
DBS0238474	drkC-	drkC	decreased phagocytosis \| decreased phagolysosome formation
DBS0238511	drkC-/ [act15]: drkC(1-497): YFP	drkC	decreased phagocytosis
DBS0238513	drkC-/ [act15]: drkC(K518R): YFP	drkC	decreased phagocytosis
DBS0238475	drkC-/ [act15]: drkC: YFP	drkC	wild type
DBS0350174	drnB-	drnB	abolished pre-miRNA processing
DBS0350218	drnB-/ [act15]: pre-miRNA	drnB	abolished pre-miRNA processing
DBS0350210	drnB-/ [act6]: lacZ/ [RNAi]lacZ	drnB	abolished production of siRNA involved in RNA interference \| abolished transitive RNA interference
DBS0235924	dscA-	dscA-1 \| dscA-2	aberrant cell morphology
DBS0350775	dscA-	dcsA	decreased cell motility
DBS0302608	dsgg(1-571: 581-733)/ dsgg-	dsgg	aberrant contractile vacuole organization \| aberrant cellular localization
DBS0302597	dsgg-	dsgg	aberrant contractile vacuole organization \| aberrant hypotonic response
DBS0302603	dsgg-/ GFP: dsgg	dsgg	wild type
DBS0302602	dsgg-/ OE]: dsgg(Delta-Fbox)	dsgg	wild type
DBS0302606	dsgg-/ [OE]: GFP: lvsD	dsgg \| lvsD	wild type
DBS0302599	dsgg-/ [OE]: dsgg	dsgg	wild type
DBS0302601	dsgg-/ [OE]: dsgg(Q551A)	dsgg	aberrant contractile vacuole organization
DBS0302600	dsgg-/ [OE]: dsggR515A)	dsgg	aberrant contractile vacuole organization
DBS0302607	dsgg-/ [OE]: lvsA	dsgg \| lvsA	aberrant contractile vacuole organization
DBS0302611	dsgg-/ [OE]: phgA	dsgg \| phgA	aberrant contractile vacuole organization
DBS0302678	dsgg-/ [OE]: rab8A	dsgg \| rab8A	aberrant contractile vacuole organization
DBS0302604	dsgg-/ lvsA-	dsgg \| lvsA	wild type
DBS0302605	dsgg-/ lvsD-	dsgg \| lvsD	aberrant contractile vacuole organization
DBS0351070	dspA-	dspA	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0235925	dstA-	dstA	abolished gene expression \| increased gene expression \| aberrant prestalk gene expression \| abolished cell migration to prestalk region \| decreased gene expression \| delayed aggregation \| decreased prestalk gene expression \| decreased cell motility \| abolished stalk cell differentiation \| aberrant fruiting body morphogenesis
DBS0235926	dstA-	dstA	aberrant prestalk gene expression \| abolished cell migration to prestalk region \| delayed aggregation \| decreased cell motility \| abolished stalk cell differentiation \| aberrant fruiting body morphogenesis
DBS0238237	dstA-/ GFP: dstA(237-707): ORF+	dstA	abolished culmination \| decreased stalk length
DBS0238236	dstA-/ GFP: dstA(237-707): ORF+/ [OE]dutA(751-1322)	dstA \| dutA	decreased stalk length
DBS0252824	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C	2C \| dstA	aberrant fruiting body morphogenesis
DBS0252823	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E	7E \| dstA \| hssB	wild type
DBS0252826	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165	DDB_G0276165 \| dstA	aberrant fruiting body morphogenesis
DBS0252825	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325	DDB_G0282325 \| dstA	aberrant fruiting body morphogenesis
DBS0252816	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA	dstA \| hssA	wild type
DBS0235928	dstA-/ [act15]: dstA	dstA	wild type
DBS0235929	dstA-/ [cprB]: dstA	dstA	wild type
DBS0235930	dstA-/ [ecmAO]: dstA	dstA	wild type
DBS0235931	dstB-	dstB	decreased gene expression \| increased gene expression \| decreased growth rate
DBS0235933	dstB-/ [act15]: dstB	dstB	wild type
DBS0235934	dstB-/ [act15]: dstB(L1025R)	dstB	wild type
DBS0235935	dstB-/ [act15]: dstB(Y1143F)	dstB	wild type
DBS0238125	dstC-	dstC	abolished gene expression \| aberrant response to cation stress \| aberrant response to osmotic stress
DBS0350425	dstC-	dstC	aberrant protein phosphorylation
DBS0235937	dtfA-	dtfA	delayed development of tipped mound \| decreased cell-cell adhesion \| aberrant cytokinesis \| aberrant cell migration to prestalk region \| aberrant fruiting body morphogenesis
DBS0350500	dupA-	dupA	increased defense response to Gram-negative bacterium \| abolished aggregation
DBS0350502	dupA-	dupA	increased defense response to Gram-negative bacterium
DBS0238234	dutA-	dutA	wild type
DBS0235939	dwwA-	dwwA	aberrant cytokinesis \| aberrant actin filament organization \| aberrant cell morphology
DBS0350411	dydA-	dydA	increased myosin II assembly \| increased actin filament polymerization \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP
DBS0350414	dydA-/ dydA(1-278: 501-1211)	dydA	decreased protein localization to cell cortex \| increased myosin II assembly \| increased actin filament polymerization \| aberrant chemotaxis to cAMP
DBS0350415	dydA-/ dydA(1-586: 703-1211)	dydA	decreased protein localization to cell cortex \| decreased chemotaxis to cAMP
DBS0350060	dymA-	dymA	decreased protein localization to cleavage furrow \| aberrant cell separation during cytokinesis \| decreased growth rate \| increased vegetative cell size \| aberrant actin filament organization
DBS0347874	dymA-	dymA	decreased pinocytosis \| aberrant cell separation during cytokinesis \| aberrant mitochondrion morphology \| decreased phagolysosome size \| increased basal disc size \| decreased growth rate \| aberrant nucleus morphology \| increased vegetative cell size \| aberrant endosome morphology \| aberrant phagosome maturation \| delayed development \| aberrant stalk development \| aberrant fruiting body morphogenesis \| decreased establishment of cell polarity \| aberrant pseudopodium formation \| abolished phagosome acidification \| increased phagocytosis \| aberrant intracellular distribution of mitochondria
DBS0349839	dymA-/ [dymA]: dymA	dymA	wild type
DBS0347875	dymB-	dymB	decreased growth rate \| aberrant hypotonic response \| increased cell-cell adhesion \| increased cell-substrate adhesion \| decreased vegetative cell size \| decreased catalase activity \| aberrant actin filament organization \| increased growth rate \| increased phagocytosis
DBS0235940	eb1-	eb1	aberrant mitosis \| aberrant cytokinesis \| aberrant protein localization
HJW117	ecmA-	ecmA	increased standing slug length \| decreased standing slug width \| decreased slime trail
HJW01	ecmB-	ecmB	wild type
HJW03	ecmB-	ecmB	wild type
DBS0235944	ecmF-	ecmF	wild type
DBS0350904	efbA-	efbA	aberrant cytokinesis \| delayed development
DBS0235945	egeA-	egeA	decreased activation of adenylate cyclase activity \| decreased gene expression \| abolished aggregation
DBS0350520	egeA-/ [unk]: YFP: carA	carA-1 \| carA-2 \| egeA	development arrests at mound stage
DBS0350521	egeA-/ [unk]: pkaC	egeA \| pkaC	decreased gene expression \| abolished aggregation
DBS0235946	egeB-	egeB	development arrests at mound stage
DBS0350802	ehd-	ehd	aberrant endosome morphology \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0350804	ehd-/ [act15]: dymA: GFP	dymA \| ehd	aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0351166	ei24-	ei24	aberrant aggregation \| decreased spore germination \| increased gene expression \| decreased gene expression \| decreased growth rate \| aberrant cell cycle \| delayed development \| decreased chemotaxis to cAMP \| decreased fruiting body size \| decreased cAMP level \| decreased sporulation
DBS0302590	elmoA-	elmoA	increased protein localization to pseudopodium \| decreased culmination \| abolished establishment of cell polarity \| increased actin filament polymerization \| decreased cell motility \| delayed development \| increased pseudopodium formation \| increased phagocytosis
DBS0302591	elmoA-/ [act15]: elmoA: GFP	elmoA	wild type
DBS0350065	elmoE-	elmoE	decreased culmination \| decreased actin filament polymerization at leading edge \| decreased chemotaxis to cAMP
DBS0351604	elp3-	elp3	decreased protein level
DBS0302448	epnA-	epnA	aberrant spore morphology \| decreased spore germination \| abolished protein localization to cell cortex \| aberrant cytokinesis \| abolished protein localization to plasma membrane \| aberrant actin cytoskeleton organization \| abolished protein phosphorylation
DBS0302457	epnA-/ [act15]: GFP: epnA(253-677)	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane \| abolished protein localization to clathrin-coated pit
DBS0302456	epnA-/ [act15]: epnA(1-133): GFP	epnA	aberrant localization to coated pits
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane \| abolished phosphatidylinositol-4,5-bisphosphate binding \| abolished protein localization to clathrin-coated pit \| abolished protein phosphorylation
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane
DBS0302454	epnA-/ [act15]: epnA: GFP	epnA	wild type
DBS0235947	eppA-	eppA	decreased growth rate \| delayed development \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased cAMP level
DBS0235948	eppA-/ [act6]: myc: eppA	eppA	wild type
DBS0350028	erkA-	erkA	decreased mound size \| decreased chemotaxis to cAMP
DBS0350622	erkA-	erkA	aberrant development of tipped mound \| aberrant stream morphology \| abolished protein kinase activation \| aberrant cellular response to extracellular stimulus \| abolished positive regulation of chemorepellant activity
DBS0350623	erkA-	erkA	decreased mound size \| precocious development
DBS0350681	erkA-/ [act15]: gpaE	erkA \| gpaE	wild type
DBS0350029	erkA-/ [act15]: mekA: FLAG	erkA \| mekA	increased protein localization to cell cortex
DBS0351296	erkB-	erkB	abolished chemotaxis to folate \| increased actin filament polymerization \| abolished protein phosphorylation
HS174	erkB-	erkB	decreased catalytic activity \| aberrant phagocytosis \| decreased cell motility \| decreased prespore gene expression \| decreased prestalk gene expression \| aberrant sorocarp development \| decreased chemotaxis to folate \| abolished aggregation \| decreased chemotaxis to cAMP \| aberrant cell morphology \| decreased sporulation
AK240	erkB-	erkB	abolished aggregation \| decreased sporulation
DBS0350606	erkB-	erkB	decreased prespore cell differentiation
DBS0350683	erkB-/ [ecmA]: lacZ	erkB	aberrant cell migration to prestalk region
DBS0350682	erkB-/ [unk]: erkB(P140S)	erkB	abolished sporulation
DBS0350530	exo1-	exo1	decreased resistance to bleomycin \| decreased double-strand break repair via homologous recombination
DBS0304864	expl7-	expl7	wild type
DBS0235951	fadA-	fadA	increased cellular thermotolerance
DBS0235952	fadB-	fadB	wild type
DBS0350240	fam21-	fam21	abolished exocytosis \| aberrant vegetative growth \| decreased protein localization to post-lysosomal vacuole \| decreased protein processing in phagocytic vesicle \| aberrant autophagic cell death \| aberrant phagosome maturation \| aberrant lysosome organization
DBS0236034	fam45-	fam45	wild type
DBS0236040	fam91-	fam91	wild type
DBS0350717	far1-	far1	aberrant binding \| decreased actin filament polymerization \| aberrant defense response to bacterium \| aberrant macropinocytosis \| decreased growth rate \| aberrant phagocytosis \| aberrant chemotaxis \| decreased engulfment during phagocytosis \| decreased chemotaxis to folate \| decreased protein kinase activation \| decreased folic acid binding \| aberrant signal transduction
DBS0351093	far1-	far1	abolished chemotaxis to folate
DBS0351545	fatA-	fatA	aberrant lipid storage \| decreased phagocytosis
DBS0235953	fbxA-	fbxA	decreased sporulation
HR6	fbxA-	fbxA	decreased socially cooperative development
DBS0235954	fbxA-/ [ecmA]: GFP(S65T)	fbxA	increased prespore cell differentiation
DBS0235956	fbxA1-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DBS0235957	fbxA2-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DBS0235958	fbxA3-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DG1148	fcpA-	fcpA	aberrant fruiting body morphogenesis
DBS0235960	fcsA-	fcsA	decreased fatty acid level \| decreased lipid droplet formation \| increased sporulation
DBS0350128	fcsB-	fcsB	decreased catalytic activity \| decreased phagocytosis
DBS0350336	febA-	febA	wild type
DBS0350953	fhbA-	fhbA	increased vegetative cell size \| aberrant cellular response to stress
DBS0350954	fhbB-	fhbB	increased vegetative cell size \| aberrant cellular response to stress
DBS0235961	fimA-	fimA	decreased vegetative cell size
HM1253	fncD2-	fncD2	decreased resistance to cisplatin
HM1416	fncE-	fncE	decreased resistance to cisplatin
HM1356	fncI-	fncI	decreased resistance to cisplatin
HM1302	fncL-	fncL	decreased resistance to cisplatin
HM1407	fncM-	fncM	decreased resistance to cisplatin
DBS0235966	forA-	forA	wild type
DBS0350667	forA-	forA	aberrant cellular response to fluid shear stress \| decreased cell motility \| increased cell motility
DBS0350669	forA-/ [act15]: GFP: mhcA	forA \| mhcA	aberrant bleb assembly
DBS0235968	forB-	forB	wild type
DBS0235969	forC-	forC	aberrant culmination \| aberrant fruiting body morphogenesis \| development arrests at tipped mound stage
DBS0350280	forC-	forC	delayed aggregation \| aberrant sorocarp development \| decreased chemotaxis to cAMP \| decreased sporulation \| abolished slug development \| delayed gene expression
DBS0304905	forC-/ [act15]: GFP: forC	forC	wild type
DBS0350287	forF-	forF	decreased fruiting body size \| aberrant phototaxis \| increased chemotaxis rate
DBS0350835	forG-	forG	decreased growth rate \| decreased phagocytosis \| aberrant actin cytoskeleton organization \| decreased macropinocytosis \| aberrant actin filament organization
DBS0235970	forH-	forH	decreased cell-substrate adhesion \| decreased chemotaxis rate \| increased cell motility \| aberrant pseudopodium formation \| aberrant cell morphology \| decreased filopodium formation
DBS0235971	forH-/ [act15]: GFP: forH	forH	increased filopodium formation \| decreased cell motility \| increased cell-substrate adhesion
HW435	fpaB-/ AX2	fpaB-1 \| fpaB-2	decreased response to hypoxia \| increased culmination \| increased stalk length
DBS0302506	frmA-	frmA	delayed aggregation \| decreased cell motility \| decreased mound size \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0304440	frmA-/ [unk]: GFP	frmA	decreased gene expression \| aberrant sorocarp development \| increased cell-cell adhesion \| delayed development \| abolished phototaxis
DBS0302507	frmA-/ [unk]: frmA-HA	frmA	wild type
DBS0350983	frmB-	frmB	aberrant aggregation \| increased mound size \| decreased cell-substrate adhesion \| increased fruiting body size
DBS0350232	fscE-	fscE	aberrant positive regulation of chemorepellant activity \| decreased growth rate \| aberrant cytokinesis
DBS0350228	fslA-	fslA	aberrant cytokinesis
DBS0350230	fslB-	fslB	aberrant positive regulation of chemorepellant activity \| decreased catalytic activity \| aberrant cytokinesis
DBS0350229	fslK-	fslK	decreased catalytic activity \| aberrant vegetative growth \| aberrant cytokinesis
DBS0350252	fspA-	fspA	decreased gene expression \| aberrant chemotaxis to folate \| aberrant vegetative growth
DBS0350253	fspA-/ [unk]: fspA: FLAG	fspA	wild type
DBS0235976	fszA-	fszA	decreased number of mitochondria \| aberrant mitochondrion morphology
DBS0235980	fszB-	fszB	aberrant mitochondrion morphology \| decreased number of mitochondria \| decreased growth rate
DG1066	fut1-	fut1	aberrant fruiting body morphogenesis
DBS0305025	gabT-	gabT	precocious development \| decreased sporulation
DBS0305026	gabT-[pkaC]: pkaC	gabT \| pkaC	aberrant protein secretion
DBS0351298	gacG-	gacG	increased chemotaxis to folate \| increased actin filament polymerization at leading edge
DBS0351318	gacG-	gacG	aberrant macropinocytosis \| abolished vegetative growth
DBS0351299	gacH-	gacH	aberrant chemotaxis to cAMP
DG1094	gacT-	gacT	aberrant fruiting body morphogenesis
DBS0235989	gadA-	gadA	decreased spore cell differentiation \| decreased sporulation
DBS0350071	gadA-	gadA	decreased spore germination
DBS0350072	gadB-	gadB	delayed aggregation
DBS0350963	gapA-	gapA	aberrant cell separation during cytokinesis
DBS0349924	gapA-	gapA	decreased actin filament bundle assembly
DBS0350399	gapA-	gapA	decreased protein localization to cleavage furrow \| increased myosin II assembly \| increased lateral pseudopodium formation \| aberrant mitotic spindle organization \| increased actin filament polymerization \| decreased chemotaxis to cAMP \| aberrant cellular response to stress
TL198	gbfA-	gbfA	abolished gene expression \| development arrests at mound stage
DBS0302689	gbfA-	gbfA	aberrant oscillatory cAMP signaling
DBS0305094	gbfA-	gbfA	abolished autophagosome organization \| abolished autophagic cell death
DBS0235994	gbpC-	gbpC	decreased protein kinase activation \| decreased fruiting body size
DBS0235995	gbpC-	gbpC	aberrant chemotaxis to cAMP \| aberrant myosin II filament organization \| decreased chemotaxis rate \| aberrant cyclic nucleotide binding \| aberrant cell morphology \| decreased establishment of cell polarity \| decreased fruiting body size
DBS0302680	gbpC-	gbpC	abolished protein localization to nucleus \| decreased mound size \| abolished protein phosphorylation
DBS0350881	gbpC-	gbpC	aberrant cyclic nucleotide binding
DBS0304912	gbpC-/ [act15]: gbpC	gbpC	wild type
DBS0304917	gbpC-/ [act15]: gbpC(1-1698: 2005-2631)	gbpC	decreased chemotaxis to cAMP
DBS0349868	gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP	gbpC	aberrant stream morphology \| decreased chemotaxis to cAMP
DBS0304918	gbpC-/ [act15]: gbpC(311-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304916	gbpC-/ [act15]: gbpC(F1892A)	gbpC	decreased chemotaxis to cAMP
DBS0304915	gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A)	gbpC	decreased chemotaxis to cAMP
DBS0304913	gbpC-/ [act15]: gbpC(K342N)	gbpC	decreased chemotaxis to cAMP
DBS0304914	gbpC-/ [act15]: gbpC(K905W)	gbpC	decreased chemotaxis to cAMP
DBS0235997	gbpD-	gbpD	increased establishment of cell polarity \| decreased cell-substrate adhesion \| decreased lateral pseudopodium formation \| increased chemotaxis rate
DBS0235998	gbpD-/ [act15]: gbpD	gbpD	increased lateral pseudopodium formation \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant actin filament organization \| abolished aggregation
DG1120	gbqA-	gbqA	aberrant fruiting body morphogenesis
DBS0350119	gcA-	gcA	decreased guanylyl cyclase activity
DBS0236002	gcsA-	gcsA	abolished sporulation \| aberrant cellular metabolic process \| decreased gene expression \| increased gene expression \| development arrests at mound stage \| abolished vegetative growth \| mitotic G1 phase arrest \| abolished aggregation \| abolished prespore gene expression
DBS0350387	gcsA-/ [act15]: carA	carA-1 \| carA-2 \| gcsA	abolished aggregation
DBS0236003	gcsA-/ [act15]: gcsA	gcsA	decreased spore germination \| development arrests at mound stage
DBS0350388	gcsA-/ [act15]: yakA	gcsA \| yakA	wild type
DBS0236004	gdt1-	gdt1	increased gene expression \| decreased growth rate \| precocious aggregation
DBS0237190	gdt1-/ [act15]: pkaR(G135E/ G261A)	gdt1 \| pkaR	increased gene expression \| abolished aggregation
DBS0236006	gdt2-	gdt2	increased gene expression \| precocious aggregation
RI19	gefA-	gefA	decreased actin filament polymerization \| decreased gene expression \| decreased activation of GTPase activity \| abolished activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased chemotaxis rate \| abolished aggregation \| increased protein kinase activation
JB10	gefA-	gefA	abolished aggregation
DBS0350821	gefA-	gefA	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| decreased protein kinase activation \| abolished aggregation
DBS0350449	gefA-/ [dscB]: rasG(S17N)	gefA \| rasG	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| decreased protein kinase activation
DBS0351451	gefB-/ AX2	gefB	wild type
DBS0236009	gefB-/ AX3	gefB	abolished pinocytosis \| delayed aggregation \| increased actin filament polymerization \| decreased phagocytosis \| decreased growth rate \| decreased mound size \| abolished vegetative growth \| aberrant fruiting body morphogenesis \| aberrant cell morphology \| increased bleb assembly \| aberrant cytoskeleton organization
DBS0236868	gefC-	gefC	wild type
DBS0236869 (DBS0235543)	gefD-	gefD	wild type \| aberrant activation of GTPase activity
DBS0236870	gefE-	gefE	aberrant thermotaxis \| aberrant activation of GTPase activity \| aberrant phototaxis
DBS0350569	gefE-	gefE	decreased activation of GTPase activity \| increased gene expression \| decreased response to DIF-1 \| increased prespore cell differentiation
DBS0350822	gefH-	gefH	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| delayed development \| decreased protein kinase activation
DBS0236012	gefK-	gefK	wild type
DBS0236871	gefL-	gefL	aberrant thermotaxis \| aberrant phototaxis
HSB61	gefM-	gefM	increased cGMP-mediated signaling \| decreased lateral pseudopodium retraction \| aberrant activation of adenylate cyclase activity \| development arrests at mound stage \| decreased chemotaxis rate
DBS0304968	gefQ-	gefQ	decreased positive regulation of GTPase activity \| increased number of mound tips \| increased myosin II assembly \| increased lateral pseudopodium formation \| abolished cell migration to prestalk region \| abolished guanyl-nucleotide exchange factor activity \| decreased growth rate \| decreased fruiting body size \| abolished phototaxis
DBS0304985	gefQ-/ [act15]: GFP: gefQ(172-654)	gefQ	abolished guanyl-nucleotide exchange factor activity \| decreased phototaxis
DBS0304986	gefQ-/ [act15]: GFP: gefQ(910-1298)	gefQ	decreased phototaxis
DBS0236014	gefR-	gefR	wild type \| decreased activation of GTPase activity
DBS0349892	gefS-	gefS	wild type
DBS0349904	gemA-	gemA	decreased ATP level \| decreased growth rate
DBS0350811	gflB-	gflB	decreased culmination \| decreased protein localization to cell cortex \| aberrant G protein-coupled receptor signaling \| delayed aggregation \| decreased mound size \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| increased actin filament polymerization at leading edge \| decreased myosin II assembly
HA201	gflB-	gflB	decreased phagocytosis \| aberrant mitotic actomyosin contractile ring contraction \| increased actin filament polymerization \| decreased macropinocytosis \| increased substrate adhesion-dependent cell spreading
DBS0350814	gflB-/ [act15]: GFP: gflB(380-1601,T1180E)	gflB	decreased chemotaxis to cAMP
DG1109	ggtA-	ggtA	aberrant fruiting body morphogenesis
DBS0351210	gip1-	gip1	decreased protein localization to plasma membrane \| aberrant chemotaxis to cAMP
DBS0266723	glcS-/ DH1	glcS	aberrant stalk morphogenesis \| decreased glycogen level \| decreased spore size \| decreased fruiting body size
DBS0266765	glcS-/ HMX	glcS	abolished cellulose biosynthesis \| decreased autophagic vacuole organization \| aberrant cell morphology
DBS0350514	glk-	glk	decreased defense response to Gram-negative bacterium
DBS0351101	glkA-	glkA	aberrant aggregation \| decreased protein localization to cell cortex \| decreased protein level \| decreased chemotaxis to cAMP \| decreased myosin II assembly \| increased activation of GTPase activity \| increased protein kinase activation
DBS0236078	glpD-	glpD	aberrant glycogen metabolism \| aberrant regulation of catalytic activity
DBS0236079	gmsA-	gmsA	decreased sexual fusion
DBS0236080	gmsA-	gmsA	decreased sexual fusion
DBS0238384	gnt14-	gnt14	wild type
DBS0238382	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238383	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238390	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0238391	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0236081	gnt2-	gnt2	abolished catalytic activity \| abolished protein modification
DBS0236082	gol-	gol	increased resistance to cisplatin
DBS0235414	gp130-	gp130	decreased response to Gram-positive bacterium \| decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0236087	gpaA-	gpaA	aberrant aggregation \| increased stalk length \| aberrant response to cAMP \| decreased stalk width
JH131	gpaA-	gpaA	aberrant cellular homeostasis \| wild type \| increased growth rate
DBS0236091	gpaA-/ [ecmB]: lacZ	gpaA	decreased prestalk gene expression
DBS0236092	gpaA-/ [gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0236093	gpaA-/ [gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0236575	gpaB-	gpaB	decreased response to cAMP \| abolished activation of GTPase activity \| aberrant phagocytosis \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| abolished aggregation \| abolished chemotaxis to cAMP
JH104	gpaB-	gpaB	decreased gene expression \| decreased activation of GTPase activity \| abolished activation of adenylate cyclase activity \| abolished aggregation \| abolished chemotaxis to cAMP
JM1	gpaB-/ [OE]: carA	carA-1 \| carA-2 \| gpaB	aberrant calcium-mediated signaling
DBS0236096	gpaB-/ [act15]: gpaB	gpaB	abolished aggregation
DBS0266942	gpaB-/ [act15]: gpaB	gpaB	delayed aggregation
DBS0266939	gpaB-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	abolished aggregation
DBS0351103	gpaB-/ [act15]: gpaB(C4A)	gpaB	abolished protein localization to plasma membrane \| decreased cGMP-mediated signaling \| abolished aggregation
DBS0237137	gpaB-/ [act15]: gpaB(D154V)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237138	gpaB-/ [act15]: gpaB(E190G)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling
DBS0351105	gpaB-/ [act15]: gpaB(G207A)	gpaB	abolished protein localization to plasma membrane
DBS0351104	gpaB-/ [act15]: gpaB(G2A)	gpaB	abolished protein localization to plasma membrane
DBS0237139	gpaB-/ [act15]: gpaB(I104S)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237140	gpaB-/ [act15]: gpaB(L110S)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237141	gpaB-/ [act15]: gpaB(L76P)	gpaB	abolished aggregation
DBS0237142	gpaB-/ [act15]: gpaB(N74D)	gpaB	decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate \| abolished aggregation
DBS0237143	gpaB-/ [act15]: gpaB(R64G)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0237144	gpaB-/ [act15]: gpaB(S155P)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0351217	gpaB-/ [act15]: gpaI	gpaB \| gpaI	wild type
DBS0351267	gpaB-/ [act15]: gpbA: YFP	gpaB \| gpbA	abolished aggregation
DBS0351214	gpaB-/ [act15]: rasG(S17N)	gpaB \| rasG	abolished activation of GTPase activity
DBS0236097	gpaB-/ [gpaA]: gpaB	gpaB	abolished aggregation
DBS0236099	gpaB-/ [gpaB]: gpaB	gpaB	wild type
DBS0236098	gpaB-/ [gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization to plasma membrane
DBS0235986	gpaC-	gpaC	aberrant activation of adenylate cyclase activity \| decreased gene expression \| increased protein kinase activity \| abolished aggregation
JH417	gpaD-	gpaD	decreased gene expression \| aberrant macropinocytosis \| decreased spore cell differentiation \| aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased protein kinase activation \| abolished protein phosphorylation \| decreased cGMP biosynthesis \| decreased sporulation
DBS0266944	gpaD-/ [act15]: gpaB	gpaB \| gpaD	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0266946	gpaD-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	aberrant fruiting body morphogenesis \| decreased cGMP biosynthesis
DBS0266943	gpaD-/ [act15]: gpaD	gpaD	wild type
DBS0350608	gpaD-/ [act15]: gpaD(Q200L)	gpaD	development arrests at loose mound stage \| decreased chemotaxis to folate \| decreased protein kinase activation
DBS0350607	gpaD-/ [act15]: gpaD(R107E,R108E)	gpaD	development arrests at slug stage \| aberrant slug development
DBS0266945	gpaD-/ [act15]: gpaE	gpaD \| gpaE	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0266947	gpaD-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0351269	gpaD-/ [act6]: AEQ	gpaD	aberrant calcium-mediated signaling
JH257	gpaE-	gpaE	delayed development of tipped mound \| increased chemotaxis to folate \| delayed prestalk gene expression \| increased vegetative cell size \| delayed prespore gene expression \| decreased cell migration to prestalk region
DBS0266941	gpaE-/ [act15]: gpaE	gpaE	precocious development of tipped mound
DBS0266948	gpaE-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	precocious development of tipped mound
DBS0350678	gpaE-/ [act15]: gpaE(K10E/ K11E)	gpaE	delayed development of tipped mound \| delayed gene expression
LW1	gpaG-	gpaG	wild type \| decreased spore cell differentiation \| aberrant GABA signaling pathway
DBS0236107	gpaH-	gpaH	wild type \| increased cell death \| decreased spore germination \| abolished negative chemotaxis \| increased growth rate \| abolished positive regulation of chemorepellant activity \| decreased sporulation
DBS0236108	gpaH-	gpaH	wild type
DBS0350972	gpaH-/ AX2	gpaH	increased growth rate
DBS0350975	gpaH-/ [ecmO]: lacZ	gpaH	aberrant cell differentiation
DBS0236109	gpaI-	gpaI	increased number of mounds \| aberrant cellular homeostasis \| increased establishment of cell polarity \| increased cell death \| aberrant activation of adenylate cyclase activity \| increased chemotaxis to cAMP \| precocious aggregation \| increased actin filament polymerization \| aberrant adaptation of signaling pathway \| decreased mound size \| decreased oscillatory cAMP signaling \| decreased lateral pseudopodium formation \| decreased fruiting body size \| increased growth rate \| aberrant protein localization to plasma membrane \| increased cGMP biosynthesis
DBS0351544	gpat-	gpat	aberrant lipid storage \| decreased lipid droplet formation \| increased sporulation \| increased phagocytosis
LW5	gpbA-	gpbA	aberrant taxis \| increased resistance to N-Phenylthiourea \| abolished aggregation
LW6	gpbA-	gpbA	decreased protein localization to plasma membrane \| aberrant cellular homeostasis \| aberrant extracellular cAMP signaling pathway \| decreased positive regulation of GTPase activity \| increased cell death \| abolished chemotaxis to folate \| aberrant phagocytosis \| aberrant chemotaxis \| abolished activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased engulfment during phagocytosis \| aberrant sorocarp development \| decreased chemotaxis to folate \| decreased protein kinase activation \| decreased chemotaxis to cAMP \| abolished actin filament polymerization \| increased growth rate \| aberrant protein localization \| aberrant signal transduction
DBS0351277	gpbA-	gpbA	aberrant cytokinesis
DBS0350470	gpbA-/ [act15]: GFP: cap	cap \| gpbA	decreased phagocytosis
LW14	gpbA-/ [act15]: carA	carA-1 \| carA-2 \| gpbA	aberrant calcium-mediated signaling \| decreased protein kinase activation \| abolished aggregation
LW17	gpbA-/ [act15]: carC	carC \| gpbA	abolished aggregation
DBS0351260	gpbA-/ [act15]: gpbA(A99T/ Y271H/ C335M)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351261	gpbA-/ [act15]: gpbA(M30V/ K85R/ S104P/ Q163H)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| decreased chemotaxis to cAMP
DBS0351263	gpbA-/ [act15]: gpbA(M48T/ I52T/ E310G)	gpbA	wild type \| decreased activation of adenylate cyclase activity \| decreased gene expression \| aberrant slug development
DBS0351259	gpbA-/ [act15]: gpbA(N147D/ H149R/ N237S)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| abolished chemotaxis to cAMP
DBS0351264	gpbA-/ [act15]: gpbA(R13G/ N74S/ S79P/ H149R/ V178A/ V194R/ F293L)	gpbA	decreased activation of adenylate cyclase activity \| decreased gene expression \| development arrests at tipped mound stage
DBS0351262	gpbA-/ [act15]: gpbA(S196G/ V199D/ C211R)	gpbA	decreased activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351258	gpbA-/ [act15]: gpbA(V88A/ F229S/ D235V)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis \| decreased chemotaxis to cAMP
DBS0351268	gpbA-/ [act6]: AEQ	gpbA	aberrant calcium-mediated signaling
HO547	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP	gpbA	aberrant cortical actin cytoskeleton organization
HO543	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: YFP: FKBP	gpbA	abolished chemotaxis to folate
DBS0351198	gpbA-/ [act6]: yakA	gpbA \| yakA	abolished vegetative growth
DBS0350832	gpbA-/ [unk]: gpbA(Q208L)	gpbA	aberrant adaptation of signaling pathway
DBS0351278	gpbA-/ mhcA-	gpbA \| mhcA	aberrant cytokinesis
AK1353	gpi-	gpi	decreased response to Gram-positive bacterium
DBS0350477	gpr89-	gpr89	aberrant spore morphology \| aberrant mitochondrion morphology \| abolished cell migration to prestalk region \| decreased gene expression \| aberrant slug development \| abolished vegetative growth \| decreased cell motility \| decreased fruiting body size \| precocious gene expression \| decreased phototaxis \| delayed gene expression
DBS0350479	gpr89-/ [act15]: gpr89: GFP	gpr89	wild type
DBS0304814	grlA-	grlA	delayed prestalk gene expression \| decreased prestalk gene expression \| decreased spore cell differentiation \| decreased sporulation \| delayed culmination
DBS0304815	grlA-/ [act15]: grlA: GFP	grlA	aberrant development of tipped mound
DBS0350074	grlB-	grlB	decreased small molecule binding \| aberrant positive regulation of chemorepellant activity \| delayed aggregation \| aberrant vegetative growth \| delayed gene expression
DBS0350227	grlD-	grlD	aberrant positive regulation of chemorepellant activity \| decreased growth rate \| aberrant cytokinesis \| abolished small molecule binding \| aberrant cellular response to extracellular stimulus
DBS0236112	grlE-	grlE	decreased spore cell differentiation \| aberrant GABA signaling pathway \| decreased sporulation
DBS0236113	grlE-	grlE	delayed aggregation \| aberrant gene expression \| decreased chemotaxis to cAMP
DBS0350075	grlE-	grlE	decreased spore germination \| delayed aggregation
DBS0350226	grlH-	grlH	aberrant positive regulation of chemorepellant activity \| aberrant protein level \| aberrant vegetative growth \| abolished activation of GTPase activity \| decreased protein binding \| increased growth rate
DBS0351147	grlH-/ [act15]: grlH	grlH	wild type
DBS0238865	grlJ-	grlJ	increased migratory slug size \| aberrant spore morphology \| decreased spore germination \| precocious development \| decreased fruiting body size \| precocious gene expression
DBS0350283	grlJ-	grlJ	aberrant spore morphology \| increased resistance to N-Phenylthiourea
DBS0238866	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0350284	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0238686	grpA-	grpA	decreased spore germination \| abolished protein secretion
DBS0238687	grpA-/ [act15]: grpA-FLAG	grpA	wild type
ARK200	gskA-	gskA	abolished stream development \| increased gene expression \| decreased gene expression \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP \| decreased sporulation
DBS0236114	gskA-	gskA	aberrant aggregation \| decreased protein localization to cell cortex \| decreased slug migration \| aberrant sorus morphology \| aberrant extracellular cAMP signaling pathway \| decreased gene expression \| abolished protein localization to plasma membrane \| abolished protein phosphorylation \| decreased chemotaxis to folate \| decreased stalk length \| abolished chemotaxis to cAMP
HM338	gskA-	gskA	precocious aggregation \| decreased prespore cell differentiation \| aberrant mitotic spindle elongation \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation \| decreased sporulation
DBS0349930	gskA-/ [act15]: GFP: tacA	gskA \| tacA	increased protein localization to nucleus
DBS0349881	gskA-/ [act15]: gskA(Y214F)	gskA	abolished stream development
DBS0349800	gskA-/ [ecmA]: LacZ	gskA	aberrant prestalk gene expression
DBS0349801	gskA-/ [ecmB]: LacZ	gskA	aberrant prestalk gene expression
DBS0350260	gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D))	gskA \| pikA	wild type
DBS0350427	gskA-/ gskA(K85R): GFP	gskA	aberrant aggregation
DBS0350426	gskA-/ gskA: GFP	gskA	wild type
DBS0350988	gst4-	gst4	decreased fruiting body size
DBS0266891	gtaC-	gtaC	decreased mound size \| aberrant stream morphology \| abolished stalk cell differentiation \| aberrant prestalk B cell differentiation
DBS0350347	gtaC-	gtaC	abolished gene expression \| decreased fruiting body size \| abolished aggregation
DBS0350357	gtaC-/ [act15]: GFP: gtaC(C500,503,522,525S)	gtaC	aberrant gene expression \| abolished aggregation \| decreased fruiting body size
DBS0350358	gtaC-/ [act15]: GFP: gtaC(T376A/ S379,380A/ C500,503,522,525S)	gtaC	aberrant protein localization to nucleus
DBS0350361	gtaC-/ [act15]: gtaC: (468-496): GFP: gtaC	gtaC	development arrests at mound stage \| decreased mound size \| precocious development
DBS0351091	gtaG-	gtaG	decreased gene expression \| development arrests at slug stage \| aberrant slug development \| decreased prestalk A cell differentiation \| decreased sporulation
DBS0236120	gxcA-	gxcA	decreased activation of GTPase activity \| decreased actin filament polymerization \| delayed development
DBS0236121	gxcB-	gxcB	decreased exocytosis \| delayed development \| aberrant cytoskeleton organization
DBS0350256	gxcC-	gxcC	delayed development
DBS0350257	gxcC-/ [act15]: GFP: gxcC	gxcC	wild type
DBS0238825	gxcDD-	gxcDD	aberrant stream morphology \| delayed development
LAS105	gxcKK-	gxcKK	decreased socially cooperative development
DBS0350268	gxcT-	gxcT	aberrant activation of GTPase activity \| increased lateral pseudopodium formation \| aberrant cytokinesis \| decreased growth rate \| delayed aggregation \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP \| decreased fruiting body size \| aberrant protein localization to plasma membrane
DBS0350269	gxcT-/ [act15]: GFP: gxcT	gxcT	wild type
DBS0350656	hatA-/ [hatB]: hatB	hatA \| hatB	aberrant cellular response to stress
DBS0236129	hbx2-	hbx2	wild type
DBS0236130	hbx2-	hbx2	wild type
DBS0350324	hbx4-/ [ecmAO]: lacZ	hbx4	increased prespore cell differentiation
DBS0350879	hbx9-	hbx9	decreased cell-cell adhesion \| decreased gene expression \| delayed aggregation \| decreased growth rate \| decreased chemotaxis to cAMP
DBS0350880	hbx9-/ [ecmA]: lacZ	hbx9	increased prestalk A cell differentiation
DBS0236153	hcpA-	hcpA	decreased growth rate
DBS0236157	hcpB-	hcpB	wild type
DBS0305109	hdaB-	hdaB	decreased sporulation \| decreased histone deacetylase activity
HM1012	helC-	helC	decreased gene expression \| delayed development \| aberrant fruiting body morphogenesis
HM444	helC-	helC	decreased gene expression \| aberrant fruiting body morphogenesis \| delayed development
DG1059	helE-	helE	increased slug migration
DBS0236163	helF-	helF	increased migratory slug size \| increased stalk cell differentiation \| delayed development \| increased post-transciptional gene silencing by RNA
DBS0350878	hephA-	hephA	increased response to cAMP \| delayed aggregation \| aberrant sorocarp development \| decreased cAMP level
DBS0350362	hfnA-	hfnA	increased phototaxis \| decreased migratory slug size \| increased slug migration
DBS0350363	hfnA-/ [ecmO]: lacZ	hfnA	aberrant slug development \| aberrant prestalk O cell differentiation
DBS0351593	hgrA-	hgrA \| matA	aberrant macrocyst formation
DBS0351590	hgrA-/ KAX3	hgrA	aberrant macrocyst formation
DBS0351594	hgrB-	hgrB \| matA	aberrant macrocyst formation
DBS0351591	hgrB-/ KAX3	hgrB	aberrant macrocyst formation
DBS0238583	hipA-	hipA	decreased spore germination \| aberrant spore morphology \| aberrant cortical actin cytoskeleton organization \| aberrant spore coat morphology \| increased protein localization to plasma membrane
DBS0351165	hspb1-	hsbp1-1 \| hsbp1-2	decreased exocytosis \| decreased protein level \| aberrant protein localization to lysosomal membrane
DBS0351532	hspc300-/ AX2	hspc300	aberrant macropinocytosis \| aberrant cytokinesis \| decreased cell motility \| decreased filopodium formation \| abolished protein level
DBS0350289	hspc300-/ [act15]: myc: hspc300	hspc300	wild type
DBS0252818	hssA-	hssA	wild type
DBS0351066	htmA-	htmA	decreased gene expression \| aberrant sorocarp development \| increased cell-substrate adhesion \| decreased cell motility
DBS0349776	htt-	htt	aberrant cell separation during cytokinesis \| decreased growth rate \| decreased chemotaxis rate \| delayed development \| delayed gene expression \| decreased myosin II assembly
DBS0349788	htt-	htt	aberrant aggregation \| abolished stream development \| development arrests at loose mound stage \| aberrant cellular response to starvation \| aberrant spore morphology \| decreased spore germination \| abolished cell motility in response to calcium ion \| increased number of mound tips \| aberrant sorocarp development \| aberrant hypotonic response \| aberrant actin filament organization \| abolished culmination \| decreased sporulation \| aberrant prespore cell differentiation \| abolished calcium-independent cell-cell adhesion \| abolished protein level \| abolished chemotaxis to cAMP
DBS0351281	htt-	htt	abolished gene expression \| aberrant sorus morphology \| decreased gene expression \| decreased growth rate \| aberrant slug development \| aberrant sorocarp development \| delayed development \| decreased cAMP level \| aberrant prestalk cell differentiation
DBS0350438	ibrA-	ibrA	aberrant substrate adhesion-dependent cell spreading \| aberrant contractile vacuole organization \| decreased phagocytosis \| decreased growth rate \| aberrant cytokinesis \| aberrant hypotonic response \| decreased contractile vacuole discharge
DBS0349794	ibrA-	ibrA	aberrant stalk development
DBS0252699	icmA-	icmA-1 \| icmA-2	abolished sporulation \| abolished stream development \| aberrant extracellular cAMP signaling pathway \| abolished establishment of cell polarity \| development arrests at mound stage \| abolished vegetative growth \| aberrant oscillatory cAMP signaling \| aberrant fruiting body morphogenesis \| aberrant protein localization to nucleus \| delayed gene expression \| aberrant protein localization
DBS0252702	icmA-/ [act15]: TAP: YFP: rasG	icmA-1 \| icmA-2 \| rasG	abolished C-terminal protein methylation
DBS0252701	icmA-/ [act15]: hICMT	icmA-1 \| icmA-2	wild type
DBS0252700	icmA-/ [act15]: icmA	icmA-1 \| icmA-2	wild type
DBS0236421	icpA-	icpA	abolished protein localization to mitotic spindle \| aberrant mitosis \| aberrant cytokinesis \| abolished protein localization to cleavage furrow \| abolished protein localization to mitotic spindle midzone \| aberrant protein localization
DBS0238521	icpA-/ [act15]: GFP: icpA(1-1013)	icpA	aberrant protein localization to mitotic spindle
BS153	ifkA-	ifkA	increased mound size \| precocious aggregation \| precocious gene expression \| decreased protein secretion
BS160	ifkB-	ifkB	increased prestalk gene expression
DBS0236425	ino1-	ino1	increased number of mound tips \| decreased phagocytosis \| abolished vegetative growth \| increased 2,3-bisphosphoglycerate level \| decreased myo-inositol level
DBS0350801	ino1-	ino1	aberrant cellular metabolic process \| increased number of autophagosomes \| decreased cell-substrate adhesion \| aberrant phosphatidylinositol metabolism \| aberrant cytokinesis \| abolished vegetative growth \| aberrant fruiting body morphogenesis \| decreased myo-inositol level
DBS0266326	iplA-	iplA	abolished cellulose biosynthesis \| abolished autophagosome organization \| abolished autophagic cell death \| aberrant autophagic cell death
HM1038	iplA-	iplA	aberrant cell motility \| precocious aggregation \| delayed aggregation \| aberrant chemotaxis \| aberrant calcium-mediated signaling \| increased bleb assembly \| increased chemotaxis to arachidonic acid \| abolished positive regulation of chemorepellant activity
DBS0351539	iplA-/ AX2	iplA	abolished response to DIF-1 \| abolished response to cAMP \| aberrant GABA signaling pathway
DBS0350439	iplA-/ [act15]: GFP: iplA	iplA	wild type
DBS0252878	iptA-	iptA	decreased spore germination \| aberrant sporulation
DBS0350400	iqgC-	iqgC	decreased myosin II assembly
DBS0351225	iqgC-	iqgC	aberrant cytokinesis \| increased macropinocytosis \| increased phagocytosis
DBS0351435	ireA-	ireA	increased number of autophagosomes \| decreased protein level \| aberrant vacuole organization \| aberrant gene expression \| aberrant cellular response to stress \| aberrant endoplasmic reticulum organization \| aberrant protein localization
DBS0351436	ireA-/ [act15]: ireA(K603N): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0351437	ireA-/ [act15]: ireA(N927A): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0236031	kctd9-	kctd9	wild type
DBS0350472	kif1-	kif1	aberrant transport
DBS0350959	kif10-/ [act15]: dhcA(1384-4725)	dhcA \| kif10	wild type
DBS0350038	kif11-	kif11	wild type
DBS0236489	kif12-	kif12	aberrant protein localization to mitotic spindle \| aberrant cell separation during cytokinesis \| aberrant cytokinesis \| aberrant myosin II filament organization \| increased bleb assembly
DBS0236490	kif12-/ [act15]: FLAG: kif12	kif12	wild type
DBS0302534	kif13-	kif13	precocious mitotic spindle elongation \| aberrant mitotic spindle organization
DBS0350039	kif4-	kif4	decreased growth rate
DBS0350042	kif4-/ [act15]: dhcA(1384-4725)	dhcA \| kif4	aberrant mitotic spindle organization
DBS0350021	kif5-	kif5	wild type
DBS0350022	kif5-/ [act15]: FLAG: kif5	kif5	aberrant cytokinesis \| aberrant cell morphology
DBS0350023	kif5-/ [act15]: FLAG: kif5(342-990)	kif5	aberrant cell morphology
DBS0350024	kif5-/ [act15]: GFP: kif5(805-990)	kif5	aberrant cytokinesis
DBS0236494	kif7-	kif7	decreased cell migration to prestalk region
DBS0350040	kif8-	kif8	aberrant microtubule cytoskeleton organization
DBS0350947	kif8-/ [act15]: dhcA(1384-4725)	dhcA \| kif8	wild type
DBS0349964	kif9-	kif9	aberrant mitotic spindle organization \| aberrant mitosis \| decreased growth rate \| aberrant protein localization to nuclear envelope \| aberrant centrosome localization \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0236491	kil1-	kil1	abolished defense response to Gram-negative bacterium \| increased defense response to fungus
DBS0350043	kil2-	kil2	aberrant response to cation stress \| aberrant defense response to bacterium \| decreased protein processing in phagocytic vesicle \| abolished defense response to Gram-negative bacterium \| increased defense response to fungus
DBS0350874	kil2-	kil2	aberrant defense response to bacterium \| decreased growth rate
DBS0350044	kil2-/ [act15]: kil1	kil1 \| kil2	abolished defense response to bacterium
DBS0351502	knkA-	knkA	decreased spore germination \| aberrant spore morphology \| decreased number of autophagosomes \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| aberrant phototaxis \| decreased sporulation
DBS0236492	krsA-	krsA	decreased chemotaxis to cAMP
DBS0238720	krsA-	krsA	abolished stream development \| precocious culmination \| abolished activation of adenylate cyclase activity \| decreased vegetative cell size \| decreased mound size \| aberrant hyperosmotic response \| precocious gene expression \| decreased cAMP level
DBS0236493	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238721	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238722	krsA-/ [act15]: GFP: krsA(K49R)	krsA	aberrant stream morphology
DBS0238723	krsA-/ [act15]: GFP: krsA(T173A)	krsA	abolished stream development
DBS0238725	krsA-/ [act15]: GFP: krsA(deltaC)	krsA	aberrant stream morphology
DBS0238724	krsA-/ [act15]: GFP: krsA(deltaKinase)	krsA	abolished stream development
DBS0238726	krsA-/ [act15]: GFP: krsA(deltaNS)	krsA	abolished stream development
DBS0350598	krsB-	krsB	aberrant stream morphology \| decreased cell motility \| increased cell-substrate adhesion \| delayed development \| decreased chemotaxis to cAMP
DBS0350599	krsB-/ [tet]: krsB(T176A): GFP	krsB	aberrant stream morphology
DBS0236495	ku80-	ku80	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0350537	ku80-/ myc: ku80(1-782)	ku80	decreased double-strand break repair via nonhomologous end joining
DBS0236498	lagD-	tgrD1	aberrant aggregation \| abolished stream development \| aberrant extracellular cAMP signaling pathway
DBS0236499	limB-	limB	decreased cell-substrate adhesion \| abolished cell migration to prestalk region \| development arrests at mound stage \| delayed prestalk gene expression \| aberrant cell-cell adhesion \| decreased prestalk gene expression \| decreased chemotaxis rate \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0236502	limB-/ [act15]: paxB: GFP	limB \| paxB	development arrests at mound stage
DBS0236500	limB-/ [cotC]: limB	limB	development arrests at mound stage
DBS0236501	limB-/ [ecmAO]: limB	limB	wild type
DBS0350563	limC-	limC	delayed aggregation \| decreased growth rate \| aberrant cytokinesis \| aberrant response to osmotic stress
DBS0350564	limD1-	limD1	increased lateral pseudopodium formation \| delayed aggregation \| decreased growth rate \| aberrant cytokinesis \| aberrant response to osmotic stress \| decreased chemotaxis to cAMP \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0236503	limE-	limE	aberrant cytokinesis
DBS0236506	limF-	limF	decreased phagocytosis
DBS0236511	lipA-	lipA	wild type
DBS0236512	lipA-	lipA	wild type
DG1006	lipA-	lipA	abolished culmination
DG1056	lipB-	captC	aberrant fruiting body morphogenesis
DBS0349950	lmbd2B-	lmbd2B	aberrant chemotaxis \| delayed development \| aberrant cell morphology \| increased pseudopodium formation
DBS0349982	lmnB-	lmnB	aberrant chromatin assembly \| aberrant centrosome localization
DBS0350354	lmpA-	lmpA	decreased lysosomal protein degradation \| decreased pinocytosis \| decreased protein level \| decreased phagocytosis \| decreased growth rate \| decreased cell motility \| decreased protein processing in phagocytic vesicle \| aberrant phagosome maturation \| decreased fruiting body size \| decreased defense response to Gram-positive bacterium \| decreased sporulation
DBS0351481	lmpB-	lmpB	decreased phagocytosis
DBS0351482	lmpC-	lmpC	decreased protein localization to cell surface \| increased protein localization to cell surface
DBS0350452	lpten-	lpten	aberrant cell motility \| decreased lateral pseudopodium retraction
DBS0350453	lpten-/ [act15]: lpten: RFP	lpten	wild type
DBS0236516	lrrA-	lrrA	increased mound size \| decreased spore germination \| decreased cell-substrate adhesion \| abolished establishment of cell polarity \| decreased gene expression \| development arrests at mound stage \| increased actin filament polymerization \| abolished positive chemotaxis \| abolished aggregation \| delayed gene expression
DBS0350407	lrrB-	lrrB	aberrant thermotaxis \| delayed slug development \| aberrant gene expression \| aberrant sorocarp development \| decreased prestalk gene expression \| aberrant phototaxis \| aberrant late culminant morphology
DBS0350478	lrrB-/ [ecmB]: lacZ	lrrB	aberrant prestalk B cell differentiation
DBS0350476	lrrB-/ [ecmO]: lacZ	lrrB	aberrant prestalk O cell differentiation
DBS0351456	lrrkA-	drkD	aberrant defense response to bacterium \| decreased protein processing in phagocytic vesicle \| abolished vegetative growth
DBS0236517	lst8-	lst8	aberrant activation of adenylate cyclase activity \| decreased actin filament polymerization \| decreased chemotaxis rate \| abolished aggregation \| decreased myosin II assembly \| abolished positive regulation of chemorepellant activity
DBS0350106	lst8-	lst8	increased phagocytosis
DBS0350114	lst8-/ [act15]: GFP: rheb(Q64L)	lst8 \| rheb	increased phagocytosis
DBS0309063	lvsA-	lvsA	increased bleb assembly
AD60	lvsA-	lvsA	abolished cytokinesis \| decreased pinocytosis \| aberrant contractile vacuole organization \| decreased phagocytosis \| aberrant hypotonic response \| increased cell-substrate adhesion
AD63	lvsA-	lvsA	abolished cytokinesis \| abolished contractile vacuole dissociation from plasma membrane \| aberrant calcium-mediated signaling
DBS0236521	lvsB-	lvsB	increased secretion of lysosomal enzymes \| increased lysosome size \| increased exocytosis \| increased pinocytosis \| aberrant protein localization to post-lysosomal vacuole \| aberrant phagosome maturation \| increased endosome size \| aberrant post-lysosomal vacuole exocytosis \| increased endosomal vesicle fusion \| aberrant lysosome organization
DBS0350567	lvsB-/ [act15]: FLAG: Rab14(N121I)	lvsB \| rab14	wild type
DBS0236522	lvsC-	lvsC	wild type
DBS0236523	lvsD-	lvsD	wild type
DBS0236524	lvsE-	lvsE	wild type
DBS0236525	lvsF-	lvsF	wild type
DBS0351162	lyC2-	lyC2	decreased growth rate
DBS0349933	macA-	macA	aberrant macrocyst formation \| decreased sexual fusion
DBS0236536	malA-	malA	wild type
DBS0351251	matA-	matA	abolished mating type determination
HM1524	matA-	matA	abolished mating type determination
DBS0350211	mef2A-	mef2A	decreased growth rate \| aberrant sorocarp development \| aberrant stream morphology \| decreased sporulation
DBS0350212	mef2A-	mef2A	decreased growth rate \| aberrant stream morphology \| aberrant sorocarp development \| aberrant gene expression \| decreased sporulation
DBS0350213	mef2A-/ [ecmA]: lacZ	mef2A	aberrant prestalk A cell differentiation
DBS0350214	mef2A-/ [ecmB]: lacZ	mef2A	aberrant prestalk B cell differentiation
DBS0350215	mef2A-/ [pspA]: lacZ	mef2A	decreased prespore cell differentiation
DBS0236543	mekA-	mekA	decreased mound size \| precocious development \| abolished chemotaxis to cAMP
DBS0350030	mekA-/ [act15]: Myc: erkA	erkA \| mekA	abolished protein localization to cell cortex
DBS0350036	mekA-/ [act15]: mekA(299-360)	mekA	decreased mound size
DBS0350035	mekA-/ [act15]: mekA(K321A)	mekA	decreased mound size
DBS0350032	mekA-/ [act15]: mekA(S444A/ T448A)	mekA	decreased mound size
DBS0350031	mekA-/ [act15]: mekA(S444E/ T448E)	mekA	development arrests at mound stage
DBS0236544	mfeA-	mfeA	aberrant cellular metabolic process \| decreased protein level \| aberrant extracellular cAMP signaling pathway \| development arrests at mound stage
DBS0351543	mfsd8-	mfsd8	increased protein secretion
DBS0266843	mgp1-	mgp1	increased phototaxis \| abolished stream development \| increased filopodium formation \| aberrant contractile vacuole organization \| decreased cell motility \| decreased fruiting body size \| decreased stalk width \| decreased stalk length
DBS0266846	mgp1-/ mgp2-	mgp1 \| mgp2	increased filopodium formation \| aberrant contractile vacuole organization \| aberrant culmination \| decreased cell motility \| decreased phototaxis \| decreased stalk length
DBS0266844	mgp2-	mgp2	increased migratory slug size \| increased mound size
HS1	mhcA-	mhcA	development arrests at mound stage \| aberrant cytokinesis \| decreased growth rate \| increased actin filament polymerization \| aberrant hypotonic response \| aberrant regulation of GTPase activity \| abolished bleb assembly \| aberrant regulation of protein kinase activity \| aberrant cellular response to stress
HS2205	mhcA-	mhcA	abolished cell motility \| decreased cell motility
HS2207	mhcA-	mhcA	abolished cytokinesis \| development arrests at mound stage
DBS0350064	mhcA-	mhcA	decreased cell motility \| decreased establishment of cell polarity
HS2206	mhcA-	mhcA	aberrant cellular response to fluid shear stress \| abolished bleb assembly
HK321	mhcA-	mhcA	aberrant cortical actin cytoskeleton organization \| aberrant chemotaxis to folate \| aberrant cell morphology
HK323	mhcA-	mhcA	decreased cell motility \| aberrant stream morphology
DBS0266674	mhcA-/ [act15]: GFP: abpC(9-148)	abpC \| mhcA	decreased uropod retraction \| decreased pseudopodium retraction
DBS0237564	mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA	ctxA \| enlA \| mhcA	aberrant mitotic actomyosin contractile ring contraction
DBS0266675	mhcA-/ [act15]: GFP: mhcA(E476K)	mhcA	decreased pseudopodium retraction
DBS0350489	mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1	mhcA \| rmd1	abolished protein localization to cleavage furrow
DBS0236548	mhcA-/ [act15]: GFP: pats1(2087-2351)	mhcA \| pats1	aberrant cytokinesis
DBS0350291	mhcA-/ [act15]: gppA: GFP	gppA \| mhcA	aberrant contractile vacuole morphology \| decreased contractile vacuole discharge
DBS0236549	mhcA-/ [act15]: limE(1-145): GFP	limE \| mhcA	increased actin filament polymerization
DBS0350808	mhcA-/ [act15]: mhcA(1-933: 1455-2116]	mhcA	wild type \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0238158	mhcA-/ [act15]: mhcA(81-2116)	mhcA	decreased growth rate \| development arrests at tipped mound stage
CW0401	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	increased myosin II assembly \| decreased growth rate \| aberrant chemotaxis
DBS0236550	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased filopodium formation
DBS0236551	mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D)	mhcA	increased filopodium formation
DBS0238399	mhcA-/ [act15]: rapA(G12V)	mhcA \| rapA	increased establishment of cell polarity \| increased actin filament polymerization \| aberrant myosin II filament organization
DBS0236552	mhcA-/ [mhcA]: mhcA(1-1224)	mhcA	aberrant cytokinesis \| development arrests at mound stage
DBS0350948	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(E683K)	mhcA	aberrant catalytic activity
DBS0350949	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R686C)	mhcA	aberrant catalytic activity
DBS0238157	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H)	mhcA	decreased actin filament sliding
DBS0236547	mhcA-/ [unk]: GFP: icpA	icpA \| mhcA	decreased protein localization to cleavage furrow
CW0371	mhkA-	mhkA	increased myosin II assembly \| aberrant chemotaxis \| decreased cell motility \| aberrant protein localization to pseudopodium
DBS0236557	mhkA-/ [act15]: mhkA	mhkA	decreased growth rate \| development arrests at mound stage \| aberrant cytokinesis \| decreased myosin II assembly
CW0166	mhkB-	mhkB	increased myosin II assembly \| decreased cell motility
CW0403	mhkC-	mhkC	increased myosin II assembly \| aberrant cytokinesis \| aberrant chemotaxis
DG1069	mhkC-	mhkC	aberrant fruiting body morphogenesis
CW0435	mhkD-	mhkD	increased myosin II assembly \| decreased cell motility
DBS0236559	midA-	midA	decreased pinocytosis \| aberrant cellular homeostasis \| aberrant spore morphology \| decreased glycogen level \| increased ammonia level \| decreased thermotaxis \| increased autophagy \| decreased mitochondrial fission \| decreased growth rate \| decreased phagocytosis \| decreased vegetative cell size \| increased slug migration \| increased glutamate level \| decreased phototaxis
DBS0350123	midA-/ [act15]: GFP: atg18	atg18 \| midA	increased number of autophagosomes
DBS0350136	midA-/ [act15]: GFP: tkt	midA \| tkt-1 \| tkt-2	increased autophagy
DBS0351180	midA/ [act15]: midA(E200A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351182	midA/ [act15]: midA(G170V/ G172V)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351181	midA/ [act15]: midA(N205A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DG1020	migA-	migA	abolished slug migration \| decreased mound size \| aberrant fruiting body morphogenesis \| decreased fruiting body size
DBS0350958	migA-	migA	decreased gene expression \| aberrant chemotaxis to cAMP
DBS0350025	mip1-	mip1-1 \| mip1-2	increased mound size \| decreased chemotaxis to cAMP
DBS0350027	mip1-/ [act15]: mekA: FLAG	mekA \| mip1-1 \| mip1-2	aberrant protein localization to cytoplasm
DBS0266620	mipp1-	mipp1	aberrant inositol phosphate metabolic process \| increased response to lithium
DBS0236560	mkcA-	mkcA	decreased prestalk gene expression
DG1101	mkcB-	mkcB	decreased fruiting body size
DBS0236564	mkkA-	mkkA	precocious culmination \| decreased sorus size \| increased stalk length
DG1121	mkpA-	mkpA	abolished aggregation
DBS0236566	mlcE-	mlcE	aberrant cytokinesis \| decreased growth rate \| delayed aggregation \| aberrant taxis \| aberrant sorocarp development \| decreased cell motility \| aberrant gene expression
DBS0238058	mlcE-/ [act15]: myc: mlcE	mlcE	wild type
DBS0236567	mlcR-	mlcR	aberrant cytokinesis \| development arrests at mound stage \| aberrant myosin II filament organization
DBS0351550	mlcR-/ [ecmAO]: GFP	mlcR	aberrant development of tipped mound
HS183	mlkA-	mlkA	aberrant cytokinesis
DBS0349919	mlkA-/ [act15]: GFP-mhcA	mlkA	aberrant stalk morphogenesis
DG1033	modA-	modA	decreased response to Gram-negative bacterium \| abolished catalytic activity \| aberrant fruiting body morphogenesis
DBS0266903	mpl1-	mpl1	abolished stream development \| decreased cell motility \| decreased chemotaxis to cAMP \| abolished aggregation
DBS0266904	mpl1-/ [act15]: flag: mpl1	mpl1	wild type
DBS0349986	mrfA-	mrfA	aberrant slug migration \| delayed development
DBS0350391	mrfA-/ [act15]: myc: mrfA(K772A): FLAG	mrfA	aberrant protein modification
DBS0350390	mrfA-/ [act15]: myc: mrfA(S767A): FLAG	mrfA	aberrant protein modification \| delayed development
DBS0350389	mrfA-/ [act15]: myc: mrfA: FLAG	mrfA	wild type
DBS0349987	mrfA-/ [emcA]: lacZ	mrfA	decreased prestalk A cell differentiation
DBS0350960	mroh1-	mroh1	aberrant exocytosis \| decreased lysosome size
DBS0236569	mrps4-	mrps4	delayed aggregation \| aberrant fruiting body morphogenesis
DBS0350868	mtpn-	mtpn	decreased actin filament polymerization \| decreased growth rate \| decreased cell motility \| aberrant stream morphology \| decreased macropinocytosis
HM1464	mus81-	mus81	wild type
DBS0350866	mvpA-	mvpA	aberrant cell morphology
DBS0236570	mybB-	mybB	decreased gene expression \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| abolished aggregation
DBS0236571	mybB-	mybB	abolished aggregation
HM388	mybC-	mybC	decreased gene expression \| development arrests at slug stage \| decreased prespore gene expression \| abolished culmination
DBS0236572	mybE-	mybE	increased migratory slug size \| increased gene expression \| abolished outer basal disc formation
DBS0237709	mybE-/ [mrrA]: lacZ	mrrA \| mybE	aberrant prestalk cell differentiation
DBS0236573	mybE-/ mybE: GFP	mybE	wild type \| aberrant prestalk cell differentiation
HDT1	myoA-	myoA	aberrant aggregation \| decreased lateral pseudopodium retraction \| delayed aggregation \| decreased cell motility \| decreased chemotaxis rate \| aberrant pseudopodium formation \| decreased chemotaxis to cAMP
HDT2	myoA-	myoA	increased secretion of lysosomal enzymes \| delayed aggregation
DBS0236579	myoB-	myoB	increased secretion of lysosomal enzymes \| aberrant aggregation \| decreased lateral pseudopodium retraction \| decreased cell motility \| decreased chemotaxis to cAMP
DBS0236580	myoB-	myoB	increased lateral pseudopodium formation \| decreased phagocytosis \| delayed aggregation \| decreased cell motility
DBS0349853	myoB-	myoB	decreased phagolysosome size \| delayed phagosome reneutralization \| aberrant phagosome maturation
DBS0236583	myoB-/ [AS]myoD	myoB \| myoD	decreased pinocytosis \| aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| decreased mound size \| decreased cell motility
DBS0236584	myoB-/ [AS]myoD/ [KD]myoC	myoB \| myoC \| myoD	decreased pinocytosis \| aberrant aggregation \| decreased pinosome size \| decreased growth rate \| decreased phagocytosis \| decreased mound size \| decreased cell motility \| increased number of pinosomes
DBS0351378	myoB-/ [act15]: GFP: myoB(1-720)	myoB	abolished protein localization to plasma membrane
DBS0351379	myoB-/ [act15]: GFP: myoB(1-800,813-1111)	myoB	abolished protein localization to actin wave \| abolished protein localization to plasma membrane
DBS0351380	myoB-/ [act15]: GFP: myoB(713-1111)	myoB	abolished protein localization to leading edge
DBS0351367	myoB-/ [act15]: myoB(S332A)	myoB	abolished protein phosphorylation
DBS0236585	myoC-	myoC	decreased phagocytosis
HDT4	myoC-	myoC	decreased pinocytosis \| decreased phagocytosis
DBS0236587	myoD-	myoD	wild type
HDT8	myoF-	myoF	aberrant aggregation \| wild type \| increased lateral pseudopodium formation \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant cell morphology
DBS0350251	myoG-	myoG	decreased protein localization to plasma membrane \| decreased actin filament polymerization \| abolished establishment of cell polarity \| aberrant chemotaxis to cAMP \| abolished aggregation
DBS0236589	myoI-	myoI	decreased spore germination
DBS0236592	myoI-	myoI	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HDT15	myoI-	myoI	decreased phagocytosis
HDT17	myoI-	myoI	decreased cell-cell adhesion \| decreased protein level \| decreased cell-substrate adhesion \| decreased phagocytosis \| decreased filopodium formation
DBS0266889	myoI-/ [act15]: GFP: myoI	myoI	wild type
DBS0351400	myoI-/ [act15]: GFP: myoI(1-1020)	myoI	abolished protein localization to pseudopodium \| decreased filopodium formation
DBS0351398	myoI-/ [act15]: GFP: myoI(2057-2357)	myoI	increased filopodium formation
DBS0266890	myoI-/ [act15]: GFP: myoI(809-1154)	myoI	decreased phagocytosis
DBS0351399	myoI-/ [act15]: GFP: myoI(K23333A,K2336A)	myoI	increased filopodium formation
DBS0237617	myoI-/ [act15]: gbpD	gbpD \| myoI	increased cell-substrate adhesion \| aberrant cell morphology \| increased pseudopodium formation
HTD7	myoJ-	myoJ	wild type
DBS0350931	myoJ-	myoJ	decreased hypotonic response \| aberrant contractile vacuole discharge \| aberrant contractile vacuole localization
DBS0349844	myoK-	myoK	aberrant cortical actin cytoskeleton organization \| delayed aggregation \| decreased phagocytosis \| aberrant engulfment during phagocytosis \| aberrant phagosome maturation \| decreased chemotaxis rate \| aberrant cell morphology \| delayed phagosome acidification
DBS0349846	myoK-/ [act15]: YFP: myoK(1-121: 262-858)	myoK	decreased phagocytosis
DBS0349850	myoK-/ [act15]: myoK	myoK	increased phagocytosis
DBS0349854	myoK-/ [act15]: pakB(1-337: 563-852)	myoK \| pakB	wild type
DBS0236595	myoM-	myoM	wild type
DBS0351046	nad2-	nad2	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant fruiting body morphogenesis \| aberrant phototaxis
DBS0351048	nad5-	nad5	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
AK1372	nagB1-	nagB1	decreased response to Gram-positive bacterium
DBS0236596	napA-	napA	aberrant cellular response to extracellular stimulus
SB12	napA-	napA	decreased cell-cell adhesion \| decreased cell-substrate adhesion \| decreased actin filament polymerization \| decreased cell motility \| decreased vegetative cell size \| decreased establishment of cell polarity \| decreased phototaxis
DBS0351534	napA-/ AX2	napA	decreased protein level \| increased membrane ruffling \| aberrant cytokinesis \| increased vegetative cell size \| decreased cell motility
HC476	ncsA-	ncsA	increased cAMP level \| precocious gene expression \| precocious development
HC477	ncsA-	ncsA	increased cAMP level \| precocious gene expression \| precocious development
DBS0350297	ncstn-	ncstn	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0350307	ncstn-	ncstn	wild type \| aberrant sorocarp development \| decreased macropinocytosis
DBS0349947	ndm-	ndm	aberrant chemotaxis \| increased pinocytosis \| decreased fruiting body size \| aberrant pseudopodium formation
DBS0349895	ndrA-	ndrA	decreased engulfment during phagocytosis
DBS0349896	ndrA-/ [unk]: GFP: ndrA	ndrA	wild type
DBS0350446	ndrC-	ndrC	increased positive regulation of GTPase activity \| increased number of centrosomes \| aberrant cell separation during cytokinesis
DBS0350121	ndufaf5-	ndufaf5	aberrant spore morphology \| decreased growth rate \| delayed development \| aberrant phototaxis \| decreased fruiting body size \| decreased sporulation
DBS0350125	ndufaf5--/ [act15]: ndufaf5(G86V): GFP: TAP	ndufaf5	decreased growth rate
DBS0350126	ndufaf5--/ [act15]: ndufaf5(L165F): GFP: TAP	ndufaf5	decreased growth rate
DBS0350127	ndufaf5--/ [act15]: ndufaf5(L235P): GFP: TAP	ndufaf5	decreased growth rate
DBS0350124	ndufaf5--/ [act15]: ndufaf5: GFP: TAP	ndufaf5	wild type
DBS0350122	ndufaf5-/ [act15]: GFP: atg18	atg18 \| ndufaf5	increased number of autophagosomes
DBS0350134	ndufaf5-/ [act15]: GFP: tkt	ndufaf5 \| tkt-1 \| tkt-2	increased autophagy
DBS0350137	ndufaf5-/ [act15]: [AS]snfA	ndufaf5 \| snfA	aberrant phototaxis
DBS0304633	nfaA-	nfaA	aberrant extracellular cAMP signaling pathway \| aberrant activation of GTPase activity \| increased actin filament polymerization \| delayed aggregation \| decreased cell motility \| aberrant regulation of GTPase activity \| aberrant regulation of protein kinase activity \| aberrant protein localization to plasma membrane \| decreased chemotaxis to cAMP \| increased pseudopodium formation
DBS0351061	ngap-	ngap	aberrant regulation of fruiting body formation \| aberrant extracellular cAMP signaling pathway \| aberrant adaptation of signaling pathway \| increased actin filament polymerization \| aberrant chemotaxis to cAMP \| aberrant regulation of protein kinase activity \| decreased establishment of cell polarity \| increased activation of GTPase activity
DBS0236604	nhe1-	nhe1	abolished cell motility in response to calcium ion \| decreased intracellular pH \| abolished establishment of cell polarity \| decreased actin filament polymerization \| decreased chemotaxis rate \| delayed development \| aberrant actin filament organization \| decreased establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0350003	nhe1-/ [act15]: GFP: aip1	aip1 \| nhe1	decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0350006	nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A)	aip1 \| nhe1	abolished aggregation \| abolished chemotaxis to cAMP
DBS0350001	nhe1-/ [act15]: aip1(168-597)	aip1 \| nhe1	delayed development
DBS0350002	nhe1-/ [act15]: aip1(383-597): FLAG	aip1 \| nhe1	decreased actin filament polymerization \| abolished establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0349841	nhe1-/ [act15]: mhcA: GFP	mhcA \| nhe1	abolished protein localization to trailing edge
DBS0236605	nhe1-/ [act15]: nhe1: HA	nhe1	wild type
DBS0350508	nlp-	nlp	wild type
DBS0236606	nosA null (15-S-12)	nosA	development arrests at mound stage
DBS0236607	nosA null (2E4)	nosA	development arrests at mound stage
DBS0235950	nosA-	nosA	development arrests at mound stage \| aberrant protein modification
DBS0236608	noxA-	noxA	abolished sporulation \| aberrant sorocarp development
DBS0236611	noxA-/ [act15]: noxA: myc2	noxA	aberrant fruiting body morphogenesis
DBS0236612	noxB-	noxB	abolished sporulation \| aberrant sorocarp development \| decreased superoxide generation
DBS0236613	noxC-	noxC	abolished sporulation \| aberrant sorocarp development
DBS0238849	npcA-	npcA	wild type
HSB60	nramp1-	nramp1	decreased defense response to Gram-negative bacterium \| decreased defense response to Gram-positive bacterium \| abolished iron ion transport
DBS0236696	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0236697	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0350092	nrampB-	nrampB	decreased defense response to Gram-negative bacterium \| delayed aggregation
DBS0236955	nxnA-	nxnA	decreased lysosomal protein degradation \| decreased culmination \| decreased growth rate \| delayed development \| decreased chemotaxis to cAMP
DBS0351164	nxnA-	nxnA	aberrant cellular response to stress
DBS0236702	nxnA-/ [act15]: GFP: nxnB	nxnA \| nxnB	development arrests at mound stage
DBS0350857	odc-	odc	aberrant cellular metabolic process \| aberrant cell cycle \| abolished vegetative growth
DBS0236704	osbA-	osbA	increased slug migration \| precocious development
DBS0238357	p2xA-	p2xA	aberrant hypotonic response
DBS0304487	p2xA-	p2xA	wild type
DBS0350312	p2xA-	p2xA	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350484	p2xA-/ AX2	p2xA	wild type \| aberrant contractile vacuole discharge
DBS0350485	p2xA-/ AX4	p2xA	aberrant contractile vacuole discharge \| aberrant hypotonic response
DBS0238362	p2xA-/ [act15]: p2xA: GFP	p2xA	wild type
DBS0350315	p2xA-/ p2xA(K67A/ K289A)	p2xA	abolished hypotonic response
DBS0350314	p2xA-/ p2xA(R285K)	p2xA	decreased hypotonic response
DBS0350313	p2xA-/ p2xA(R63A)	p2xA	precocious hypotonic response
DBS0306166	p2xB-	p2xB	wild type
DBS0306167	p2xC-	p2xC	wild type
DBS0306168	p2xD-	p2xD	wild type
DBS0304486	p2xE-	p2xE	wild type
DBS0350013	pah-	pah	abolished catalytic activity \| abolished vegetative growth
DBS0350014	pah-/ [act15]: 6xHis: pah	pah	wild type
DBS0350016	pah-/ [act15]: 6xHis: pah(92-415)	pah	abolished vegetative growth
DBS0350015	pah-/ [act15]: 6xHis: pah(92-441)	pah	wild type
DBS0236705	pakA-	pakA	aberrant cytokinesis \| delayed development \| decreased myosin II assembly
DBS0236706	pakA-	pakA	wild type
DBS0349885	pakA-	pakA	delayed development \| decreased chemotaxis to cAMP \| increased bleb assembly
DBS0236707	pakA-/ [act15]: pakA	pakA	wild type
DBS0350810	pakA-/ [act15]: pakA(T579A)	pakA	decreased chemotaxis to cAMP
DBS0236709	pakB-	pakB	decreased growth rate \| decreased bleb assembly
DBS0236708	pakB-	pakB	abolished establishment of cell polarity \| decreased lateral pseudopodium retraction
DBS0236712	pakB-/ [act15]: GFP-pak(1-600)	pakB	abolished cytokinesis
DBS0236710	pakB-/ [act15]: GFP-pakB(1-337: 563-851)	pakB	abolished cytokinesis \| increased pinocytosis \| increased phagocytosis
DBS0350428	pakB-/ [act15]: RFP: abpE	abpE-1 \| abpE-2 \| pakB	decreased chemotaxis to cAMP \| aberrant establishment or maintenance of cell polarity \| abolished aggregation \| abolished protein localization to leading edge
DBS0350430	pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180)	abpE-1 \| abpE-2 \| pakB	wild type
DBS0236716	pakC-	pakC	decreased lateral pseudopodium retraction \| decreased bleb assembly \| decreased chemotaxis rate
DBS0350281	pakD-	pakD	aberrant cellular homeostasis \| aberrant filopodium formation \| aberrant actin cytoskeleton organization \| abolished negative regulation of vegetative growth \| abolished aggregation \| aberrant actin filament polymerization \| aberrant establishment or maintenance of cell polarity \| decreased chemotaxis to cAMP \| increased growth rate \| aberrant cellular response to extracellular stimulus \| abolished positive regulation of chemorepellant activity
DBS0350282	pakD-/ [act15]: pakD	pakD	development arrests at mound stage
DBS0350395	pakD-/ [act15]: pakD: GFP	pakD	wild type
HC392	patB-	patB	abolished vegetative growth
DBS0236726	pats1-	pats1	aberrant cytokinesis
DBS0350097	pats1-	pats1	aberrant cytokinesis
LAS45	pats1-	pats1	decreased socially cooperative development
DBS0236727	pats1-/ [act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0236728	paxB-	paxB	decreased exocytosis \| decreased cell-substrate adhesion \| abolished slug migration \| increased chemotaxis to cAMP \| development arrests at mound stage \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| decreased cell migration to prestalk region \| increased phagocytosis
DBS0304926	paxB-	paxB	aberrant cell separation during cytokinesis \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased cell motility
DBS0304930	paxB-/ [act15]: GFP: paxB	paxB	wild type
DBS0350973	paxB-/ [act15]: gpaH	gpaH \| paxB	aberrant cytokinesis
DBS0350094	paxB-/ [act15]: pldB	paxB \| pldB	wild type \| increased phagocytosis
DBS0236730	paxB-/ [ecmA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0236732	paxB-/ [pspA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0236733	pcp-	pcp	wild type \| aberrant hypotonic response
DBS0236734	pde4-	pde4	decreased culmination \| abolished stream development \| delayed slug development \| increased number of early culminant tips \| increased protein level \| delayed culmination
DBS0236735	pde4-/ [act15]: pde4: GFP	pde4	wild type
DBS0235991	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity
DBS0236736	pdeD-	pdeD	aberrant calcium-mediated signaling
DBS0350517	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity \| increased fruiting body size \| aberrant stream morphology
DBS0351194	pdeD-	pdeD	decreased protein localization to cell cortex \| abolished protein localization to cell cortex \| aberrant chemotaxis to cAMP \| aberrant actin filament polymerization \| decreased myosin II assembly \| increased activation of GTPase activity
DBS0350518	pdeD-/ [act15]: pdeD: YFP	pdeD	wild type
DBS0350900	pdeE-	pdeE	increased oscillatory cAMP signaling \| abolished 3',5'-cyclic-AMP phosphodiesterase activity
DBS0235993	pdeE-	pdeE	decreased 3',5'-cyclic-AMP phosphodiesterase activity \| aberrant chemotaxis to cAMP
DBS0236740	pdiA-	pdiA	decreased mound size \| aberrant oscillatory cAMP signaling \| decreased fruiting body size
DBS0350797	pdkA-	pdkA	aberrant macropinocytosis \| decreased protein kinase activation
DBS0350817	pdkA-	pdkA	decreased mound size \| decreased protein kinase activation
DBS0350798	pdkB-	pdkB	increased macropinocytosis
DBS0350818	pdkB-	pdkB	decreased mound size
DBS0237029	pdsA-	pdsA	aberrant chemotaxis to cAMP \| aberrant stream morphology
UK7	pdsA-	pdsA	decreased 3',5'-cyclic-AMP phosphodiesterase activity \| decreased gene expression \| aberrant sorocarp development \| abolished aggregation
DBS0236741	pefA-	pefA	wild type
DBS0236744	pefB-	pefB	wild type
HW260	pgtA-	pgtA	increased vegetative cell size
DBS0305022	pgtB-	pgtB	aberrant cellular metabolic process \| aberrant spore coat morphology \| aberrant hyperosmotic response
DBS0305023	pgtC-	pgtC	aberrant cellular metabolic process \| aberrant hyperosmotic response
DBS0236752	phdA-	phdA	decreased actin filament polymerization \| decreased mound size \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236753	phdA-/ [act15]: phdA	phdA	wild type
DBS0236754	phdA-/ [act15]: phdA: GFP	phdA	wild type
DBS0350865	phdG-	phdG	decreased chemotaxis to cAMP
DBS0236755	phg1A-	phg1A	increased secretion of lysosomal enzymes \| decreased lysosomal protein degradation \| decreased protein level \| decreased cell-substrate adhesion \| decreased gene expression \| aberrant defense response to bacterium \| aberrant cytokinesis \| decreased phagocytosis \| abolished defense response to bacterium \| decreased growth rate \| development arrests at slug stage \| decreased protein localization to cell surface \| aberrant phagocytosis \| increased lysosomal pH \| decreased protein stabilization
DBS0351549	phg1A-	phg1A	decreased cell-substrate adhesion \| decreased phagocytosis
DBS0236757	phg1A-/ [act15]: kil1	kil1 \| phg1A	decreased lysosomal protein degradation \| increased secretion of lysosomal enzymes \| wild type \| increased lysosomal pH \| decreased protein stabilization
DBS0304869	phg1A-/ [act15]: phg1A(1-276): phg1B221-587)	phg1A \| phg1B	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1B	phg1A \| phg1B	increased secretion of lysosomal enzymes \| wild type \| decreased cell-substrate adhesion \| aberrant protein level \| decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1B(1-220): phg1a(277-642)	phg1A \| phg1B	decreased phagocytosis
DBS0304866	phg1B-	phg1B	increased secretion of lysosomal enzymes \| decreased protein level \| decreased phagocytosis \| decreased growth rate \| abolished culmination
DBS0236758	phg2-	phg2	decreased cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology \| aberrant actin filament organization \| precocious development \| precocious gene expression \| aberrant response to nutrient
DBS0238400	phg2-	phg2	increased filopodium formation \| increased actin filament polymerization \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP \| aberrant cell morphology \| increased phagocytosis
DBS0350578	phg2-	phg2	abolished gene expression \| decreased protein phosphorylation \| aberrant protein localization to nucleus
DBS0236760	phg2-/ [act15]: GFP: phg2(199-1389)	phg2	decreased phagocytosis
DBS0237615	phg2-/ [act15]: gbpD	gbpD \| phg2	aberrant cell morphology \| abolished chemotaxis to cAMP \| increased pseudopodium formation
DBS0350580	phg2-/ [act15]: myc: ptpC	phg2 \| ptpC	abolished protein phosphorylation
HG1648	phgA-	phgA	increased contractile vacuole size \| aberrant contractile vacuole organization \| aberrant hypotonic response \| aberrant pore formation during contractile vacuole discharge
DBS0302610	phgA-/ [OE]: dsgg	dsgg \| phgA	aberrant contractile vacuole organization
DBS0236761	phgA-/ lvsA-/ [act6]: GFP: lvsA	lvsA \| phgA	aberrant protein localization to contractile vacuole
DBS0236762	phlp1-	phlp1	decreased response to cAMP \| aberrant regulation of protein modification \| abolished chemotaxis to folate \| decreased growth rate \| abolished protein localization to plasma membrane \| decreased cGMP-mediated signaling \| abolished aggregation \| abolished chemotaxis to cAMP
DBS0236763	phlp1-/ [OE]: phpl1	phlp1	wild type
DBS0236764	phlp3-	phlp3	wild type
DBS0350824	phr-	phr	aberrant chemotaxis to cAMP \| delayed development
HW288	phyA-	phyA	abolished sporulation \| abolished stalk development \| abolished peptidyl-proline hydroxylation \| abolished culmination \| increased response to hypoxia
DBS0266771	phyA-/ [ecmA]: phyA(D132N): myc	phyA	decreased peptidyl-proline hydroxylation
DBS0266770	phyA-/ [ecmA]: phyA(R276A): myc	phyA	abolished peptidyl-proline hydroxylation \| abolished culmination
DBS0236767	piaA-	piaA	aberrant activation of adenylate cyclase activity
DBS0236770	piaA-	piaA	aberrant cytokinesis
DBS0236771	piaA-	piaA	abolished aggregation \| decreased myosin II assembly \| increased phagocytosis
DBS0304637	piaA-	piaA	decreased cell motility \| decreased chemotaxis rate \| decreased establishment of cell polarity \| aberrant protein tyrosine phosphorylation
DBS0351319	piaA-	piaA	decreased taxis
DBS0349879	piaA-	piaA	decreased protein phosphorylation \| decreased protein kinase activity \| abolished protein phosphorylation \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| increased activation of GTPase activity \| abolished positive regulation of chemorepellant activity
DBS0351403	piaA-	piaA	aberrant cytokinesis
DBS0236779	pik6-	pik6	decreased gene expression \| abolished aggregation
DBS0236772	pikA-	pikA	wild type
DBS0236774	pikB-	pikB	wild type
DBS0236776	pikC-	pikC	wild type
DBS0236777	pikD1	pikD	abolished slug migration \| delayed aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0236778	pikE-	pikE	wild type
HM1241	pikF-	pikF	decreased pinocytosis \| decreased growth rate \| aberrant pinosome maturation
LAS31	pikG-	pikG	aberrant socially cooperative development
HM1513	pikI-	pikI	decreased catalytic activity \| decreased actin filament polymerization \| decreased growth rate \| aberrant chemotaxis to cAMP \| decreased cGMP-mediated signaling \| aberrant calcium-mediated signaling \| decreased protein kinase activation \| increased bleb assembly
DBS0350828	pinA-/ [ecmAO]: lacZ	pinA	aberrant prestalk cell differentiation
DBS0350827	pinA-/ [pspA]: lacZ	pinA	aberrant prespore cell differentiation
DBS0351429	pip5k3-/ AX2	pip5k3	decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle \| decreased protein localization to phagocytic vesicle
DBS0351428	pip5k3-/ AX3	pip5k3	aberrant macropinocytosis \| decreased growth rate
SB16	pirA-	pirA	decreased vegetative cell size \| increased cell motility
SB3	pirA-	pirA	increased actin filament polymerization \| increased vegetative cell size \| decreased cell motility \| aberrant cellular response to stress \| increased pseudopodium formation
DBS0351205	pirA-	pirA	decreased cell motility \| aberrant pseudopodium formation \| abolished protein level
DBS0351533	pirA-/ AX2	pirA	decreased protein level \| aberrant macropinocytosis \| aberrant cytokinesis \| increased vegetative cell size \| decreased cell motility \| decreased pseudopodium formation \| increased bleb assembly \| decreased filopodium formation
DBS0351206	pirA-/ pirA(K193D/ R194D): EGFP	pirA	abolished protein localization to cell periphery \| decreased protein phosphorylation
DBS0349901	pisA-	pisA	increased gene expression \| precocious development \| decreased fruiting body size \| aberrant prestalk cell differentiation
DBS0236783	pkaC-	pkaC	abolished gene expression \| increased protein phosphorylation \| aberrant response to abiotic stimulus \| decreased protein level \| decreased gene expression \| decreased activation of GTPase activity \| abolished catalytic activity \| aberrant response to cAMP \| increased cellular thermotolerance \| aberrant myosin II filament organization \| decreased protein kinase activation \| abolished aggregation \| aberrant actin filament organization \| aberrant protein localization to plasma membrane \| aberrant protein localization to cell cortex \| abolished chemotaxis to cAMP \| increased protein kinase activation \| increased activation of GTPase activity \| abolished positive regulation of chemorepellant activity
DBS0350694	pkaC-/ [act15]: pkaC	pkaC	abolished culmination
DBS0350708	pkaC-/ [act6]: pkaC(303-648)	pkaC	wild type
DBS0350707	pkaC-/ [act6]: pkaC(330-648)	pkaC	abolished aggregation
DBS0350710	pkaC-/ [dscC]: LUC	pkaC	decreased gene expression \| increased macropinocytosis
DBS0235411	pkaR-	pkaR	abolished stream development \| increased resistance to valproic acid \| decreased spore germination \| aberrant extracellular cAMP signaling pathway \| aberrant response to lithium \| increased gene expression \| precocious sporulation \| increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP \| decreased cell motility \| decreased fruiting body size \| aberrant cell morphology
DBS0351315	pkbA-	pkbA	decreased macropinocytosis
DBS0236784	pkbA-	pkbA	decreased pinocytosis \| decreased protein phosphorylation \| aberrant macropinocytosis \| decreased bleb assembly \| abolished protein kinase activation \| abolished protein localization \| abolished protein localization to trailing edge \| aberrant phagosome maturation \| increased phagocytosis \| decreased myosin II assembly
DBS0349876	pkbA-	pkbA	aberrant cellular response to extracellular stimulus \| increased protein kinase activation
DBS0350113	pkbA-/ [act15]: GFP: rheb(Q64L)	pkbA \| rheb	decreased phagocytosis
DBS0350916	pkcA-	pkcA	decreased cell-cell adhesion \| decreased protein level \| increased chemotaxis to cAMP \| decreased gene expression \| increased number of mound tips \| increased actin filament polymerization \| aberrant oscillatory cAMP signaling \| decreased fruiting body size \| abolished positive regulation of chemorepellant activity
DBS0350918	pkcA-	pkcA	aberrant aggregation \| decreased catalytic activity \| aberrant cytokinesis \| aberrant sorocarp development
DBS0350919	pkcA-/ [act15]: pldB	pkcA \| pldB	aberrant aggregation \| decreased sporulation
DBS0350917	pkcA-/ [ecmA]: GFP	pkcA	aberrant prestalk gene expression
DBS0350475	pkd2-	pkd2	increased resistance to naringenin \| decreased growth rate
DBS0350367	pkd2-	pkd2	aberrant cellular response to fluid shear stress \| aberrant exocytosis
DBS0351540	pkd2-/ AX2	pkd2	aberrant calcium-mediated signaling
DBS0236786	pkgB-	pkgB	decreased protein phosphorylation \| development arrests at mound stage \| abolished spore cell differentiation
DBS0350328	pkgB-	pkgB	aberrant sorocarp development
DBS0351316	pkgB-	pkgB	decreased macropinocytosis
DBS0304638	pkgB-	pkgB	decreased cell-substrate adhesion \| development arrests at mound stage \| decreased chemotaxis rate \| decreased taxis \| increased cell motility \| increased bleb assembly
DBS0236787	pkgB-/ [act15]: pkbA	pkbA \| pkgB	wild type
DBS0236789	pkgB-/ [act15]: pkgB(K182M)	pkgB	development arrests at mound stage
DBS0350329	pkgB-/ [emcB]: lacZ	pkgB	abolished prestalk gene expression
DBS0236790	pkgB-/ [gbfA]: pkbA	pkbA \| pkgB	wild type
DBS0236791	pkgB-/ [gbfA]: pkgB	pkgB	wild type
DBS0350319	pks17-	pks17	decreased fatty acid level \| increased gene expression \| delayed development \| decreased fruiting body size
LAS44	pks2-	pks2	decreased socially cooperative development
LAS19	pks26-	pks26	aberrant socially cooperative development
DBS0238068	plaA-	plaA	aberrant chemotaxis to cAMP \| abolished aggregation \| abolished positive regulation of chemorepellant activity
DBS0238067	plaA-	plaA	abolished aggregation
DG1067	plbG-	plbG	decreased stalk width \| decreased stalk length
HAD236	plc-	plc	decreased protein localization to plasma membrane \| aberrant chemotaxis to cAMP \| decreased protein localization to cytoplasm \| decreased protein kinase activation \| abolished aggregation
HD1.19	plc-	plc	aberrant negative chemotaxis
HD10	plc-	plc	aberrant cellular homeostasis \| wild type \| aberrant spore germination
DBS0267125	plc-/ [OE]: dagA(PH): GFP/ [OE]: plc	dagA \| plc	increased protein localization to plasma membrane \| decreased chemotaxis to cAMP
DBS0350047	plc-/ [act15]: pten: GFP	plc \| pten	wild type \| aberrant protein localization to cytoplasm
DBS0236796	pldB-	pldB	decreased catalytic activity \| precocious aggregation
DBS0236797	pldB-/ [act15]: pldB: GFP	pldB	abolished aggregation
DBS0350604	pldB-/ [unk]: GFP	pldB	increased cell migration to prestalk region
DBS0350605	pldB-/ [unk]: lacZ	pldB	increased cell migration to prestalk region
DBS0236799	plip-	plip	delayed aggregation
DBS0351187	plnA-	plnA	aberrant defense response to bacterium
DBS0350007	png-	png	delayed aggregation \| decreased mound size \| aberrant fruiting body morphogenesis
DBS0350492	png-/ [ecmAO]: lacZ	png	aberrant prestalk cell differentiation
DBS0350491	png-/ [ecmA]: lacZ	png	aberrant prestalk A cell differentiation
DBS0350493	png-/ [pspA]: lacZ	png	decreased prespore cell differentiation
DBS0236820	ponA-	ponA	precocious aggregation \| decreased actin nucleation \| aberrant sorocarp development \| aberrant pseudopodium formation
DBS0236821	ponA-	ponA	precocious aggregation \| decreased actin nucleation \| aberrant sorocarp development \| aberrant pseudopodium formation
DG1057	potA-	potA	aberrant fruiting body morphogenesis
DBS0351064	poxA-	poxA	aberrant defense response to bacterium
DBS0236824	ppk1-	ppk1	decreased growth rate \| decreased phagocytosis \| decreased fruiting body size \| delayed culmination \| decreased sporulation
ASH01	ppk1-	ppk1	aberrant cellular homeostasis \| decreased ATP level \| decreased growth rate \| aberrant spore germination \| aberrant macromolecule biosynthesis \| decreased fruiting body size \| increased growth rate
DBS0351356	ppk1-/ [act15]: GFP: hsp48	hsp48 \| ppk1	decreased protein level
DBS0236825	ppk1-/ [act15]: ppk1	ppk1	wild type
DBS0238099	ppp4C-	ppp4c	development arrests at mound stage \| delayed development
DBS0238110	ppp4C-/ [act15]: smkA	ppp4c \| smkA	development arrests at mound stage \| delayed development
DBS0238033	proC-	proC	increased lateral pseudopodium formation \| decreased chemotaxis rate \| decreased establishment of cell polarity
DBS0238034	proC-/ [unk]: FLAG: proC	proC	wild type
DBS0266716	pscA-	pscA	wild type
DBS0266803	psenA-	psenA	aberrant culmination \| decreased prespore cell differentiation
DBS0350302	psenA-	psenA	decreased prespore cell differentiation \| aberrant calcium-mediated signaling
DBS0350295	psenB-	psenB	decreased phagocytosis \| abolished catalytic activity
DBS0350303	psenB-	psenB	decreased prespore cell differentiation \| aberrant calcium-mediated signaling
DBS0351095	psenB-	psenB	aberrant response to chemical
HOK2	psiA-	psiA	abolished prespore cell division
DBS0351581	psiA-/ [ecmB]: lacZ	psiA	precocious prestalk gene expression
DBS0351578	psiA-/ [rnrB]: lacZ	psiA	aberrant prespore gene expression
DBS0236021	psiM-	psiM	wild type
DBS0236022	psiM-	psiM	wild type
DBS0236828	pslA-	pslA	abolished sporulation \| increased mound size \| decreased sorus size \| aberrant prestalk gene expression \| increased stalk length \| abolished stalk cell differentiation \| abolished prespore gene expression
DBS0236829	psmC1-	psmC1	increased resistance to spectinomycin \| aberrant standing slug morphology \| abolished slug migration \| increased vegetative cell size
HW70	pspB-	pspB	aberrant spore coat morphology \| precocious spore germination
DBS0302352	psrA-	psrA	decreased culmination \| increased protein phosphorylation \| decreased activation of GTPase activity \| delayed prestalk gene expression \| decreased cell motility \| delayed development \| increased protein kinase activation
DBS0351094	psrA-	psrA	aberrant response to chemical
DBS0302356	psrA-/ [act15]: FLAG: gskA	gskA \| psrA	increased protein kinase activation
DBS0302353	psrA-/ [act15]: ecmA: lacZ	psrA	aberrant prestalk gene expression
DBS0302354	psrA-/ [act15]: ecmB: lacZ	psrA	aberrant prestalk gene expression
DBS0302357	psrA-/ [act15]: gskA(K84M/ K85M)	gskA \| psrA	decreased culmination \| decreased prespore gene expression \| delayed development \| increased protein kinase activation
DBS0302355	psrA-/ [act15]: psrA	psrA	wild type
DBS0350829	psrA-/ [unk]: FLAG: rasD(G12T)	psrA \| rasD	increased protein kinase activation
HM1289	pten-	pten	aberrant cell motility \| decreased lateral pseudopodium retraction \| decreased cell motility \| decreased macropinocytosis \| abolished aggregation \| decreased chemotaxis to cAMP
DBS0236830	pten-	pten	decreased response to Gram-negative bacterium \| decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| decreased lateral pseudopodium retraction \| abolished protein localization to plasma membrane \| decreased growth rate \| increased actin filament polymerization \| decreased phagocytosis \| decreased bleb assembly \| decreased cell motility \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP \| abolished aggregation \| aberrant pseudopodium formation \| increased pseudopodium formation \| aberrant signal transduction \| abolished positive regulation of chemorepellant activity
DBS0349884	pten-	pten	aberrant cytokinesis \| increased protein kinase activity \| decreased chemotaxis to cAMP \| decreased establishment of cell polarity
DBS0350660	pten-	pten	decreased uropod retraction \| decreased protein localization to cleavage furrow \| decreased growth rate \| aberrant cytokinesis \| decreased protein localization to pseudopodium
DBS0350454	pten-/ [act15]: lpten: RFP	lpten \| pten	wild type
DBS0349890	pten-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0350754	pten-/ [act15]: pten(186-515): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0350755	pten-/ [act15]: pten(C124S): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0351587	pten-/ [act15]: pten(G129E)	pten	increased lateral pseudopodium formation \| aberrant localization
DBS0236831	pten-/ [act15]: pten: GFP	pten	wild type
DBS0349900	pten-/ pakA-/ [act15]: pakA(T585E): GFP	pakA \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349899	pten-/ pakA-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0236832	ptpA1-	ptpA1-1 \| ptpA1-2	decreased prespore cell differentiation \| precocious development \| increased prestalk O cell differentiation
DBS0236833	ptpB-	ptpB	increased migratory slug size
DBS0350675	ptpB-/ [act15]: 6xHis: erkA	erkA \| ptpB	aberrant stream morphology
DBS0236835	pufA-	pufA	increased protein kinase activity \| aberrant fruiting body morphogenesis \| increased protein level \| precocious development
DBS0304391	pyk3-	pyk3	increased prespore gene expression \| decreased prestalk gene expression \| increased prespore cell differentiation \| delayed culmination
DBS0350577	pyk3-	pyk3	decreased protein phosphorylation \| decreased gene expression \| aberrant protein localization to nucleus
DBS0350581	pyk3-	pyk3	decreased protein phosphorylation \| decreased gene expression
DBS0304393	pyk3-/ [act15]: T7: pyk3	pyk3	wild type
DBS0236837	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid \| abolished uracil biosynthetic process
DBS0236838	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid \| abolished uracil biosynthetic process
DBS0351499	pzoA-	pzoA	aberrant cellular response to fluid shear stress \| aberrant chemotaxis to cAMP
DBS0350017	qdpr-	qdpr	decreased spore germination \| decreased growth rate \| abolished catalytic activity \| aberrant response to oxidative stress
DBS0350018	qdpr-/ [act15]: pah	pah \| qdpr	decreased growth rate
DBS0236839	qkgA-	qkgA-1 \| qkgA-2	increased mound size \| delayed aggregation \| aberrant vegetative growth \| aberrant nucleus organization \| increased growth rate \| abolished negative chemotaxis
DBS0351552	qkgA-	qkgA-1 \| qkgA-2	aberrant aggregation \| decreased actin filament polymerization \| aberrant cytokinesis \| decreased cell motility \| decreased chemotaxis to cAMP
DBS0350011	qkgA-/ [act15]: bzpN: GFP	bzpN \| qkgA-1 \| qkgA-2	abolished negative regulation of vegetative growth
DBS0351560	qtrt1-	qtrt1	aberrant response to stimulus
DBS0350263	rab7A-	rab7A	decreased growth rate
DBS0236841	racB-	racB	decreased actin filament polymerization \| delayed aggregation \| aberrant fruiting body morphogenesis \| decreased chemotaxis rate \| decreased myosin II assembly
DBS0236842	racC-	racC	decreased protein localization to plasma membrane \| decreased actin filament polymerization \| aberrant cytokinesis \| aberrant stream morphology \| decreased chemotaxis rate \| aberrant cell morphology \| aberrant protein localization
DBS0350272	racC-	racC	aberrant cytokinesis \| decreased growth rate \| abolished positive regulation of chemorepellant activity
DBS0237191	racC-/ [act15]: CFP: racC	racC	increased actin filament polymerization
DBS0235413	racE-	racE	abolished cytokinesis \| aberrant cortical actin cytoskeleton organization \| abolished protein localization to cell cortex
DBS0350271	racE-	racE	decreased protein phosphorylation \| increased lateral pseudopodium formation \| aberrant cytokinesis \| delayed aggregation \| decreased growth rate \| aberrant regulation of GTPase activity \| aberrant protein localization to plasma membrane \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0351308	racE-	racE	aberrant cortical actin cytoskeleton organization \| abolished protein localization to cell cortex \| aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology
DBS0351348	racE-/ [act15]: GFP: racE(G20V)	racE	decreased protein phosphorylation \| decreased chemotaxis to cAMP
DBS0351349	racE-/ [act15]: GFP: racE(G23V)	racE	increased protein phosphorylation
DBS0351350	racE-/ [act15]: GFP: racE(S192D)	racE	increased protein phosphorylation \| wild type
DBS0351347	racE-/ [act15]: GFP: racE(T25N)	racE	wild type
DBS0351614	racE-/ [act15]: GFP: racE(T25N/ S192D)	racE	wild type
DBS0351351	racE-/ [act15]: GFP: rasC(Q62L)	racE \| rasC	decreased protein phosphorylation
DBS0349949	racE-/ [act15]: fttB	fttB \| racE	decreased growth rate
DBS0349946	racE-/ [act15]: fttB: GFP	fttB \| racE	abolished protein localization to cell cortex
DBS0350956	racE-/ [act15]racE(G20V)	racE	wild type
DBS0350957	racE-/ [act15]racE(T25N)	racE	abolished cytokinesis
DBS0351505	racF1-	racF1	wild type
DBS0236843	racF2-	racF2	increased mound size \| increased cell-cell adhesion \| decreased sexual fusion
DBS0236849	racG-	racG	decreased cell motility \| decreased protein localization to phagocytic vesicle
DBS0236850	racH-	racH	decreased exocytosis \| aberrant protein localization to cytoplasmic vesicle \| decreased pinocytosis \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| decreased defense response to bacterium
DBS0351149	rapC-	rapC	increased number of mound tips \| aberrant cytokinesis \| increased cell-substrate adhesion \| decreased cell motility \| aberrant cell morphology
DBS0266936	rapgap1-	rapgap1	decreased positive regulation of GTPase activity \| increased actin filament polymerization \| increased cell-substrate adhesion \| decreased cell motility \| decreased myosin II assembly \| increased protein kinase activation
DBS0266937	rapgap1-/ [act15]: GFP: rapgap1	rapgap1	increased positive regulation of GTPase activity \| increased lateral pseudopodium formation \| decreased cell-substrate adhesion \| increased myosin II assembly \| increased actin filament polymerization \| increased cell motility
DBS0351487	rapgap3-	rapgap3	increased cell motility \| increased activation of GTPase activity
DBS0350864	rapgap3-/ AX2	rapgap3	delayed aggregation \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0350863	rapgap3-/ KAX3	rapgap3	delayed development of tipped mound \| increased calcium-dependent cell-cell adhesion \| decreased cell motility \| aberrant cell migration to prestalk region \| aberrant regulation of GTPase activity
DBS0350316	rapgap9-	rapgap9	increased filopodium formation \| increased actin filament polymerization \| aberrant cytokinesis \| decreased spore size \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP
DBS0350317	rapgap9-/ [act15]: GFP: rapgap9	rapgap9	wild type
DBS0350628	rapgapB-	rapgapB	aberrant aggregation \| increased cell-substrate adhesion \| aberrant regulation of GTPase activity \| aberrant actin filament organization
DBS0350630	rapgapB-/ [ecmAO]: RFP	ecmA \| rapgapB	aberrant cell-cell adhesion
DBS0350631	rapgapB-/ [ecmA]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350632	rapgapB-/ [ecmO]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350629	rapgapB-/ [pspA]: RFP	pspA \| rapgapB	aberrant cell-cell adhesion
DBS0236852	rasB-	rasB	decreased growth rate
DBS0350836	rasB-	rasB	decreased phagocytosis \| decreased macropinocytosis \| aberrant actin filament organization
DBS0236853	rasC-/ AX2	rasC	increased rate of endocytosis \| aberrant response to cAMP \| decreased cell motility \| increased vegetative cell size \| abolished protein kinase activation \| decreased protein kinase activation \| decreased taxis \| abolished aggregation \| aberrant pseudopodium formation \| aberrant actin filament organization \| aberrant protein localization to cell cortex \| aberrant cellular response to extracellular stimulus
DBS0236854	rasC-/ JH10	rasC	wild type \| aberrant gene expression \| decreased protein kinase activation \| abolished aggregation \| abolished chemotaxis to cAMP
DBS0237614	rasC-/ [act15]: gbpD	gbpD \| rasC	increased cell-substrate adhesion \| aberrant cell morphology
DBS0350740	rasC-/ [rasC]: rasG	rasC \| rasG	abolished activation of adenylate cyclase activity \| abolished aggregation
DBS0350742	rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189)	rasC \| rasG	wild type
DBS0350741	rasC-/ [rasC]: rasG(D30A)	rasC \| rasG	aberrant aggregation \| decreased activation of adenylate cyclase activity
DBS0351213	rasC-[act15]: rasG(S17N)	rasC \| rasG	abolished activation of GTPase activity \| decreased chemotaxis to cAMP
DBS0236860	rasD-	rasD	aberrant thermotaxis \| aberrant phototaxis
DBS0351459	rasD-/ AX3	rasD	increased gene expression \| increased prespore cell differentiation
DBS0236862	rasG-/ AX2	rasG	decreased pinocytosis \| decreased gene expression \| delayed aggregation \| aberrant taxis \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| delayed gene expression
IR15	rasG-/ AX2	rasG	aberrant cell separation during cytokinesis \| aberrant filopodium formation \| decreased actin filament polymerization \| decreased growth rate \| increased vegetative cell size \| decreased macropinocytosis \| decreased cell motility \| decreased protein kinase activation \| decreased establishment of cell polarity \| aberrant actin filament organization
IR17	rasG-/ AX3	rasG	aberrant cytokinesis \| decreased cell motility \| increased vegetative cell size
DBS0351460	rasG-/ AX3	rasG	increased prestalk cell differentiation
DBS0236863	rasG-/ JH10	rasG	aberrant cell separation during cytokinesis \| wild type \| decreased gene expression \| delayed aggregation \| abolished activation of GTPase activity \| aberrant chemotaxis to folate \| decreased growth rate \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| delayed gene expression
DBS0236864	rasG-/ [OE]: rasB	rasB \| rasG	decreased growth rate
DBS0350572	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R)	rasG	aberrant cytokinesis
DBS0350571	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R,K179R,K180R,K184R)	rasG	decreased protein modification
DBS0350448	rasG-/ [dscB]: rasG(S17N)	rasG	decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| decreased protein kinase activation \| decreased chemotaxis to cAMP
DBS0236872	rasS-/ AX2	rasS	decreased macropinocytosis \| decreased cell motility \| aberrant pinosome maturation \| decreased establishment of cell polarity
DBS0351446	rasS-/ AX2	rasS	aberrant macropinocytosis
DBS0236873	rasS-/ DH1	rasS	decreased rate of endocytosis \| decreased growth rate \| increased actin filament polymerization \| abolished vegetative growth \| increased cell motility \| aberrant cytoskeleton organization
DBS0351314	rasS-/ DdB	rasS	decreased macropinocytosis \| increased cell motility
DBS0236874	rasZ-	rasZ	wild type
DBS0351598	rbdB-	rbdB	abolished pre-miRNA processing
DBS0350261	rbg3-	rbg3	precocious development \| increased growth rate
DBS0236877	rblA-	rblA	increased cell migration to prestalk region \| decreased spore germination \| decreased gene expression \| increased gene expression \| abolished negative regulation of vegetative growth \| decreased growth rate \| aberrant vegetative growth \| decreased vegetative cell size \| precocious development \| increased prestalk cell differentiation
DBS0349999	rblA-/ [act15]: GFP	rblA	increased cell migration to prestalk region
DBS0349996	rblA-/ [act15]: GFP/ [act15]: myc: btg	btg \| rblA	increased cell migration to prestalk region
DBS0236878	rbrA-	rbrA	increased gene expression \| decreased gene expression \| development arrests at slug stage \| aberrant prespore gene expression \| decreased cell migration to prestalk region \| decreased phototaxis \| decreased sporulation
DBS0236879	rbrA-/ [unk]: rbrA	rbrA	wild type
DBS0305613	rccA-	rccA	increased resistance to cheating during development
DBS0236880	rckA-	rckA	increased mound size \| precocious aggregation \| delayed slug development \| delayed prestalk gene expression \| delayed prespore gene expression \| increased chemotaxis rate
DBS0236885	rckA-/ [act15]: myc: rckA	rckA	delayed development \| decreased chemotaxis rate
DBS0236881	rckA-/ [act15]: myc: rckA(C551A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0236882	rckA-/ [act15]: myc: rckA(E510G)	rckA	wild type \| decreased chemotaxis rate
DBS0236883	rckA-/ [act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0236884	rckA-/ [act15]: myc: rckA(K867A)	rckA	development arrests at mound stage \| decreased chemotaxis rate
FR17	rdeA-	rdeA	precocious aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| precocious development \| precocious gene expression
WTC10	rdeA-	rdeA	aberrant chemotaxis to cAMP \| increased cAMP level \| decreased macropinocytosis
FR17	rdeA-	rdeA	precocious aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| precocious development \| precocious gene expression
DBS0236886	rdeA-/ [act15]: rdeA	rdeA	wild type
DBS0350468	rdiA-	rdiA	decreased pinocytosis \| decreased protein localization to cell cortex \| decreased protein level \| decreased actin filament polymerization \| aberrant contractile vacuole morphology \| decreased growth rate \| aberrant cytokinesis
DBS0351504	rdiA-	rdiA	aberrant cytokinesis
DBS0236887	recA-	recA	decreased resistance to hydrogen peroxide \| aberrant response to UV \| decreased resistance to mitomycin C
DBS0266664	redA-	redA	development arrests at mound stage \| aberrant mound color
DBS0350511	redA-	redA	decreased defense response to Gram-negative bacterium
DG1047	redA-	redA	development arrests at mound stage \| aberrant mound color
DBS0236889	regA-	regA	increased resistance to cisplatin \| aberrant chemotaxis to cAMP \| increased cAMP level \| aberrant fruiting body morphogenesis
DBS0236958	regA-	regA	decreased spore germination \| precocious sporulation \| abolished protein localization to cell cortex \| increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP
HM332	regA-	regA	decreased lateral pseudopodium retraction
HR45	regA-	regA	aberrant fruiting body morphogenesis
HM1015	regA-	regA	increased cAMP level \| decreased macropinocytosis \| aberrant oscillatory cAMP signaling
DBS0350372	regA-/ KAX3	regA	precocious sporulation \| increased sporulation
DBS0235706	regA-/ [act15]: dhkK(D1125N)	dhkK \| regA	aberrant fruiting body morphogenesis \| precocious development
DBS0235708	regA-/ [act15]: dhkK(H825Q)	dhkK \| regA	aberrant fruiting body morphogenesis \| precocious development
DBS0351475	regA-/ [act15]: erkA	erkA \| regA	delayed slug development
DBS0351472	regA-/ [act15]: regA(R588A,R589A,L594A,I595A,L596A)	regA	delayed development
DBS0351284	regA-/ [act15]: regA(S142A)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0351283	regA-/ [act15]: regA(S142E)	regA	delayed development
DBS0351285	regA-/ [act15]: regA(S413A)	regA	increased mound size \| delayed development
DBS0351286	regA-/ [act15]: regA(S413E)	regA	increased mound size \| delayed development
DBS0351287	regA-/ [act15]: regA(T676A)	regA	delayed sporulation
DBS0351288	regA-/ [act15]: regA(T676E)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0350689	regA-/ [regA]: regA	regA	wild type
DBS0350670	regA-/ [regA]: regA(D212N)	regA	precocious sporulation
DBS0351473	regA-/ regA(R588A,R589A,L594A,I595A,L596)	regA	precocious sporulation \| decreased mound size \| increased protein binding \| aberrant fruiting body morphogenesis
HM1351	rev3-	rev3	aberrant vegetative growth \| decreased resistance to cisplatin
HM1451	rev3-/ xpf-	rev3 \| xpf	decreased resistance to cisplatin
DBS0236893	rgaA-	rgaA	abolished cell migration to prestalk region \| aberrant cytokinesis \| abolished stalk cell differentiation \| decreased protein kinase activation \| abolished culmination \| decreased sporulation
DBS0349935	rgaA-	rgaA	aberrant stalk morphogenesis \| increased number of tip-organizers \| aberrant cellular response to fluid shear stress \| increased actin filament polymerization \| increased growth rate \| increased cell motility \| aberrant actin filament organization
DBS0350398	rgaA-	rgaA	increased lateral pseudopodium formation \| decreased myosin II assembly \| increased chemotaxis rate
DBS0349921	rgaA-/ [act15]: GFP-mhcA	rgaA	aberrant stalk morphogenesis \| aberrant development of tipped mound \| abolished protein localization to apical plasma membrane
DBS0351526	rgbA-/ AX2	rgbA	aberrant macropinocytosis \| aberrant activation of GTPase activity \| decreased macropinocytosis \| aberrant engulfment during phagocytosis \| decreased chemotaxis to folate
DBS0351527	rgbA-/ DdB	rgbA	aberrant macropinocytosis \| increased activation of GTPase activity
DBS0350019	rgfA-	rgfA	wild type
DBS0350020	rgfA-/ [act15]: rgfA	rgfA	decreased chemotaxis to folate \| delayed development
DBS0350108	rheb-	rheb	increased phagocytosis
DBS0236894	rhgA-	rhgA	wild type
DBS0350192	ric8-	ric8	abolished gene expression \| abolished chemotaxis to folate \| decreased chemotaxis to cAMP \| abolished aggregation \| aberrant signal transduction
DBS0350193	ric8-/ [act15]: GFP: ric8	ric8	wild type
DBS0236900	ripA-	ripA	decreased guanylyl cyclase activity \| abolished activation of adenylate cyclase activity \| decreased chemotaxis rate \| decreased taxis \| abolished aggregation \| decreased establishment of cell polarity \| aberrant regulation of protein kinase activity \| decreased myosin II assembly \| increased phagocytosis
DBS0350770	ripA-/ [act15]: GFP: rapA(G12V)	rapA \| ripA	decreased protein kinase activation
DBS0350115	ripA-/ [act15]: GFP: rheb(Q64L)	rheb \| ripA	increased phagocytosis
DBS0236902	ripA-/ [unk]: ripA(K680E/ R681E)	ripA	aberrant sorocarp development \| decreased chemotaxis rate
DBS0236901	ripA-/ [unk]ripA	ripA	wild type
DBS0351068	rnf113-	rnf113	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0351042	rnlA-	rnlA	decreased thermotaxis \| decreased growth rate \| decreased defense response to bacterium \| decreased phototaxis
DBS0236903	rnpA-	rnpA	increased gene expression
DBS0350096	roco11-	roco11	increased stalk length
DBS0350095	roco4-	roco4	delayed slug development \| aberrant stalk development \| delayed culmination
DBS0350100	roco4-/ [unk]: roco4(1018-1292(G1179S))	roco4	increased catalytic activity
DBS0350098	roco4-/ [unk]: roco4(1018-1292(S1187A))	roco4	abolished catalytic activity
DBS0350099	roco4-/ [unk]: roco4(1018-1292(S1189A))	roco4	decreased catalytic activity
DBS0238225	rpkA-	rpkA	development arrests at loose mound stage \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased phagocytosis \| decreased cell motility \| decreased establishment of cell polarity \| abolished aggregation \| aberrant cellular response to extracellular stimulus
DBS0236906	rrpA-	rrpA	abolished post-transciptional gene silencing by RNA
DBS0350209	rrpC-	rrpC	decreased gene expression \| increased gene expression
DBS0350219	rrpC-/ [act15]: pre-miRNA	rrpC	increased pre-miRNA processing
DBS0350216	rrpC-/ [act6]: LacZ/ [RNAi]lacZ	rrpC	abolished transitive RNA interference
DBS0350217	rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpC	aberrant production of siRNA involved in RNA interference
DBS0236875	rtoA-	rtoA	decreased rate of endocytosis \| increased defense response to Gram-negative bacterium \| increased prestalk cell differentiation \| delayed culmination
DBS0236911	rtoA-	rtoA	delayed development
DBS0236914	rzpA-	rzpA	aberrant aggregation \| decreased slug migration \| increased mound size \| increased prespore gene expression \| decreased prestalk gene expression \| delayed development
DBS0309040	sadA-	sadA	abolished protein localization to cell surface \| decreased phagocytosis \| decreased protein stabilization
DBS0236921	sadA-	sadA	abolished cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| increased growth rate \| aberrant actin filament organization \| aberrant cell morphology
DBS0350974	sadA-/ [act15]: gpaH	gpaH \| sadA	aberrant cytokinesis
DBS0349790	sadA-/ [act15]: sadA(1-923): GFP	sadA	decreased cell-substrate adhesion
DBS0349792	sadA-/ [act15]: sadA(S924A/ S925A): GFP	sadA	wild type
DBS0349791	sadA-/ [act15]: sadA(S924E/ S925E): GFP	sadA	decreased cell-substrate adhesion
DBS0236922	sadA-/ [act15]: sadA: GFP	sadA	wild type
DG1105	scaA-	scaA	abolished aggregation
DBS0350825	scaA-	scaA	decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| abolished activation of GTPase activity \| decreased protein kinase activation \| abolished aggregation
DBS0236924	scrA-	scrA	increased number of tip-organizers \| abolished protein localization to endolysosome \| decreased exocytosis \| decreased pinocytosis \| decreased actin filament polymerization \| increased lateral pseudopodium formation \| decreased phagocytosis \| decreased vegetative cell size \| decreased fruiting body size \| precocious development
IR46	scrA-	scrA	aberrant mitotic spindle organization \| aberrant cytokinesis \| abolished activation of GTPase activity \| decreased vegetative cell size \| decreased cell motility \| aberrant cellular response to stress \| aberrant pseudopodium formation \| increased bleb assembly \| abolished positive regulation of chemorepellant activity
IR48	scrA-	scrA	decreased growth rate \| aberrant cytokinesis \| decreased bleb assembly \| decreased phototaxis
DBS0236925	scrA-	scrA	increased filopodium formation \| decreased protein level \| aberrant macropinocytosis \| aberrant cytokinesis \| decreased macropinocytosis \| decreased cell motility \| aberrant actin filament organization \| aberrant pseudopodium formation
DBS0351524	scrA-/ [act15]: scrA(R177A,R179A,K180A,R183A,R184A,R187A,K190A,K191A,K194A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351611	scrA-/ [act15]: scrA(S287,290,301,335,339,384,388,389,430,432,433,437,440A)	scrA	aberrant pseudopodium formation
DBS0351522	scrA-/ [act15]: scrA(S430A,S432A,S433A,S437A,S440A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351523	scrA-/ [act15]: scrA(S430D,S432D,S433D,S437D,S440D)	scrA	decreased pseudopodium size
DBS0349927	scrA-/ [act15]: wasA: GFP/ [ act8]: RFP: arcD	scrA	decreased establishment of cell polarity \| decreased pseudopodium formation
DBS0350063	scrA-/ [tet]: scrA/ mhcA-	mhcA \| scrA	aberrant cytokinesis
DBS0351610	scrA-/ [tet]: scrA/ wasA-	scrA \| wasA	aberrant cell motility \| abolished vegetative growth \| abolished bleb assembly \| aberrant pseudopodium formation
DBS0238440	scrA-/ [unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis \| increased vegetative cell size \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0238446	scrA-/ [unk]: scrA: GFP	scrA	wild type
HM1163	sec1-/ sec1(M213K/ E258G/ M427V/ K527I/ T541N/ F558S/ N581D)	sec1	abolished cell motility
HM1325	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)	sec1	abolished cytokinesis \| aberrant hypotonic response \| abolished cell motility \| aberrant plasma membrane organization \| aberrant cell morphology
DBS0350286	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)/ gppA: GFP	gppA \| sec1	abolished contractile vacuole discharge
DBS0350101	sec7-	sec7	aberrant cell motility \| decreased phagocytosis \| decreased growth rate \| aberrant phototaxis \| decreased protein secretion
DBS0306234	secG-	secG	decreased cell-substrate adhesion \| decreased chemotaxis rate
DBS0351035	seiP-	seiP	aberrant lipid droplet formation
DBS0350264	sepA-	sepA	aberrant cytokinesis \| delayed aggregation \| decreased growth rate \| decreased fruiting body size
DBS0351077	sepA-	sepA	aberrant gene expression \| increased cell-substrate adhesion \| decreased cell motility
DBS0350906	sepA-	sepA	decreased protein phosphorylation \| aberrant pseudopodium formation
DBS0351252	sesn-	sesn	increased mound size \| aberrant standing slug morphology \| decreased gene expression \| decreased autophagy \| aberrant response to oxidative stress
DBS0236928	set1-	set1	precocious aggregation \| abolished histone H3-K4 methylation \| precocious gene expression
DG1008	sfbA-	sfbA	decreased fruiting body size
DBS0350889	sgcA-/ AX2	sgcA	aberrant aggregation \| decreased guanylyl cyclase activity \| aberrant chemotaxis to cAMP
DBS0350888	sgcA-/ AX3	sgcA	aberrant aggregation \| decreased guanylyl cyclase activity \| aberrant chemotaxis to cAMP
SA576	sgkA-	sgkA	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
HM1091	sgkB-	sgkB	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
SA555	sglA-	sglA	increased stalk width \| increased resistance to cisplatin \| increased mound size \| decreased lateral pseudopodium retraction \| decreased gene expression \| abolished slug migration \| decreased cell motility \| decreased chemotaxis rate \| decreased fruiting body size \| aberrant cytoskeleton organization \| decreased sporulation \| increased resistance to carboplatin
SA554	sglA-	sglA	delayed aggregation \| decreased mound size
DBS0236934	shkA-	shkA	aberrant aggregation \| decreased phagocytosis \| aberrant cytokinesis \| decreased chemotaxis rate \| decreased fruiting body size \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0236935	sibA-	sibA	decreased cell-substrate adhesion \| decreased phagocytosis
DBS0302653	sibC-	sibC	decreased phagocytosis
DBS0236936	sigB-	sigB	wild type
DBS0236937	sigD-	sigD	wild type
DBS0351170	sir2A-	sir2A	abolished slug migration \| increased number of mound tips \| increased gene expression \| decreased gene expression \| decreased growth rate \| aberrant sorocarp development \| decreased autophagy \| decreased chemotaxis to cAMP \| decreased cAMP level
DBS0350859	sir2D-	sir2D	decreased gene expression \| increased gene expression \| increased number of mound tips \| delayed aggregation \| decreased growth rate \| decreased autophagy \| decreased mound size \| decreased stalk length
DBS0350860	sir2D-/ [ecmAO]: lacZ	sir2D	decreased prestalk cell differentiation
DBS0350861	sir2D-/ [pspA]: lacZ	sir2D	aberrant prespore cell differentiation
DBS0350985	slc4-	slc4	aberrant transport
DBS0349958	sma-	sma	increased chemotaxis to folate \| decreased gene expression \| increased cell-substrate adhesion \| decreased vegetative cell size \| increased cell-cell adhesion
DBS0349957	sma-/ ampA/ [ampA]: ampA	ampA \| sma	decreased chemotaxis to folate
DBS0350327	smdA-/ [pspA]: lacZ	smdA	aberrant gene expression
DBS0236938	smkA-	smkA	aberrant cytokinesis \| delayed development \| decreased chemotaxis rate \| decreased myosin II assembly
HDB7YA	smlA-	smlA	increased oscillatory cAMP signaling \| decreased cell-cell adhesion \| aberrant cellular metabolic process \| decreased response to Gram-negative bacterium \| increased resistance to cisplatin \| decreased protein level \| decreased guanylyl cyclase activity \| increased myosin II assembly \| increased actin filament polymerization \| decreased cGMP-mediated signaling \| decreased mound size \| increased protein level \| decreased secretion of lysosomal enzymes \| increased cell motility \| decreased fruiting body size
DBS0304496	smlA-/ sslA1(CR11)	smlA \| sslA1	increased fruiting body size
DBS0350977	snfA-	snfA	decreased pinocytosis \| increased cell death \| decreased autophagic cell death \| decreased phagocytosis \| decreased number of autophagosomes \| aberrant sorocarp development \| decreased prespore cell differentiation \| aberrant gene expression \| aberrant protein modification \| increased growth rate \| aberrant prestalk cell differentiation \| aberrant sporulation
DBS0302523	sodC-	sodC	aberrant cytokinesis
DBS0302524	sodC-	sodC	aberrant aggregation \| decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| increased actin filament polymerization \| aberrant chemotaxis to cAMP \| increased protein localization to plasma membrane \| decreased chemotaxis rate \| aberrant regulation of GTPase activity \| aberrant protein localization to plasma membrane \| aberrant cell morphology \| increased protein kinase activation
DBS0351063	sodC-/ [unk]: rasG(C118A)	rasG \| sodC	aberrant regulation of GTPase activity
DBS0350894	sodD-	sodD	aberrant response to UV
DBS0351196	sogA-	sogA	aberrant chemotaxis to cAMP \| increased activation of GTPase activity
DBS0350966	spaA-	spaA	abolished sporulation
AK1346	spc3-	spc3	decreased response to Gram-negative bacterium
DBS0350891	spdA-	spdA	decreased substrate adhesion-dependent cell spreading \| decreased phagocytosis
HL351	spiA-	spiA	decreased spore germination
DBS0236945	splA-	splA	abolished sporulation \| aberrant spore morphology \| increased sorus size \| aberrant sorus color \| decreased stalk length
DBS0350131	splB-	splB	abolished protein tyrosine phosphorylation \| abolished protein localization to nucleus \| abolished response to DIF-1 \| decreased gene expression
DBS0236947	spnA-	spnA	abolished prespore cell differentiation \| development arrests at mound stage \| abolished prestalk cell differentiation \| aberrant sorocarp development
DBS0236949	spr-	spr	decreased spore germination \| decreased pteridine level \| decreased cytochrome C oxidase activity \| decreased growth rate
DBS0350914	spsA-	spsA	decreased stalk length
DBS0351174	srcp1-	srcp1	aberrant protein modification
DBS0236950	srfA(1-8): lacZ	srfA	decreased slug migration \| aberrant fruiting body morphogenesis \| delayed culmination
DBS0236951	srfA-	srfA	aberrant spore morphology \| decreased spore germination \| aberrant spore coat morphology \| decreased gene expression
DBS0266691	srfB-	srfB	abolished stream development \| aberrant extracellular cAMP signaling pathway \| increased lateral pseudopodium formation \| precocious aggregation \| decreased growth rate \| increased pinocytosis \| aberrant cytokinesis \| precocious gene expression
DBS0304409	srsA-	srsA	increased mound size \| decreased gene expression \| increased gene expression \| delayed aggregation
DBS0236952	stkA-	stkA	decreased gene expression \| increased prestalk gene expression \| delayed prespore gene expression \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation
HM1157	stlA-	stlA	aberrant aggregation \| abolished sporulation \| wild type \| increased gene expression \| decreased gene expression \| aberrant stream morphology \| decreased spore cell differentiation \| decreased chemotaxis to cAMP \| aberrant sorus color \| abolished MPBD level \| decreased cAMP level \| aberrant sporulation
DBS0350222	stlA-/ [cotB]: lacZ	stlA	decreased sporulation \| aberrant prespore cell differentiation
HM1154	stlB-	stlB	abolished DIF-1 biosynthesis \| abolished prestalk B cell differentiation \| aberrant gene expression \| aberrant fruiting body morphogenesis \| decreased prestalk O cell differentiation \| abolished lower cup formation \| abolished outer basal disc formation \| decreased prestalk cell differentiation
DBS0351220	stlB-	stlB	abolished autophagosome organization \| abolished autophagic cell death
DBS0350409	stlB-/ [act15]: stlB	stlB	wild type
DBS0304547	svkA-	svkA	delayed cell separation during cytokinesis \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0236055	swip-	swip	aberrant protein localization to cytoplasm \| abolished exocytosis \| abolished phagosome reneutralization \| abolished actin filament polymerization \| aberrant protein localization
AK1321	swp1-	swp1	decreased response to Gram-positive bacterium
AK1200	tagA-	tagA	decreased spore cell differentiation \| aberrant fruiting body morphogenesis
AK859	tagA-	tagA	decreased spore germination \| increased number of mound tips \| decreased spore cell differentiation \| increased prestalk A cell differentiation \| delayed culmination \| decreased sporulation
AK1201	tagA-/ [ecmA]: GFP	tagA	abolished cell migration to prestalk region
AK228	tagB-	tagB	abolished sporulation \| abolished DIF-1 biosynthesis \| development arrests at mound stage \| aberrant prestalk A cell differentiation
DBS0350637	tagB-/ [pkaC]: pkaC	pkaC \| tagB	aberrant response to biotic stimulus \| abolished spore cell differentiation
DBS0236975	tagC-	tagC	abolished sporulation \| development arrests at mound stage
DBS0350698	tagC-/ [pkaC]: pkaC	pkaC \| tagC	development arrests at mound stage \| abolished spore cell differentiation
DBS0236976	talA-	talA	decreased protein level \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HG1666	talA-	talA	decreased cell-cell adhesion \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased cell-substrate adhesion
HG1663	talA-	talA	decreased cell-substrate adhesion
HG1664	talA-	talA	decreased uropod retraction \| decreased growth rate \| decreased phagocytosis \| aberrant mitotic actomyosin contractile ring contraction
HG1665	talA-	talA	decreased cell-cell adhesion \| aberrant cytokinesis
DBS0304585	talA-/ [act15]: FLAG: talB	talA \| talB	decreased cell-substrate adhesion
DBS0237616	talA-/ [act15]: gbpD	gbpD \| talA	increased cell-substrate adhesion \| aberrant cell morphology \| increased pseudopodium formation
DBS0238395	talA-/ [act15]: rapA(G12V)	rapA \| talA	increased cell-substrate adhesion
DBS0304582	talA-/ talB-/ [act15]: FLAG: talB	talA \| talB	wild type
HKT104	talB-	talB	decreased slug migration \| aberrant extracellular cAMP signaling pathway \| aberrant cellular process \| decreased cell motility \| development arrests at tipped mound stage \| increased protein level \| aberrant signal transduction
DBS0302472	talB-	talB	abolished autophagosome organization \| abolished autophagic cell death \| aberrant autophagic cell death
DBS0304586	talB-/ [act15]: talA: GFP	talA \| talB	aberrant fruiting body morphogenesis
DBS0350712	talB-/ [act15]: talB(K16A)	talB	development arrests at tipped mound stage
DBS0351346	tert-	tert	increased gene expression \| decreased gene expression \| aberrant cell adhesion \| aberrant chemotaxis to cAMP \| aberrant sorocarp development \| delayed development \| aberrant oscillatory cAMP signaling \| decreased cAMP level
DBS0351559	tert-	tert	decreased catalytic activity \| increased gene expression
AK1505	tgrB1-	tgrB1	development arrests at loose mound stage \| delayed sporulation \| decreased cell motility \| decreased sporulation
AK127	tgrC1-	tgrC1	development arrests at loose mound stage \| aberrant aggregation \| abolished gene expression \| increased mound size \| decreased gene expression
AK1521	tgrC1-	tgrC1	abolished sporulation \| development arrests at loose mound stage \| decreased cell motility
AK1657	tgrC1-/ (QS38\|tgrC1)/ alg9(-19ins)	alg9 \| tgrC1	delayed development \| decreased fruiting body size \| decreased sporulation
AK1661	tgrC1-/ alg9(-19ins)	alg9 \| tgrC1	delayed development \| decreased fruiting body size \| decreased sporulation
DBS0350743	tgrC1-/ alg9(-19ins)-REMI	alg9 \| tgrC1	decreased sporulation
DBS0350625	tgrC1-/ stcA-	stcA \| tgrC1	decreased mound size \| delayed development \| decreased sporulation
DBS0350626	tgrC1-/ stcB-	stcB \| tgrC1	decreased mound size \| delayed development \| decreased sporulation
DBS0350627	tgrC1-/ stcC-	stcC \| tgrC1	aberrant stream morphology \| delayed development \| decreased fruiting body size \| decreased sporulation
AK244	tipA-	tipA	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| decreased prestalk gene expression
DBS0351500	tipB-	tipB	increased number of mound tips
JS56	tipB-	tipB	increased number of tip-organizers \| increased mound size \| increased number of mound tips \| development arrests at mound stage
JS55	tipC-	tipC	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| decreased number of autophagosomes \| decreased autophagy
DBS0350729	tipC-/ [unk]: tipC(2725-3848): GFP	tipC	decreased fruiting body size
JS93	tipD-	tipD	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| aberrant vacuole organization \| decreased autophagy
DBS0350730	tipD-	tipD	decreased pinocytosis \| increased cell death \| decreased spore germination \| decreased catalytic activity \| increased gene expression \| increased number of mound tips \| increased protein modification \| aberrant phagosome maturation \| aberrant slug development \| aberrant fruiting body morphogenesis \| abolished protein localization to autophagosome
DBS0304519	tirA-	tirA	decreased response to Gram-negative bacterium \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| decreased growth rate \| aberrant phagocytosis \| aberrant vegetative growth
YLD31A	tlp2-	tlp2	decreased growth rate
DBS0236016	tmcB-/ V12	tmcB	decreased macrocyst size \| aberrant macrocyst formation
DBS0236018	tmcC-/ V12	tmcC	aberrant macrocyst formation
DBS0350285	tom1-	tom1	decreased rate of endocytosis
DBS0237017	torA-	torA	delayed aggregation \| decreased growth rate \| decreased cell motility \| decreased chemotaxis rate
DBS0237018	torA-/ [act15]: torA: GFP	torA	abolished vegetative growth
DBS0351498	tpc2-	tpc2	increased number of autophagosomes \| increased gene expression \| decreased gene expression \| aberrant vegetative growth \| aberrant calcium-mediated signaling \| increased protein kinase activity \| delayed development \| increased lysosomal pH
DBS0350506	tpp1-	tpp1	aberrant response to chemical
DBS0350504	tpp1-	tpp1	increased autophagic cell death \| decreased catalytic activity \| aberrant response to chemical \| aberrant cell morphology \| precocious development \| decreased sporulation
DBS0350505	tpp1-/ [cotB]: tpp1	tpp1	wild type
DBS0351017	tpp1F-	tpp1F	wild type
DBS0351558	tpt1-	tpt1	decreased spore germination \| decreased gene expression \| decreased growth rate \| aberrant cytokinesis \| decreased number of mounds \| decreased macropinocytosis \| delayed development \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation
DBS0351265	trfA-	trfA	aberrant aggregation \| aberrant vegetative growth \| decreased chemotaxis to cAMP
DBS0237924	triA-	triA	decreased cell-cell adhesion \| increased stalk width \| increased number of mounds \| decreased spore germination \| aberrant upper cup formation \| aberrant cell motility \| aberrant stream morphology \| decreased spore size \| decreased cell fate determination \| aberrant late culminant morphology
DBS0237996	triA-	triA	aberrant late culminant morphology
DBS0237997	triA-	triA	aberrant late culminant morphology
DBS0237998	triA-/ [act15]: GFP	triA	aberrant late culminant morphology
DBS0237999	triA-/ [ecmAO]: lacZ: [ecmAO]: gus	triA	increased prestalk O cell differentiation
DBS0238001	triA-/ [psA]: lacZ: [psA]: gus	triA	increased prespore cell differentiation
DBS0351605	trm9-	trm9	decreased protein level
DBS0350107	tsc2-	tsc2	decreased phagocytosis
DBS0237022	tsg101-	tsg101	decreased fruiting body size
DBS0351612	tsg101-	tsg101	aberrant cellular process \| decreased protein localization \| increased defense response to Gram-positive bacterium
DBS0350816	tspC-	tspC	aberrant response to osmotic stress
HM1725	tstD-	tstD	decreased growth rate \| decreased plasma membrane organization \| increased growth rate
DBS0302370	tsuA-	tsuA	increased oscillatory cAMP signaling \| abolished establishment of cell polarity \| aberrant chemotaxis to folate \| aberrant chemotaxis to cAMP \| delayed aggregation \| decreased mound size \| decreased fruiting body size \| aberrant pseudopodium formation
DBS0302383	tsuA-/ [unk]: tsuA(1-1774): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302385	tsuA-/ [unk]: tsuA(1-260): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302384	tsuA-/ [unk]: tsuA(1774-2247): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302382	tsuA-/ [unk]: tsuA(K34R): YFP	tsuA	decreased mound size \| decreased fruiting body size
DBS0302381	tsuA-/ [unk]: tsuA: YFP	tsuA	wild type
DBS0237024	ubcB-	ubcB	increased number of tip-organizers \| development arrests at mound stage
DBS0306165	ube2t-	ube2t	decreased resistance to cisplatin
DBS0237025	ubpA-	ubpA	decreased gene expression \| decreased chemotaxis rate \| abolished aggregation
DBS0237026	ubpB-	ubpB	aberrant sorus morphology \| increased prestalk gene expression \| decreased prespore gene expression \| precocious development
DBS0351464	uduB-/ AX3	uduB	increased prestalk cell differentiation
DBS0237027	ufc1-	ufc1	wild type
DBS0237028	ugpB-/ DH1	ugpB	abolished sporulation \| decreased glycogen level \| aberrant cell differentiation \| decreased fruiting body size \| delayed culmination
DBS0266763	ugpB-/ DH1	ugpB	decreased stalk length
DBS0266764	ugpB-/ HMX	ugpB	abolished cellulose biosynthesis \| decreased autophagic vacuole organization \| aberrant cell morphology
DBS0350591	uppA-	uppA	decreased catalytic activity
DBS0237031	vacA-	vacA	wild type
DBS0351567	vacA-	vacA	decreased phagocytosis
DBS0237032	vacB-	vacB	decreased exocytosis \| increased defense response to bacterium
DBS0351568	vacB-	vacB	decreased phagocytosis
DBS0351570	vacB-/ vacC-	vacB \| vacC	decreased phagocytosis
DBS0351569	vacC-	vacC	decreased phagocytosis
DBS0237034	vasP-	vasP	abolished filopodium formation
DBS0237035	vasP-	vasP	decreased lateral pseudopodium retraction \| decreased cell-substrate adhesion \| decreased vegetative cell size \| decreased cell motility \| decreased chemotaxis rate \| aberrant hyperosmotic response \| aberrant actin filament organization \| decreased chemotaxis to cAMP \| abolished filopodium formation \| decreased filopodium formation
DBS0237033	vasP-/ [act15]: GFP: vasP(1-264/ 285-380)	vasP	abolished filopodium formation
DBS0237836	vasP-/ [act15]: YFP: wipA	vasP \| wipA	decreased filopodium formation
DBS0237842	vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG	vasP \| wipA	increased filopodium formation
DBS0351313	vasP-/ [act15]: abpB(129-295)	abpB \| vasP	aberrant cellular process
DBS0351300	vasP-/ [act15]: eYFP: vasP(S141A)	vasP	decreased protein localization to cell cortex \| wild type \| decreased lateral pseudopodium retraction \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0351301	vasP-/ [act15]: eYFP: vasP(S141D)	vasP	aberrant hyperosmotic response \| decreased filopodium formation
DBS0237036	vasP-/ [act15]: myr: vasP	vasP	increased filopodium formation \| aberrant cytokinesis \| increased actin filament polymerization
DBS0237040	vasP-/ [act15]: vasP	vasP	decreased filopodium formation
DBS0237840	vasP-/ [act15]: vasP	vasP	increased filopodium formation \| increased actin filament polymerization
DBS0237037	vasP-/ [act15]: vasP(1-110: 231-380)	vasP	aberrant cytokinesis \| increased actin filament polymerization \| decreased filopodium formation
DBS0237038	vasP-/ [act15]: vasP(1-228)	vasP	decreased filopodium formation
DBS0237039	vasP-/ [act15]: vasP(111-380)	vasP	increased filopodium formation \| increased actin filament polymerization
DBS0350466	vasP-/ [unk]: vasP(1-197: 221-380)	vasP	wild type
DBS0350467	vasP-/ [unk]: vasP(1-261: 285-380)	vasP	decreased cell motility \| abolished filopodium formation
DBS0350602	vilA-	vilA	decreased chemotaxis to cAMP \| decreased phototaxis
DBS0236058	vmp1-	vmp1	aberrant aggregation \| decreased exocytosis \| increased cell death \| aberrant autophagy \| decreased gene expression \| decreased growth rate \| aberrant hypotonic response \| decreased macropinocytosis \| aberrant vacuole organization \| aberrant protein localization to autophagosome \| aberrant protein localization \| aberrant signal transduction
DBS0351250	vmp1-/ [act15]: vmp1(G268L): GFP	vmp1	aberrant aggregation \| aberrant protein localization to autophagosome
DBS0350873	vps13F-	vps13F	aberrant defense response to bacterium \| decreased growth rate
DG1118	vps46-	vps46	increased sorus size
DBS0237046	vwkA-	vwkA	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis \| aberrant contractile vacuole morphology \| aberrant hypotonic response \| delayed development \| increased protein level \| aberrant fruiting body morphogenesis \| decreased contractile vacuole discharge
DBS0350290	vwkA-/ [act15]: GFP: mhcA	mhcA \| vwkA	aberrant myosin II filament organization
TL61	wacA-	wacA	wild type
TL99	wacA-	wacA	wild type
DBS0237048	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0237049	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0351506	wasA-	wasA	aberrant protein localization to trailing edge
DBS0351509	wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A)	scrA \| wasA	aberrant pseudopodium formation
DBS0351508	wasA-/ [unk]: GFP: wasA(I173A/ F179A)	wasA	aberrant protein localization to trailing edge \| decreased establishment of cell polarity
DBS0350254	wasB-	wasB	abolished protein localization to cytoplasmic vesicle \| aberrant chemotaxis to cAMP \| increased actin filament polymerization \| increased protein level \| aberrant pseudopodium formation
DBS0350255	wasB-/ [act15]: YFP: wasB	wasB	wild type
DBS0351525	wasC-	wasC	increased actin filament polymerization \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate
DBS0350239	washc5-	washc5	abolished exocytosis \| decreased protein level \| decreased growth rate \| decreased phagocytosis \| aberrant endosome morphology \| decreased vegetative cell size \| abolished phagosome reneutralization \| decreased secretion of lysosomal enzymes \| abolished actin filament polymerization \| aberrant lysosome organization
DBS0351185	washc5-/ [act15]: washc5(N457D): GFP	washc5	abolished exocytosis
DG1053	wimA-	wimA	aberrant fruiting body morphogenesis
DG1064	wimA-	wimA	aberrant fruiting body morphogenesis
DBS0349863	wshA-	wshA	increased protein localization \| abolished exocytosis \| decreased defense response to Gram-negative bacterium \| decreased macroautophagy \| abolished endocytic recycling \| aberrant vegetative growth \| decreased phagocytosis \| decreased protein processing in phagocytic vesicle \| aberrant phagosome maturation \| abolished phagosome reneutralization \| decreased secretion of lysosomal enzymes \| increased defense response to Gram-positive bacterium \| decreased protein localization \| aberrant lysosome organization \| aberrant protein localization
DBS0350943	xacA-	xacA	decreased hypotonic response \| aberrant contractile vacuole morphology \| aberrant actin filament organization
DBS0350950	xacA-	xacA	increased lateral pseudopodium formation \| decreased chemotaxis to cAMP \| aberrant actin filament organization
DBS0350944	xacA-/ [act15]: xacA(1-320)	xacA	decreased growth rate \| aberrant cytokinesis
DBS0350945	xacA-/ [act15]: xacA(779-1335)	xacA	decreased hypotonic response \| aberrant contractile vacuole morphology
HM1456	xpc-	xpc	wild type \| aberrant vegetative growth
HM1403	xpf-	xpf	aberrant vegetative growth \| decreased resistance to cisplatin
AK235	yakA-	yakA	abolished aggregation
AK800	yakA-	yakA	decreased protein localization to cell cortex \| decreased gene expression \| aberrant cell cycle \| increased cellular thermotolerance \| aberrant gene expression \| decreased protein kinase activation \| abolished aggregation \| aberrant response to oxidative stress \| aberrant cellular response to stress \| decreased cAMP level
DBS0237087	yakA-/ AX3	yakA	decreased growth rate \| abolished aggregation \| abolished actin filament polymerization \| decreased cGMP biosynthesis
DBS0237091	yakA-/ [crlA]: crlA	crlA \| yakA	abolished vegetative growth
DBS0350058	yakA-/ keaA-	keaA \| yakA	wild type
DBS0350898	yelA-/ AX2	yelA	precocious prestalk gene expression \| increased basal disc size
DG1014	yelA-/ AX4	yelA	aberrant spore morphology \| precocious sporulation \| development arrests at mound stage \| aberrant mound color \| aberrant sporulation
DBS0349797	zak2-	zak2	decreased prespore gene expression \| decreased protein kinase activation \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0349883	zak2-/ [act15]: GFP	zak2	decreased sporulation
DBS0349798	zak2-/ [ecmA]: LacZ	zak2	aberrant prestalk gene expression
DBS0349882	zak2-/ [ecmA]: zakA	zak2 \| zakA	precocious prestalk gene expression
ARK100-110	zakA-	zakA	abolished stream development \| decreased protein kinase activity \| increased prestalk gene expression \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| decreased chemotaxis to cAMP \| delayed culmination \| decreased sporulation
DBS0238142	zakA-	zakA	development arrests at tipped mound stage
DBS0349803	zakA-/ [ecmB]: LacZ	zakA	aberrant prestalk gene expression
DG1050	zipA-	zipA	decreased fruiting body size
DBS0350068	zizB-	zizB	aberrant fruiting body morphogenesis \| delayed development \| decreased chemotaxis to cAMP

Last updated July 28, 2024